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Abstract
Scavenger receptors are cell surface molecules which avidly bind modified
lipoproteins and a broad range of other polyanionic molecules and macromolecular
complexes. To better understand the structural basis for the ligand specificity of
mammalian class A macrophage scavenger receptors (SR-A), I have examined the
ability of these receptors to distinguish polynucleotide ligands (poly(l) and poly(G))
from polynucleotides which are not ligands (poly(A) and poly(C)). I found that only
those poly- and oligonucleotides which can form four-stranded helical structures are
SR-AI ligands. Binding of these molecules is reversibly disrupted by denaturing, and
then renaturing, their quadruplex structure. Presumably, this structure generates a
negatively charged surface complementary to the positively charged collagenous
ligand-binding domain of SR-AI. The in vivo functions of the predominantly
macrophage-expressed SR-A receptors are largely unknown. Their broad ligand
binding specificity, and their ability to bind microbial surface constituents, suggests that
these receptors might be pattern recognition receptors involved in the rapid and direct
recognition of pathogenic microorganisms during innate immune responses. Since
innate immunity is evolutionarily ancient, pattern recognition receptors might also exist
in invertebrates such as Drosophila melanogaster. Interestingly, Drosophila embryos,
and a hemocyte-derived Drosophila cell line, exhibit an SR-A-like activity. To gain a
better understanding of the in vivo function(s) of scavenger receptors, a gene was
isolated whose product can account for at least some of this scavenger receptor
activity. This gene, dSR-CI, defines a new class of scavenger receptor which is
structurally unrelated to the SR-As. dSR-CI is expressed throughout development,
and in embryos is expressed specifically by hemocytes and macrophages. dSR-CI
recognizes not only a broad range of polyanionic molecules, but also the microbial 8-
glucan laminarin, a potent inducer of the Drosophila immune response. dSR-CI might
therefore play an important role in Drosophila host defense. During work toward
isolating dSR-CI mutants, two dSR-CI - related genes were discovered which are
expressed during distinct stages of Drosophila development. Future work on thedSR-
Cl gene, and perhaps also on other members of the dSR-C gene family, should
provide new insights into the functions of the dSR-CI protein during Drosophila
development and host defense.
Thesis Supervisor: Dr. Monty Krieger
Title: Professor of Biology
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Introduction
The circulating monocytes and tissue macrophages of mammals, and the
hemocytes of invertebrates, mediate many of the innate immune responses to
microbial infection (Gordon et al, 1988; Hultmark, 1993; Hoffmann, 1995). In some
cases, these evolutionarily ancient phagocytic cells recognize and engulf pathogens
which have been opsonized by serum proteins such as complement (Gordon et al,
1988). However, macrophages and hemocytes can also bind pathogens directly, and
this direct recognition plays a crucial role in host defense (Gordon et al, 1988;
Janeway, 1989, 1992; Hultmark, 1993). Janeway (1989, 1992) has proposed that
activation of the innate, or non-adaptive, immune system (and importantly, also of the
adaptive immune system; see also Ibrahim et al, 1995; Fearon and Locksley, 1996) is
initiated when pathogens bind to non-clonally distributed "pattern recognition
receptors" on immune cells. These receptors are proposed to exhibit binding
specificities for structural patterns typically displayed by the surface molecules of many
microorganisms (e.g. lipopolysaccharides (LPS, endotoxin), glucans), patterns which
are not normally found on host cells. By virtue of their ability to mediate pathogen
binding, pattern recognition receptors should, in principle, be able to participate both
in the activation of innate immune cells and in the effector mechanisms (e. g.
phagocytosis) these cells employ.
Several soluble and membrane-bound mammalian proteins, including the
mannose receptor (Ezekowitz et al, 1991; Drickamer and Taylor, 1993), the collectins(Epstein et al, 1996), the 82 integrins CR3 (CD1 1 b/CD18; CR = complement receptor)(Thornton et al, 1996) and CR4 (CD 1 c/CD18) (Ingalls and Golenbock, 1995), and the
LPS receptor CD14 (Pugin et al, 1994; Kusunoki et al, 1996) exhibit the properties of
pattern recognition molecules. A common theme among all of these molecules
appears to be their ability to recognize non-self carbohydrate and lipid structures
including LPS, lipoteichoic acids, mannans and glucans (Janeway, 1989; Fearon and
Locksley, 1996; Epstein et al, 1996). CR3, which mediates macrophage and
polymorphonuclear leukocyte (PMN, neutrophil) engulfment of particles coated with
complement component C3, provides a particularly interesting example of the
importance of pattern recognition for eliciting an immune response: PMN readily kill
iC3b-osponized yeast, but do not lyse iC3b-opsonized erythrocytes or kill iC3b
opsonized tumor cells. However, if the PMN are incubated with soluble yeast 13-
glucans, which bind directly to CR3 (Thornton et al, 1996), the receptor is primed and
can subsequently mediate the lysis and killing of iC3b coated erythrocytes and tumor
cells (Vetvicka et al, 1996). Thus, the CR3 mediated cytotoxic activity of PMN requires
the direct recognition by CR3 of a molecular pattern found only on non-self cells.
Several invertebrate proteins have also been postulated to be pattern recognition
receptors which may participate in hemocyte activation (see Chapter 3), including a
crayfish protein with integrin-like characteristics (Duvic and Sbderhall, 1992;
S6derhall, 1992).
Scavenger receptors (SRs) have been suggested to be attractive candidates for
another class of non-self pattern recognition receptors (Freeman et al, 1990; Abrams
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et al, 1992; Janeway, 1992; Hultmark, 1993; Krieger and Herz, 1994; Hoffmann, 1995;
Pearson et al, 1995). This suggestion has been based on several findings. First, SRs
receptors exhibit broad ligand binding specificity (Table 1), a characteristic feature of
pattern recognition receptors. Second, some SRs can bind both microbial surface
molecules and intact bacteria. Third, SRs are expressed by macrophages, hemocytes,
and other immunologically relevant cells. Fourth, SR activity is evolutionarily ancient(Abrams et al, 1992). In addition to their pattern recognition receptor-like properties,
some SRs exhibit adhesion molecule-like activities.
Until recently, only two SRs were known, both products of the same gene. In
the last three years several additional SR genes have been identified, establishing
four independent SR classes (Figure 1, see Acton et al, 1994, for definition of classes).Scavenger receptors have historically been defined by their ability to bind modified
low density lipoproteins (LDLs), such as oxidized LDL (OxLDL) and acetylated LDL(AcLDL), and they were initially studied primarily for their potential role in
atherogenesis, during which lipoprotein-derived cholesterol accumulates in the cells
of the arterial wall (Krieger and Herz, 1994). In later chapters, I will discuss my
experimental work on the class A and class C scavenger receptors. This chapter,
which is an updated and expanded version of a review recently published in Current
Opinion in Immunology (Pearson, 1996), will review recent developments in the SR
field, in particular as they relate to the potential roles of SRs in host defense. The
original publication is included in this thesis as Appendix A. A significant amount of
the discussion regarding the Drosophila class C SR which was included in the
originally published review has now been moved to Chapter 3 of this thesis, where it
more appropriately belongs. Finally, a note of caution is appropriate here: many
findings have "raised the possibility" that SRs may participate, either directly or
indirectly, in one or another of a variety of different host defense related processes.
Almost all of these possibilities have been based upon 1)in vitro observations that a
particular molecule or class of molecules can bind to SRs, 2) in vitro observations of
the effects of one or another treatment (e.g. cytokine, LPS) on SR expression, or 3)
observations of the in vivo patterns of receptor expression. Until very recently, there
has been very little genetic or pharmacologic evidence which would argue for or
against any of the suggested SR functions. Until such evidence can be obtained, most
of the functions which have been suggested for SRs, and which will be described
below, will remain simply suggestions. However, these suggestions provide a
valuable source of hypotheses which can be tested as genetic models become
available for study.
Scavenger Receptor Classes
The two class A SRs, SR-AI and SR-AII, were the first macrophage SRs to be
identified (Kodama et al, 1990; Rohrer et al, 1990) (see Krieger and Herz, 1994, for a
recent review). These receptors comprise six domains, including extracellular a-
helical coiled-coil and collagenous regions which oligomerize to form a mature
trimeric glycoprotein with a molecular weight of 220 - 240 kD (Figure 1). SR-AI has an
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additional C-terminal extracellular scavenger-receptor-cysteine-rich (SRCR) domain,
which has been found in more than one dozen other proteins to date (Freeman et al,
1990; Resnick et al, 1994; Resnick, 1996; Appendix C). In spite of this structural
difference, SR-Al and SR-AII exhibit nearly identical binding properties and can
specifically bind a broad array of polyanionic ligands with high affinity. Studies with
SR-Al have shown that these ligands include surface constituents of both Gram-
positive and Gram-negative bacteria, as well as intact bacteria themselves (Table 1)
(Krieger and Herz, 1994; Hampton et al, 1991; Dunne et al, 1994).
SR-AI and/or SR-AII are expressed primarily by monocytes and by peritoneal
and most tissue macrophages (Table 2). Some dendritic cells and microglia, which
are ontogenetically related to macrophages (Theele and Streit, 1993; Peters et al,
1996), certain specialized endothelial cells (EC), and smooth muscle cells in
atherosclerotic lesions also appear to express the protein(s). A variety of different
stimuli have been found to modulate SR-A/II levels in vitro (Table 2), and substantial
progress is being made in defining the regulatory elements controlling the
macrophage specific expression of the SR-AI/II gene (Horvai et al, 1995; Aftring and
Freeman, 1995). In a major advance for the SR field, Kodama and colleagues have
recently succeeded in disrupting the murine SR-Al/II gene by homologous
recombination, and have thereby generated SR-AI/II deficient mice (H Suzuki, Y
Kurihara, T Kodama, personal communication).
A third SR-A, termed MARCO, has recently been identified and shown to bind
both AcLDL and bacteria (Elomaa et al, 1995). MARCO expression has been detected
only in peritoneal macrophages and in a limited subset of tissue macrophages
residing in the spleen and lymph nodes. All of these macrophages also express SR-
AI/II. The C-terminal portion of MARCO is homologous to the collagenous and SRCR
domains of SR-AI, although the MARCO collagenous domain is much longer than that
of SR-AI/II. MARCO does not share any other domains with SR-AI/II. The primary
ligand binding region of all three SR-As is located near the C-terminus. In SR-AI/II,
and perhaps also in MARCO, the ligand binding region appears to be a cluster of
basic residues located at the C-terminal end of the collagenous domain (Acton et al,
1993; Doi et al, 1993; Krieger and Herz, 1994; Elomaa et al, 1995; Tanaka et al, 1996).
The search for additional SRs led to the identification of two class B SRs, CD36
(Endemann et al, 1993) and SR-BI (Acton et al, 1994). These receptors, together with
the lysosomal protein Limp II (Vega et al, 1991), the Drosophila emp (Hart and Wilcox,
1993) and croquemort (Franc et al, 1996) proteins, and a putative C. elegans protein
(Genbank accession number 728534), define the CD36 family (Greenwalt et al, 1992).
At the moment, more is known about the biology of the CD36 family proteins than
about that of the proteins belonging to any of the other SR classes. These 74 - 88 kD
proteins have a single conserved extracytoplasmic domain which shows 25% -- 30%
homology between any two family members and is composed of an amino terminal
region containing most of the potential N-glycosylation sites, and a carboxy terminal
region rich in conserved proline, glycine, and cysteine residues (Figure 1) (Greenwalt
et al, 1992). Non-conserved putative transmembrane and cytoplasmic domains flank
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the extracellular domain. Whether both or only one (C-terminal) of the hydrophobic
regions act as transmembrane domains is currently unclear and is a matter of some
contention (Vega at al, 1991; Pearce at al, 1994; Tao et al, 1996). CD36 appears to be
palmitoylated on two cysteines located near the N-terminus and two located near the
C-terminus of the protein (Tao et al, 1996). While this would seem to indicate that both
termini are cytoplasmic, it has been reported that some CD36 palmitoylation may be
extracellular (Jochen and Hays, 1993). In addition, it has been reported that C-
terminal deletion mutants expressed in transfected Bowes melanoma cells are
secreted into the culture medium (Pearce et al, 1994). Interestingly, croquemort lacks
a C-terminal hydrophobic region, yet is tightly membrane bound (Franc at al, 1996). If
it turns out that the N-terminal hydrophobic domain in this family of proteins is not a
transmembrane domain, the tight membrane association of croquemort suggests that
at least some of the CD36 family proteins may use additional mechanisms for
membrane association (Vega et al, 1991; Greenwalt at al, 1992; Jochen and Hays,
1993).
CD36 and SR-BI bind a wide variety of ligands, at least some of which are
polyanionic (Table 1). Interestingly, the class B receptors (and other CD36 family
members?) may primarily be lipid binding proteins expressed by tissues and cells
involved in host defense and/or lipid metabolism and lipid-dependent processes (e.g.
coagulation) (Greenwalt at al, 1995; Nicholson at al, 1995; Acton at al, 1996; Ibrahimi
at al, 1996; Huh et al, 1996; Landschultz et al, 1996; Wang et al, 1996). These cells
include monocytes and monocyte derived macrophages (but apparently not most
tissue macrophages), B lymphocytes, capillary endothelial cells, platelets, and
adipocytes (Table 2). Similarly, the croquemort gene is expressed in hemocytes and
the fat body (Franc at al, 1996). In at least some of these cells, CD36 appears to be
associated with caveolae (Lisanti at al, 1994), which have been implicated in both lipid
transport and signal transduction (Parton, 1996). Initial studies of the biosynthesis,
processing and intracellular transport of CD36 in macrophage cell lines have recently
been reported (Alessio at al, 1996), as have studies of the transcriptional regulation of
CD36 gene expression (Armesilla and Vega, 1994; K6nig at al, 1995).
CD36 and SR-BI have recently been identified as receptors for the anionic
phospholipids phosphatidylserine (PS) and phosphatidylinositol (Rigotti at al, 1995).
Although there are likely to be additional PS receptors (see below), these are currently
the only molecularly identified cell surface proteins which can bind PS and PI. Thus,
CD36 family proteins may at least partially account for some old results which
demonstrated that both mammalian macrophages and insect hemocytes can
internalize anionic phospholipid vesicles (Ratner at al, 1986). PS is not normally
expressed on the outer leaflet of cell membranes, but is externally exposed on
activated platelets, damaged tissues, and apoptotic cells (discussed in more detail
below). Thus, anionic phospholipids may represent one type of pattern not associated
with normal host cells. Indeed, it has been previously suggested that the recognition of
anionic phospholipids may be one primitive mechanism by which phagocytes
distinguish self from non-self and damaged-self (Ratner at al, 1986). Initial reports that
SR-AI/II could bind PS vesicles (Nishikawa at al, 1990) have since been shown to be
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incorrect (Lee et al, 1992). The PS binding observed by Nishikawa and coworkers(1990) may have actually been due to one or more of the class B SRs, and/or to other
PS receptors expressed on macrophages.
After the striking finding that Drosophila embryonic hemocytes express SR
activity (Abrams et al, 1992), the class C SR gene, dSR-CI, was cloned from the
hemocyte-like S2 cell line (Pearson et al, 1995). The cloning and characterization of
this gene are described in more detail in Chapter 3; here I will briefly review the salient
features of this receptor. The extracellular portion of the 170 kD dSR-CI protein
contains two N-terminal complement control protein (CCP) domains. In mammals,
CCP domains mediate the binding of complement receptors and complement
regulatory proteins to the central component of the complement cascade, C3 (Reid
and Day, 1989). The extracellular region of dSR-CI also contains MAM and
somatomedin B domains, and a mucin-like domain which is heavily O-glycosylated.
Which of the extracellular domains of dSR-CI mediate ligand binding is currently
unknown. It is striking, however, that even though dSR-CI has absolutely no homology
to SR-AI/II, it is nonetheless very similar to SR-AI/II in it's ability to bind to a broad array
of polyanionic ligands with high affinity (Table 1). Interestingly, dSR-CI also binds the
uncharged microbial B-glucan laminarin, which is a potent inducer of the Drosophila
immune response (Hultmark, 1993). As discussed in more detail in Chapter 3, these
findings suggest that dSR-CI might be able to mediate the direct recognition of
microbial pathogens by hemocytes. Indeed, dSR-CI is expressed in the hemocytes of
the Drosophila embryo (Pearson et al, 1995). Additional Drosophila SRs probably
exist (see Chapter 3); these could potentially include both SR-A and SR-B
homologues.
There are likely to be additional, as yet unidentified, SRs in mammals as well.
For example, macrosialin/CD68 has recently been identified as an OxLDL-binding
protein present in membrane preparations from elicited peritoneal macrophages and
the murine macrophage cell line, RAW 264.7 (Ramprasad et al, 1995). Although only
membrane blots have so far been used to study the ligand binding specificity of
macrosialin/CD68, it appears that this protein may, like SR-AI/II and dSR-CI, have
broad polyanionic ligand binding properties. Interestingly, PS vesicles may also be
ligands (Ottnad et al, 1995; Sambrano and Steinberg, 1995; Ramprasad et al, 1995).
Macrosialin/CD68 has two extracytoplasmic domains: a mucin-like domain and a
domain with homology to lysosomal membrane proteins. Indeed, the protein is
expressed predominantly in endosomes, and to a lesser extent in lysosomes; only
small amounts are expressed on the cell surface (Holness et al, 1993; Ramprasad et
al, 1995). Thus, the potential roles of macrosialin/CD68 as a SR and as a host defense
protein remain uncertain. It is interesting to note, however, that there may be a cell
surface isoform which is upregulated in response to inflammatory stimuli (Holness at
al, 1993). Resolution of these issues is important, as there are clearly mammalian
macrophage SR activities distinguishable from both the SR-As and SR-Bs (see, for
example Arai et al, 1989; Nishikawa et al, 1990; Schnitzer and Bravo, 1993;
Kuzmenko et al, 1994; Nozaki et al, 1995; Sambrano and Steinberg, 1995; Lougheed
and Steinbrecher, 1996; de Rijke and van Berkel, 1994).
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Scavenger Receptor Functions in Innate Immunity
Lipopolysaccharide (LPS) from Gram-negative bacteria is a potent inducer of
the immune response in both vertebrates and invertebrates (Hultmark, 1993; Ulevitch
and Tobias, 1994; Wright, 1995; Hoffman, 1995). In mammals, serum LPS binding
protein (LBP) and the "LPS receptor," CD14, play a critical role in mediating the
cellular responses to LPS (Ulevitch and Tobias, 1994; Wright, 1995; Haziot et al,
1996). LBP facilitates the formation of LPS-CD14 complexes by transferring LPS from
insoluble aggregates (and perhaps also from intact bacteria (Katz et al, 1996; Jack et
al, 1995)) to either of the two CD14 isoforms. The GPI-anchored isoform (mCD14), is
expressed primarily by cells of the monocytic lineage, while a soluble isoform (sCD14)
is present in serum and can mediate the responses of non-mCD14 expressing cells(particularly endothelial cells) to LPS. Although CD14 enhances the ability of LPS to
induce cellular responses by 100 to 10,000 fold, it does not transduce a
transmembrane signal itself. Instead, CD14 appears to solubilize LPS and act as a
shuttle (Wurfel et al, 1995; Wright, 1995) which transports individual LPS molecules
through aqueous environments and on the cell surface, most likely to an associated
signal transducing receptor (Ulevitch and Tobias, 1994; Wright, 1995; Delude et al,
1995; Haziot et al, 1996). By their joint action, LBP and CD14 can concentrate LPS
molecules at the cell surface, and may thereby amplify the ability of LPS to induce
cellular responses (Wright, 1995). This may in fact be a general function of CD14 in
host defense, since it appears to act as a pattern recognition receptor which enhances
cellular responses to a wide range of microbial surface constituents (Pugin et al, 1994;
Wright, 1995).
The identification of the mammalian CD14 associated signal transducer(s) is
currently the subject of intense research. Recent studies suggest that there are
probably several distinct proteins which are important for transducing signals in
response to different CD14 bound microbial surface molecules (Pugin et al, 1994;
Savedra et al, 1996). There may even be several different proteins which mediate
signal transduction events in response to CD14 bound LPS, since multiple, somewhat
independent signal transduction pathways appear to be activated in cells responding
to LPS (Delude et al, 1994; Arditi et al, 1995; Haziot et al, 1996). Theoretically, LPS
responsive transducer proteins might recognize CD14-bound LPS (Ulevitch and
Tobias, 1994), they might recognize LPS directly transferred from CD14 (Wright, 1995;
Gegner et al, 1995), or they might recognize LPS indirectly transferred from CD14 via
a membrane bound protein functionally analogous to LBP. While it is known that CR3
recognizes LPS (Wright et al, 1989), and that LPS-mCD14 complexes associate with
CR3 (Zarewych et al, 1996), this integrin may not be a CD14 associated signal
transducing receptor since CD18 deficient and CD18 positive monocytes respond
identically to LPS (Wright et al, 1990).
The broad ligand binding properties of the SRs suggest that one or more of
them might participate in infection induced signal transduction. However, two findings
indicate that the mammalian SR-As are probably not critically important for LPS
induced, CD14-dependent signal transduction: 1) AcLDL blocks most Lipid IVa (a
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bioactive LPS precursor) binding to RAW 264.7 cells, but has no effect on their ability
to release TNF -a in response to Lipid-IVa induction (Hampton et al, 1991), and 2)
CD14 transfected CHO cells respond strongly to LPS (Golenbock et al, 1993) yet have
only very low levels of endogenous SR activity (Freeman et al, 1991).
Whether the SR-B class scavenger receptors can participate in LPS induced
signal transduction has not yet been examined. In fact, it is not even known if these
proteins can bind LPS. This question should be examined, particularly since it is
known that CD36 can bind to both fatty acids and a variety of polyanions and that both
CD36 and SR-BI can bind to anionic phospholipids (Table 1). Keeping in mind that
the LPS binding capabilities of CD36 and SR-BI are unknown, several findings
provide circumstantial evidence that one or more of the CD36 family proteins might be
able to participate in CD14 dependent LPS induced signal transduction. First, CD36
family proteins are expressed by most LPS responsive cells (compare Ulevitch to
Table II), and are colocalized with CD14 to caveolae (Lisanti et al, 1994). Second, the
binding of certain CD36 antibodies can initiate signal transduction events in
monocytes (Greenwalt et al, 1992). Interestingly, CD36 co-immunoprecipitates with
several src family tyrosine kinases, including the lyn kinase (Huang et al, 1991), which
also co-immunoprecipitates with mCD14 and participates in LPS-induced and CD14-
dependent signal transduction (Stefanova et al, 1993; Arditi et al, 1995). However, it is
not clear whether the co-immunoprecipitation of lyn with CD36 and CD14 is
functionally significant, or simply reflects the colocalization of all three proteins to
caveolae (Parolini et al, 1996). Third, it has recently been determined that >99% of
serum LBP is physically associated with HDL particles, and that purified apo-AI
containing lipoproteins can recapitulate the entire process by which whole plasma first
enables and then neutralizes the ability of LPS to stimulate cells (Wurfel et al, 1994).
This process apparently involves the sequential LBP catalyzed transfer of LPS from
insoluble aggregates (including bacteria?) to CD14, and then from CD14 to the HDL
particle (Wurfel et al, 1995). Given the ability of CD36 and SR-BI to bind HDL, it is
conceivable that some CD36 family members might localize LBP on the surface of a
cell, where it could then fulfill its role in the sequential transfer of LPS from micelles or
bacteria to CD14 and HDL. Interestingly, such a role for the CD36 type proteins would
not actually require them to bind to LPS. It would be interesting to determine what
effects, if any, blocking anti-CD36 or anti-SR-BI antibodies have on LPS induced
signal transduction in monocytes, endothelial cells, and other cell types.
In addition to CD14 dependent signal transduction processes, which are
sensitive to very low levels of LPS (1 ng or less), there are also CD14 independent
signal transduction processes which act at higher LPS concentrations (10 to 100 ng or
more). These processes are mediated by low affinity LPS receptors such as CR4(CD1 1 c/CD18) and may enable macrophage detection of infections in tissues that lack
serum proteins and are exposed to high local concentrations of LPS (Ingalls and
Golenbock, 1995). Recent data suggests that even monocytes, which express CD14
and are exposed to serum, may predominantly use CD14 independent signal
transduction mechanisms at high LPS concentrations (Cohen et al, 1995).
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Of the various known SRs, only SR-AVI/II has thus far been examined to see if it
can enable CD14 independent cellular activation. The results of these studies
suggest that SR-AI/II probably does not participate in such activation, since CHO cells
transfected with rabbit SR-AII do not synthesize arachidonic acid in response to 100
ng/ml LPS or Lipid IVa (Golenbock et al, 1993). However, it is important to note that
measuring only one indicator of cell activation in a non-macrophage cell line which is
exposed to levels of LPS which are below the Kd of this ligand for SR-Al/II, as these
researchers did, does not definitively test the involvement of SR-AI/II in LPS induced
signal transduction. Since CD14 deficient macrophages can still respond to high
levels of LPS (Haziot et al, 1996), the involvement of SR-AI/II in LPS induced signal
transduction should now be tested in SR-AI/II -CD14 double knockout mice. Such an
experiment should finally provide definitive evidence for or against the participation of
SR-AI/II in LPS inducted signal transduction events.
Should it be found that CD36 type proteins do bind LPS, it would be interesting
to determine if they could participate in CD14 independent signal transduction. This
might be done by isolating monocytes and endothelial cells from CD14 deficient mice
and testing the effects which blocking antibodies directed against these proteins have
on LPS induced cellular activation. As for macrosialin/CD68, there are two findings
relevant to its potential participation in CD14 independent LPS induced signal
transduction. On the one hand, it has been reported that RAW264.7 membrane
fractions contain a 95 kD serum independent lipid IVa binding protein which is
strikingly similar to macrosialin/CD68 (B; Ramprasad et al, 1995). On the other hand, it
has also been reported that lipid A is not able to compete for OxLDL binding to this
protein isolated from Kupffer cells (de Rijke and van Berkel, 1994). What is clearly
required now is to examine LPS binding to transfected cells expressing
macrosialin/CD68.
Rather than regulating cellular activation, SRs may primarily be effector
molecules which participate in the phagocytic clearance of microbes and the endocytic
clearance of microbial surface constituents, from the body (Hampton et al, 1991;
Abrams et al, 1992; Holness et al, 1993; Dunne et al, 1994; Bell et al, 1994; Krieger
and Herz, 1994; Pearson et al, 1995). In addition to their broad binding specificities,
and their expression in macrophages and liver EC, several recent findings support the
involvement of at least some SRs in these processes. First, in clearance studies, the
co-injection of SR ligands (poly (I), AcLDL) significantly reduces hepatic uptake of
Lipid IVa in mice (Hampton et al, 1991). (Similar experiments with alveolar
macrophages have demonstrated that SRs may participate in the clearance of anionic
environmental particulates from the lung (Resnick et al, 1993; Kobzik, 1995)). Second,
the addition of AcLDL to alveolar macrophages increases their level of TNF-a
production in response to LPS. Since this is evidently not due to priming of the
macrophages, the effect of AcLDL may have been to block SR mediated clearance of
LPS, thus increasing its availability for CD14 dependent cellular activation (Mendez et
al, 1995). These results indicate that SRs may play an important protective role in the
host by preventing detrimental hyperactivation of the innate immune system by
microbial molecules. Third, in support of such a role for SR-AI/II, reports from several
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groups now indicate that both peritoneal macrophages (H Suzuki, Y Kurihara, T
Kodama, personal communication) and liver EC (van Amersfoort et al, 1996) obtained
from SR-AI/II knockout mice exhibit a 50% reduction in LPS binding and uptake.
Furthermore, these mice appear to be more susceptible to endotoxic shock. Recalling
the studies, cited above, which indicated that SR-AI/II probably does not directly
participate in LPS induced cellular activation, these more recent studies suggest that
the major protective function of SR-AI/II in host defense may indeed be its participation
in the clearance of LPS, and perhaps bacteria, from the body. It will be interesting to
see if the SR-AI/II knockout mice exhibit an altered susceptibility to infection relative to
normal mice. Fourth, LPS can in some circumstances induce the upregulation of SR-
Al/il protein expression, presumably enabling efficient endocytic and phagocytic
clearance of bacteria (Bell et al, 1994). However, this result must be balanced against
the finding that LPS can also down-regulate SR-AI/II message levels, and also
presumably protein levels (Dufva et al, 1995; Hsu et al, 1996). The meaning of these
conflicting results is not clear. Perhaps they simply demonstrate the long known fact
that microenvironmental cues are critically important in regulating macrophage
phenotype (Gordon et al, 1988; Rutherford et al, 1993). Fifth, the association of LPS
with HDL suggests that CD36 family proteins, expressed in the liver and elsewhere,
may facilitate LPS clearance (Levine at al, 1993). Indeed, since only a small fraction(<1%) of the total serum HDL contains LBP under normal circumstances (Wurfel at al,
1994; Park and Wright, 1996), the hypothesis presented earlier, that CD36 type
proteins participate in LPS induced cellular activation by binding to HDL-LBP, seems
somewhat unlikely. In contrast, the hypothesis that CD36 type proteins might play a
quantitatively important role in LPS clearance seems more likely since the serum
concentration of LBP, and presumably also of LBP-HDL complexes, dramatically
increases in response to infection (Gegner et al, 1995). As with other hypotheses, this
hypothesis could be tested by determining the effects of blocking antibodies directed
against the CD36 type proteins on LPS clearance. Although not discussed here, the
properties of dSR-CI and croquemort suggest that these receptors could play effector
functions in Drosophila hemocytes which are analogous to the potential effector
functions of the mammalian SRs.
It has been suggested that, as phagocytic and endocytic receptors expressed
on macrophages and dendritic cells, some mammalian SRs may also participate in the
activation of the adaptive immune system by mediating antigen uptake and/or
processing for presentation to B and T cells (Holness et al, 1994; Geng and Hansson,
1995). In this regard, it has recently been shown that maleylation of proteins, which
converts them to SR ligands, enhances their ability to elicit antibody and T cell
responses in the absence of adjuvant in vivo, and enhances their presentation to T
cells by macrophages in vitro (Abraham et al, 1995).
One final role for SRs during the immune response has been previously
suggested: participation as adhesion proteins in the recruitment of peripheral blood
monocytes (PBM) to infected tissues (Holness at al, 1994; Hughes et al, 1995; Huh et
al, 1995), a process which requires PBM extravasation through vascular endothelial
cell layers (Springer, 1994). Several findings have led to these suggestions: 1) the
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monocyte/macrophage growth and differentiation factor M-CSF, which induces
monocyte migration (Wang at al, 1988) and is locally released by macrophages and
TNF a activated EC in response to infection (Hennet et al, 1992; Peng et al, 1995),
also upregulates both SR-AI/II expression by and SR-AI/II mediated adhesion of
macrophages (see below) (de Villiers at al, 1994a). 2) M-CSF treatment of monocytes
upregulates total CD36 levels (Yessner et al, 1996), and to a lesser extent surface
CD36 levels (Huh at al, 1995). It has been suggested that M-CSF might be priming
the monocytes for subsequent mobilization of CD36 to the cell surface in response to
secondary stimuli (Yessner et al, 1996). 3) Interestingly, expression of CD36 on the
surface of PBM is upregulated upon their adherence to TNF-a activated EC (Huh at al
1995). Thus, PBM adhesion to activated EC may generate one type of secondary
stimulus which acts on M-CSF primed monocytes to alter surface levels of CD36
protein. It must be stressed that all of these findings are only consistent with, and far
from prove, a role for SRs in the recruitment of PBM to infected tissues.
Scavenger Receptor Functions in Immune Related Processes
Establishment of macrophaae. yIvmphocvte and hemocvte poopulations
In order to effectively participate as sentinel and effector cells in first line host
defense, mammalian monocytes must establish residence throughout the body as
permanently differentiated tissue macrophages (Gordon et al, 1988; Rutherford et al,
1993). It has been suggested that SR-AI/II might be homing and/or retention molecules
involved in this process (Hughes at al, 1995). Three recent reports support this
hypothesis. First, and most importantly, it has been found that the monoclonal
antibody 2F8, which recognizes both SR-Al and SR-AII, can inhibit the cation-
independent (non-integrin, non-selectin) adhesion of macrophages to tissue culture
plastic (Fraser at al, 1993) and to frozen splenic, thymic, and lymph node tissue
sections (Hughes at al, 1995). SR-AI/II mediated adhesion to plastic requires a serum
ligand, while adhesion to tissues involves either an endogenously expressed ligand
and/or homophilic binding interactions between macrophages and resident SR-AI/Il-
expressing cells in tissues. Second, as mentioned earlier, M-CSF upregulates both
SR-AI/II expression by macrophages and SR-AI/II mediated macrophage adhesion (de
Villiers at al, 1994a). Indeed, M-CSF may be critical for SR-AI/II expression since such
expression is dramatically reduced in M-CSF deficient mice (Gordon at al, 1995)
Third, CD6, which is composed entirely of SRCR domains, has recently been shown to
bind to an Ig domain containing ligand called ALCAM (Bowen at al, 1996), thus
demonstrating that SRCR domains can mediate binding interactions. It has also
recently been suggested that SR-AI/II may participate in the adhesive events
regulating lymphocyte recirculation. However, it must be noted that this suggestion is
based solely on the observation that SR-AI/II is expressed by lymph node high
endothelial venules (Geng and Hansson, 1995). What is now necessary is for these
hypotheses to be tested using the SR-AI/II knockout mice.
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It is not known whether Drosophila hemocytes establish permanent residence
in specific tissues. However, they do migrate throughout the body of the developing
and adult fly, and in some cases they appear to follow specific guidance cues (Tepass
et al, 1994; Zhou et al, 1995). Since dSR-CI is expressed in hemocytes prior to the
onset of migration and contains several potentially adhesive domains, it might be able
to participate in the hemocyte migration process (Pearson et al, 1995).
Response to wounding
Wounding induces activation of the innate immune system in both mammals
and invertebrates (Burnet, 1968; Rizki and Rizki, 1984; Lackie, 1988; Gordon et al,
1988; Hultmark, 1993; Baumann and Gauldie, 1994; Mansfield and Suchard, 1994;
Matzinger, 1994; Ibrahim et al, 1995; Hoffmann, 1995; Harris and Gelfand, 1995; ).
Dendritic cells, monocytes, macrophages and hemocytes are the central mediators of
this innate immune response, playing critical roles in guarding against infection, in
clearing wound-associated debris, and in wound healing. It has been suggested that
wound recognition by these cells may be somewhat analogous to the recognition of
infectious microorganisms (Burnet, 1968; Lackie, 1988; Matzinger, 1994; Mansfield
and Suchard, 1994; Hoffman, 1995). Perhaps this process, at least in part, represents
another manifestation of pattern recognition. Indeed, as described below, wounding
exposes molecular structures and patterns on damaged cells and tissues, and on
activated platelets recruited to the wound site, which are not found on normal cells and
tissues.
SRs may participate in wound recognition, both as adhesion molecules and
also as pattern recognition receptors. For example, it has been suggested that
monocyte adhesion to the wound site may be facilitated in part by CD36 mediated
binding to thrombospondin (TSP) secreted by activated platelets already attached to
the wounded tissue (Silverstein et al, 1989). In addition, both collagen and PS are
exposed on wounded tissues and cells themselves (Lackie et al, 1988; Davie et al,
1991; Machin, 1992), and recognition of these damaged-self structures by CD36 may
also contribute to direct binding of monocytes to wound surfaces. Finally, since
activated platelets also express PS externally (Davie et al, 1991; Machin, 1992), CD36
mediated recognition of activated platelets via PS binding might further contribute to
monocyte adhesion. After mediating wound detection by one of these mechanisms,
CD36 could potentially act as signal transducing receptors which initiate cellular
activation, thereby contributing to an inflammatory immune response and enhanced
clotting.
SRs could also directly participate in the clotting process. Since both platelets
and insect hemocytes express CD36 family members (Greenwalt et al, 1992; Franc et
al, 1996), mechanisms similar to those just described for monocytes may also
contribute to the initial recognition of wounds by platelets and hemocytes. In addition,
CD36 family members might also participate in the growth and stabilization of platelet
and hemocyte clots (Greenwalt et al, 1992; but see Saelman et al, 1994). This is
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suggested by the knowledge that activation of platelets and hemocytes not only
induces the secretion of clotting factors, such as TSP in mammals and lipoproteins in
invertebrates (Hall et al, 1995), but activation also induces changes in the surface
characteristics of these cells (Rizki and Rizki, 1984; Lackie, 1988; Davie et al, 1991;
Machin, 1992; Satta at al, 1994). In particular, in addition to exposing PS, activated
platelets translocate lysosomal proteins (including LIMPII? Greenwalt et al, 1992) and
intracellular CD36 stores (Berger et al, 1993) to the plasma membrane.
It must be noted, however, that while CD36 can bind TSP, collagen, and PS,
these binding events may not be physiologically significant mechanisms for either
monocyte or platelet adhesion to wound sites. Indeed, the in vivo relevance of CD36
mediated cellular adhesion to collagen and TSP has been repeatedly questioned and
is currently a matter of some debate (see Greenwalt at al, 1992; McKeown at al, 1994).
What is clear from several studies (Greenwalt et al, 1992; McKeown at al, 1994;
Saelman et al, 1994) is that CD36 is not necessary for adhesion to these proteins.
This may be due in part to the existence of several additional monocyte and platelet
membrane proteins which can bind to TSP and collagen, which may therefore
participate in wound recognition and clotting (McKeown at al, 1994). Although CD36
does not appear to be essential for monocyte and platelet binding to TSP and
collagen binding, by binding these ligands in cooperation with other receptors, it may
enhance cellular adhesion (Greenwalt at al, 1992; Saelman at al, 1994; Diaz-Ricart at
al, 1993). It has been found, for example, that CD36 facilitates (but is not essential for)
the earliest stages of platelet adhesion to collagen, but subsequently plays no
significant role once adhesion has been established (Greenwalt at al, 1992; Diaz-
Ricart at al, 1993).
Finally, it has been suggested that SR-AI/II may participate in the clearance of
wound associated debris during the healing process, since SR-AI/II expression is
dramatically upregulated in glial cells and recruited macrophages after optic nerve
crush (Bell et al, 1994). Other SRs may also be involved in the clearance of damaged
cells, since macrophage binding of a model damaged cell, the oxidized red blood cell
(OxRBC), is completely inhibited by both PS and OxLDL (Sambrano and Steinberg,
1995). The ability of various SRs to bind and perhaps mediate the clearance of
advanced glycosylation end-products (SR-AI/II - Araki at al, 1995), Type I and Type III
procollagen propeptides (Melkko at al, 1994), 8-amyloid aggregates (Paresce at al,
1996; El Khoury et al, 1996; see also Christie at al, 1996), and shed photoreceptor rod
outer segments (CD36 - Ryeom at al, 1996a) are all consistent with the idea that SRs
may generally be involved in the removal of cellular and extracellular debris. The
potential for cooperation between SRs and other receptors (e.g. the Receptor for
Advanced Glycation End-products (RAGE, Yan et al, 1996) in these processes has not
yet been examined.
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Recoanition and engulfment of apoototic cells
The induction of apoptosis during an immune response is an important effector
mechanism for host defense in higher eukaryotes from plants to animals (Savill et al,
1993; Greenberg et al, 1994; Shresta at al, 1995; Munn et al, 1995; Scott et al, 1996).
In animals, apoptosis also plays an important role in the normal development and
turnover of organs, tissues and cells, including those of the immune system (Savill et
al, 1993; Surh and Sprent, 1994; Steller, 1995; Munn at al, 1996). The phagocytic
clearance of apoptotic cells, and also of damaged and senescent cells, is a primary
function of monocytes, macrophages and hemocytes (Gordon et al, 1988; Savill et al,
1993; Tepass et al, 1994; Sonnenfeld and Jacobs, 1995). These phagocytes may
recognize engulf effete cells in part by using pattern recognition mechanisms similar to
those used for the recognition and engulfment of infectious microorganisms (Burnet,
1968; Gordon et al, 1988; Ibrahim et al, 1995). Indeed, apoptotic cells, like damaged
cells and tissues, express surface characteristics not usually found on normal self cells
(Fadok at al, 1992a; Savill et al, 1993; Falasca et al, 1996). For example, PS is rapidly
exposed on the surface of most, if not all, cells undergoing apoptotic cell death (Fadok
at al, 1992a, 1992b; Martin at al, 1995; Verhoven et al, 1995).
Multiple receptors and mechanisms have been implicated in the process of
apoptotic cell engulfment by macrophages (Savill et al, 1993; Flora and Gregory,
1994; Sambrano and Steinberg, 1995; Falasca at al, 1996; Ren et al, 1996). This is
not surprising given the importance of clearing apoptotic cells from the body (Savill et
al, 1993), and the considerable heterogeneity displayed by macrophages of different
origins (defined by differing microenvironments and states of activation). The extent to
which these various receptors can replace or compensate for each other (i.e. are
functionally redundant) is currently unknown. In addition, with one exception (see
below), it is not known whether any of these receptors exhibit either cooperativity or
co-dependence during the apoptotic cell engulfment process.
It has repeatedly been suggested that SRs may participate in some of these
mechanisms (Abrams at al, 1992; Krieger and Herz, 1994; Pearson et al, 1995;
Hughes et al, 1995; Sambrano and Steinberg, 1995; Rigotti at al, 1995). Evidence is
now accumulating which supports these suggestions, although the precise roles of the
SRs, and sometimes their actual identities, have not yet been fully established.
Strong support for the direct involvement of SR-AI/II in apoptotic cell engulfment
has been provided by two recent findings: 1) the anti-SR-AI/II monoclonal antibody
2F8 inhibits 50% of apoptotic thymocyte uptake by thymic macrophages and elicited
peritoneal macrophages (Platt et al, 1995), and 2) thymic macrophages from SR-AI/II
knockout mice exhibit a 50% reduction in apoptotic cell uptake (S Gordon, personal
communication). The nature of the ligand on apoptotic cells which is recognized by
SR-AI/II is not yet known, but can not be PS (Lee et al, 1992). Macrophages from
SRAI/II deficient mice only exhibit a 50% reduction in apoptotic thymocyte engulfment,
demonstrating that additional receptors must also be involved in this process. Since
these receptors have not yet been identified, it is difficult to determine the relative
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contribution that each makes to apoptotic thymocyte engulfment in vivo . Indeed, even
for SR-AI/II, it is not yet known if the absence of this receptor has any quantitative or
qualitative in vivo effects on T cell numbers, T cell development, or thymus function
and morphology. It is possible, for example, that by upregulating the expression of
other receptors, the thymus may be able to compensate for SR-AI/II deficiency. The
identification and targetted disruption of these additional receptors, both alone and in
combination with SR-Al/II, may contribute to the resolution of this question.
The results of Platt et al (1995) suggest that some of the additional receptors
involved in apoptotic thymocyte engulfment may be non-class A SRs. Indeed, it has
been found, in other contexts, that some of the SR-Bs can mediate the engulfment of
apoptotic cells. For example, both PBM-derived macrophages and bone-marrow
derived macrophages can use a combination of CD36, the vitronectin receptor (VnR,
avB3 integrin), and thrombospondin to engulf apoptotic leukocytes (Savill et al, 1992;
Fadok et al, 1992b). A direct role for CD36 in this VnR/TSP dependent apoptotic cell
uptake mechanism was recently demonstrated by transfecting a CD36 cDNA into
Bowes melanoma and COS cells, both of which constitutively express the VnR. The
transfected cells, but not the untransfected cells, were able to phagocytose apoptotic
cells. In the Bowes cells transfectants, this phagocytosis was inhibitable by blocking
antibodies individually directed against CD36, TSP, or the VnR (Ren et al, 1995).
Importantly (see below), VnR/TSP dependence has not been demonstrated for the
engulfment of apoptotic cells by the COS cell CD36 transfectants.
As opposed to PBM and bone marrow derived macrophages, both resident and
elicited peritoneal macrophages recognize and/or engulf apoptotic cells and damaged
red blood cells by VnR independent mechanisms. At least some of these mechanisms
clearly require the involvement of SRs, since OxLDL can partially or completely inhibit
the binding and/or engulfment of these cells, depending on the nature of the target
(Sambrano and Steinberg, 1995; Ottnad et al, 1995). The identity of the relevant SRs
is currently unknown, but they may include SR-AI/II, CD36 and/or SR-BI, and
macrosialin/CD68, all of which bind OxLDL.
Some of the VnR independent engulfment mechanisms used by elicited and
resident peritoneal macrophages are based upon the recognition of PS exposed on
the surface of the target cells (Fadok et al, 1992a, 1992b). The extent to which the
VnR-independent/SR-mediated engulfment mechanisms overlap with the VnR-
independent/PS-dependent engulfment mechanisms is currently unknown.
Interestingly, OxLDL can partially block the PS dependent uptake of target cells,
indicating that both SRs and non-SR PS receptors appear to participate in this process
(Fadok et al, 1992a, Sambrano and Steinberg, 1995). The ability of macrosialin/CD68
to bind to PS vesicles suggests that it might be one such SR (Sambrano and
Steinberg, 1995; but see Ramprasad et al, 1995).
Several findings suggest the intriguing possibility that the SR-Bs, and/or other
CD36 family members, might also play a role as PS receptors in this process. First,
CD36 is expressed by both elicited and resident peritoneal macrophages (Greenwalt
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et al, 1992; Endemann et al, 1993; Ottnad et al, 1995). Second, PS vesicles are SR-B
ligands and can cross-compete with OxLDL for receptor binding (Rigotti et al, 1995).
Third, SR-BI transfected COS cells bind and engulf apoptotic mast cells (Fukasawa et
al, 1996). Fourth, the same CD36 transfected Bowes cells, described above, which
engulf apoptotic cells in a VnR/TSP dependent manner, can also bind and engulf
photoreceptor rod outer segments (ROS) using a VnR/TSP independent mechanism
(Ryeom et al, 1996a). It is now important to determine if the engulfment of apoptotic
cells by CD36 and SR-BI transfected COS cells can be inhibited by PS vesicles.
There is some reason to believe that it will be, since the engulfment of PS-expressing
ROS by CD36-expressing retinal pigment epithelial cells can be inhibited both by an
anti-CD36 antibody and by PS vesicles (Ryeom et al, 1996a, 1996b). Interestingly,
this inhibition is only partial, suggesting the involvement of another receptor in ROS
engulfment (Ryeom et al, 1996a, 1996b). In further support of this possibility,
croquemort-transfected COS cells also recognize and engulf apoptotic thymocytes
(Franc et al, 1996), and this engulfment is inhibitable by PS vesicles (J.-L. Dimarcq, N.
Franc, A. Ezekowitz, and J. Hoffmann, personal communication).
The extent to which CD36 type proteins are physiologically important apoptotic
cell receptors is not yet known. However, it appears that CD36 type proteins have the
potential to participate in at least two different modes of apoptotic and senescent or
damaged cell uptake. This is particularly so for CD36 itself, which can mediate
engulfment by both VnR/TSP dependent and PS dependent mechanisms.
Interestingly, these two mechanisms so far appear to be mutually exclusive (Fadok et
al, 1992a; Fadok et al, 1993; Ren and Savill, 1995). Is there a way to make some
sense out of these results? This question is particularly intriguing because COS cells
are not normally phagocytic and because CD36 and SR-BI do not themselves appear
to have substantial phagocytic, or even endocytic, capabilities (Greenwalt et al, 1995;
Ottnad et al, 1995; Acton et al, 1996). Perhaps the primary role of the CD36 family
proteins during apoptotic cell engulfment is not in the actual phagocytic process itself,
but rather, is to act as proteins which somehow participate in the activation of
macrophage (and COS cell) phagocytic mechanisms by recognizing PS on the
surface of apoptotic cells.
In addition to the results already mentioned, several other findings are
consistent with, but by no means prove, this hypothesis: 1) external PS appears to be
a universal indication that a cell is undergoing apoptosis (Martin et al, 1995; Verhoven
et al, 1995); 2) every macrophage population so far used in studies of apoptotic cell
engulfment appears to recognize PS (Nishikawa et al, 1990; Fadok et al, 1992a,
1992b; Sambrano and Steinberg, 1995; Ottnad et al, 1995), as do insect hemocytes
(Ratner et al, 1986); and 3) as mentioned earlier in regard to LPS induced
macrophage activation, CD36 is a signal transducing receptor associated with lyn
kinase (and other src family kinases) (Huang et al, 1991). This kinase participates in
signal transduction events leading to the activation of macrophage and neutrophil
phagocytosis in response to a wide range of stimuli (Greenberg, 1995).
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Although this hypothesis does not require the involvement of CD36 type
proteins in the actual phagocytic process, it does not eliminate the possibility that, after
recognizing PS and participating in the activation of macrophage phagocytic
mechanisms, they might also participate in phagocytosis. If CD36 type proteins do
participate in phagocytosis, it may be important that they do so in cooperation with
additional co-receptors. Indeed, this appears to be the case for the VnR/TSP
dependent mechanism described above. The choice of co-receptors which might be
used for phagocytosis would presumably depend on the particular phenotype of the
macrophage, and, in addition to the VnR, may include SR-AI, macrosialin/CD68, other
PS receptors (Fadok et al, 1992a; Sambrano and Steinberg, 1995, Ottnad et al, 1995),
and any of several other receptors which have so far been identified solely on the
basis of their apoptotic cell engulfment activity (Flora and Gregory, 1994; Falasca at al,
1996). In this regard, it is interesting to note the recent report that macrophage uptake
of "post-apoptotic" PMN is mediated by a mechanism which is inhibitable by poly(l)
and fucoidan, but not by the anti-SRAI/II antibody 2F8, and which also requires the
participation of CR3 (Ren et al, 1996). It will be interesting to determine whether this
polyanion inhibitable activity is a CD36 type protein.
Recent studies have delineated a 28 residue domain of CD36 which may be
important for apoptotic cell engulfment (Puento-Navazo et al, 1996a), ROS engulfment(Ryeom et al, 1996a) and OxLDL binding (Puento-Navazo et al, 1996b). Interestingly,
this domain is distinct from another region of the protein which has been implicated in
TSP binding (Asch et al, 1993; Pearce et al, 1995). The implications of these findings
for CD36 function as an apoptotic cell receptor are currently unclear.
Conclusion
A common characteristic of infectious microorganisms, damaged cells and
tissues, and apoptotic and senescent cells is their surface expression of molecular
structures and patterns not found on normal host tissues and cells. That the
mechanisms used by vertebrate and invertebrate immune cells for the recognition of
and response to these diverse targets may be related is an old concept (Burnet, 1968;
Gordon et al, 1988; Hoffmann, 1995; Ibrahim et al, 1995). These mechanisms may
include pattern recognition receptor mediated recognition of the target cells, as first
proposed by Janeway for the recognition of microbial pathogens (Janeway, 1989,
1992).
Scavenger receptors have often been proposed to be pattern recognition
receptors. This chapter has presented the rationale behind these suggestions and
has reviewed the current state of knowledge regarding the involvement of the SRs in
host defense related processes. While many suggestions have been made over the
past several years with regard to the functions of the SRs in these processes, not until
very recently has there been any in vivo evidence either supporting or refuting these
hypotheses. This state of affairs is likely to change as strains of mice and flies are
generated which are deficient for one or more of the SRs. Of the numerous potential
-- page 25 --
functions for SRs which have been proposed, the strongest evidence currently
supports a role for the participation SR-AI/II in LPS clearance, and for the participation
of both SR-AI/II and CD36 type proteins in apoptotic cell engulfment.
Many potential functions have been proposed, here and by others, for the SR-
Bs. Since macrophages must be capable of distinguishing different ligands from each
other and responding appropriately, it would seem that for the CD36 family members
to participate in even only some of the systems which have been suggested would
require either that different family members participate in different functions, or that any
given member be coupled to multiple co-receptors which would allow various targets
to be distinguished from one another. This may be best illustrated by the fact that,
while it is clear that CD36 and SR-BI can participate in the phagocytic engulfment of
apoptotic cells, and may do so in vivo , there is also substantial evidence indicating
that CD36 and SR-BI may participate in normal physiological lipid metabolism (see
above). Perhaps a basic function of the CD36 family members is to bind anionic lipids
and then deliver them to other proteins which initiate or mediate the various
downstream events (lipid/cholesterol transport, adhesion, activation, phagocytosis)
induced by these lipids.
Although strains of mice carrying disruptions of these genes have not yet been
generated, there are individuals who appear to lack all platelet, monocyte and
macrophage CD36 expression. The frequency with which such individuals are found
is fairly high (approximately 0.1% in Japan, for example), and as far as anyone knows,
these individuals are perfectly healthy (Nozaki et al, 1995). This fact is too often
ignored when considering the possible functions of CD36. While it seems unlikely that
CD36 is a completely vestigial gene, it is clear that, at least in humans, CD36 does not
have any functions which are essential for normal health and development.
This raises the more general issue of functional redundancy among the SRs. It
is striking that there are multiple SRs which can all recognize some of the same
groups of polyanionic ligands. In addition, SRs are not the only cell surface proteins
which can bind to some of these ligands (e. g. CD14 and CR3 bind LPS, the VnR and
maybe CR3 bind apoptotic cells, GPla/lla binds TSP, GPIIb/Illa binds TSP and
collagen, etc.). It is not clear why there should be so many different proteins which
have broad and overlapping binding specificities (see also Epstein et al, 1996, for a
discussion of the collectins). While different temporal and spatial patterns of
expression may account for some of this apparent redundancy, many of these proteins
appear to have overlapping expression patterns. It is important for host defense, the
maintenance of homeostasis, and normal development, that infectious
microorganisms and cellular and extracellular debris be eliminated from the body.
Perhaps by expressing a variety of different pattern recognition receptors, each having
broad and overlapping, but also somewhat distinct, specificities and expression
patterns, innate immune cells may be able to effectively distinguish a wide range of
non-self and altered self structures from normal self structures anywhere in the body.
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Targeted disruption of SR genes should greatly contribute to the elucidation of
the roles that SRs play in host defense. SR-AVII knockout mice have already been
generated (H Suzuki, Y Kurihara, T Kodama, personal communication), and SR-BI
and CD36 knockouts are under construction. Given the degree of redundancy which
may be built into SR and other pattern recognition receptor systems, it may be
necessary to construct strains deficient in multiple different SRs in order to see any
major effects due to the absence of SR expression. In addition, there are now
numerous examples in which multiple receptors either additively or cooperatively
participate in the phagocytic engulfment of various targets (Blackwell et al, 1985;
Gordon et al, 1988; Schlessinger et al, 1991; Savill et al, 1993; Mosser, 1994; Gegner
et al, 1995; Greenberg, 1995; Petty and Todd,1996;). It seems possible that SRs might
also participate in additive or cooperative interactions with other receptors during
various immune responses. Therefore, in order to really understand the roles of SRs
during immune responses, it might be necessary (and also interesting) to create
double mutants lacking both a particular SR gene and a gene encoding another
receptor of interest. For example, from in vitro and in vivo evidence, it seems likely that
both CD14 and SRs, including SR-AI/II, may contribute to the clearance of LPS from
the body (Hampton et al, 1991; Gegner et al, 1995; Van Amersfoort et al, 1996). Yet,
recent reports indicate that any one receptor alone may play only a relatively minor
role in this process (Van Amersfoort et al, 1996; Haziot et al, 1996). It would be
interesting to see how LPS clearance is affected when both genes are eliminated.
Similarly, multiple knockouts may be required in order to generate noticeable defects
in apoptotic cell clearance.
Finally, the similarities between the innate immune systems of mammals and
insects, and between the mammalian and Drosophila SRs, make it likely that genetic
studies in Drosophila will also contribute to our understanding of both innate immunity
and of SR functions in innate immunity. Thus, in the coming years new studies of SR
function in both flies and mammals should provide clear insights into the roles that
these receptors play in innate immunity and host defense.
The following chapters describe work I have carried out in the Krieger Lab. In
Chapter 2, I discuss experiments designed at elucidating the basis for the
polynucleotide ligand specificity of the bovine class A scavenger receptors. Given the
similar ligand specificities displayed by all three scavenger receptor classes, these
studies may shed some light on the mechanisms by which scavenger receptors
recognize their ligands. In Chapter 3, I discuss the identification, cloning, and
characterization of the class C scavenger receptor of Drosophila melanogaster. As
stated above, it is hoped that genetic studies of this receptor will provide insight into
the role it plays during Drosophila development and host defense. Chapter 4
describes the first steps that have been taken toward identifying and isolating flies
lacking dSR-CI function. This work has resulted in the identification of a dSR-C gene
family. The initial characterization of this family is reported, and ongoing experiments
are described which should yield information on the functions of these genes and how
these functions are fulfilled.
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Figure 1-1. Structures of the Class A, Class B, Class C and Class D Scavenger
Receptors
There are currently seven defined scavenger receptors, belonging to four
independent classes, A, B, C and D. The class A scavenger receptors SR-Al and SR-
All are trimeric glycoproteins generated by alternative splicing of mRNA transcripts
from the same gene. They comprise, from amino to carboxy terminus, cytoplasmic (50
amino acids), transmembrane, spacer, a-helical coiled-coil (black), and collagenous
(gray) domains. The collagenous domain mediate ligand binding. SR-AI in addition
contains a C-terminal scavenger receptor cysteine rich (SRCR) domain. MARCO is a
new SR-A protein comprised of N-terminal cytoplasmic (49 amino acids),
transmembrane and spacer domains distinct from those of SR-Al/II. These are
followed by a long collagenous domain with C-terminal homology to that of SR-Al/II,
and then a C-terminal SRCR domain. The somewhat tentative model presented for
the Class B receptors SR-BI and CD36 is based on current reports regarding CD36
structure. Note, however, that this issue is a matter of some controversy (see text for
discussion). CD36 has a very short C-terminal cytoplasmic domain (< 10 residues; 45
residues in SR-BI), a single transmembrane domain (in this representation), and a
single large extracellular domain comprising an N-terminal region containing most of
the N-glycosylation sites and a C-terminal region rich in proline, glycine, and cysteine
residues (the cysteines are indicated). The Drosophila class C scavenger receptor,
dSR-CI, comprises several domains. From N-terminus to C-terminus, they are a signal
sequence which is likely cleaved from the mature protein, two complement control
protein (CCP) domains (gray), a large MAM domain (thick stripes), a small spacer
domain, a somatomedin B domain (thin stripes), a serine/threonine rich mucin like
domain which may be heavily glycosylated (black), another spacer domain, a
transmembrane domain, and finally a small cytoplasmic domain (cross-hatched, 64
amino acids). Macrosialin/CD68 may represent a fourth class of cell surface scavenger
receptors (see text). This protein comprises two extracellular domains separated by a
proline-rich hinge: an amino terminal mucin-like domain which is heavily O-
glycosylated (sticks with open circles), and a compact, membrane-proximal domain
probably containing two disulfide bonds which is homologous to domains found in
lysosomal membrane proteins. Both domains are N-glycosylated (sticks with closed
circles). This protein has a very short (2-10 residue, depending on species)
cytoplasmic domain. Figure adapted from M Krieger (unpublished), with permission.
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Four Classes of Scavenger Receptors
r C CC C
SR-Al SR-AII MARCO
C
NNN NNN
CD36 SR-BI SR-C Macrosialin
Table 1-1. Ligand Specificities of the Scavenger Receptors
Scavenger receptor ligand specificities reported in the literature have been
determined both by directly testing the ability of a given compound to bind to a
particular scavenger receptor (SR), and by testing the ability of a given compound to
inhibit the binding of a known ligand to SR transfected cells. It is important to note that
scavenger receptors exhibit some unusual binding properties, such as species
specific differences in ligand binding, and non-reciprocal cross competition between
two ligands (Krieger and Herz, 1994; Lougheed and Steinbrecher, 1996). Therefore,
the inability of compound A to inhibit the binding of compound B does not necessarily
mean that compound A is not a ligand. Caution must be exercised in interpreting
negative data unless direct binding studies have been performed.
Notes:
a Abbreviations: LDL, low density lipoprotein; AcLDL and OxLDL, acetylated and
oxidized LDL; HDL, high density lipoprotein; BSA, bovine serum albumin; M-BSA,
maleylated BSA; ReLPS, reduced form of lipopolysaccharide (LPS); LTA, lipoteichoic
acid; RBC, red blood cell; TSP, thrombospondin; PMN, polymorphonuclear leukocyte
b The binding of AcLDL to CD36 is controversial (Endemann et al, 1993; Acton et al,
1994; Nicholson et al, 1995; Nozaki et al, 1995). Since AcLDL is used as an inhibitor
to evaluate the contribution of SRs to various macrophage functions, resolution of this
issue is important.
C nd, not determined
d There appear to be species specific differences in the ligand specificity of CD36
(Huang et al, 1996).
References:
SR-Al/Il: Araki et al, 1995; Dunne et al, 1994; Hampton et al, 1991; Kodama et al,
1990; Krieger and Herz, 1994; Melkko et al, 1994; Paresce et al, 1996;
Pearson et al, 1993; Platt eat al, 1995; Resnick et al, 1993; Rohrer et al, 1990;
El Khoury et al, 1996; Chapter Two, this thesis.
MARCO/SR-AIII: Elomaa et al, 1995
SR-BI: Acton et al, 1994; Acton et al, 1996; Fukusawa et al, 1996; Huang et al, 1996;
Rigotti et al, 1995.
CD36: Abumrad et al, 1993; Endemann et al, 1993; Greenwalt et al, 1992; Huang et al,
1996; Nicholson et al, 1995; Nozaki et al, 1995; Ren et al, 1995; Rigotti et al,
1995; Paresce et al, 1996.
dSR-CI: Pearson et al, 1995; A Pearson, S Xu, M Krieger, N Franc, A Ezekowitz,
unpublished data.
Macrosialin/CD68: Ramprasad et al, 1995; Sambrano and Steinberg, 1995.
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Ligand Specificities of the Scavenger Receptors
SR-AI/II MARCO SR-BI CD36 dSR-CI macrosialin/CD68
Lipoproteins/proteins
AcLDLa + + + + +
OxLDL + ndc + + nd +
M-BSA + nd + + + nd
LDL nd +
HDL nd + + nd nd
BSA nd - nd
Poly- and oligonucleotides
polyl /polyG/oligo dG + nd d + +?
polyC/oligo dA nd - - nd
Anionic Polysaccharides
fucoidan + nd d + +?
dextran sulfate + nd - nd + nd
chondroitan sulfate nd - nd nd nd
Phospholipids
phosphatidylserine - nd + + - +
phosphatidylcholine - nd - - nd
Poly D-glutamic acid nd nd nd + nd
Lipid IVa/ReLPS + nd nd nd nd nd
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other apoptotic cells
LTA, S. aureus,
other Gram-
positive bacteria
1-amyloid
aggregates
AGE-proteins
PINP/PIIINP
phosphorothioate
oligonucleotides
crocidolite-
asbestos
S. aureus
E. co/i
apoptotic cells apoptotic cells
laminarin
(8-glucan)
apoptotic cells ?
oxidized RBC?
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apoptotic cells
P. falciparum -
infected RBC
B-amyloid
aggregates
collagen, TSP
oleate, palmitate
Table 1-2. Expression Patterns and Regulation of the Scavenger Receptors
Notes:
"a The superscripts r and n indicate molecular weight determination under reducing and
non-reducing conditions, respectively.
b Those tissues indicated in bold type have been shown to be major locations for
receptor expression
References:
SR-Al/II: Aftring and Freeman, 1995; Ashkenas et al, 1993; Bell et al, 1994; Bickel and
Freeman, 1992; Christie et al, 1996; de Villiers et al, 1994a; deVilliers et al,
1994b; de Rijke and van Berkel, 1994; Dufva et al, 1995; Geng and Hansson,
1995; Geng et al, 1994; Horvai et al, 1995; Hsu et al, 1996; Hughes et al,
1995; Li et al, 1995; Mato et al, 1996; Matsumoto et al, 1990; Naito et al 1991;
Shackelford et al, 1995; van der Kooij et al, 1996.
SR-AIII/MARCO: Elomaa et al, 1995.
SR-BI: Acton et al, 1994; Acton et al, 1996; Landschultz et al, 1996; Wang et al, 1996.
CD36: Abumrad et al, 1993; Alessio et al, 1996; Greenwalt et al, 1992; Greenwalt et al,
1995; Huh et al, 1995; Huh et al, 1996; K6nig et al, 1995; Ottnad et al, 1995;
Ren and Savill, 1995; Ryeom et al, 1996a, 1996b; Swerlick et al, 1992; Yesner
et al, 1996.
dSR-CI: Pearson et al, 1995; A. Pearson, D. Trigatti and M. Krieger unpublished.
Macrosialin/CD68: de Rijke and van Berkel, 1994; deVilliers et al, 1994; Geng and
Hansson, 1995; Holness et al, 1993; Ramprasad et al, 1995.
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Receptor/ MW,(kD) Expression Pattern b Regulation
SRAVI/II
monomer: 76/65'
trimer: 240/220n
Nearly all tissue macrophages. including:
Spleen: marginal zone, red pulp, metallophilic
Lymph node: subcapsular sinus, medullary cord
germinal center, paracortex
Thymus: medulla, cortex
Lung: Alveolar macrophages
Liver: Kupffer cells
Peritoneal macrophages
Other tissues and cells:
Lymph node: postcapillary HEV
follicular dendritic cells - B cel zone
Blood: monocytes
Brain: macrophages,
perivascular microglia
Liver: sinusoidal endothelial cells
Smooth muscle cells of atherosclerotic plaques
No expression observed in:
hepatocytes, Langerhans cells, neurons,
arterial endothelial cells, normal smooth muscle cells
SRAIII/MARCO
monomer: 80(
trimer: 210"
Selected tissue macrophages:
Spleen: marginal zone
Lymph node: medulla
Peritoneal macrophages
No expression observed in
spleen metallophilic macrophages
Lung or Liver macrophages
mRNA: adrenal and ovarysteroldogenic cells
moderate: intestine, epididymal fat, mammary
low: lung, testis, liver
Adrenal gland:
ACTH, estrogen, Apo-AI deficiency and
hepatic lipase deficiency, all increase protein/mRNA
monocvtes < macrophages
M-CSF upregulates during differentiation, perhaps via
PU.1, AP1/ets, GATA transcription factors
monocvte derived macrophages:
IFN-y decreases mRNA /activity levels
LPS, GM-CSF decrease mRNA and maybe protein levels
M-CSF increases total and surface protein levels
IFN-y, LPS may act via PU.1
elicited peritoneal macrophages:
M-CSF increases mRNA, surface protein levels
brain: LPS increases protein levels in microglia
increased expression in Alzheimer's disease
SMC: PDGF-BB, PDGF-AA, TNF-a, and phorbol esters
increase mRNA
IFN-y, TGF-B - conflicting reports of up/down-regulation
Unknown
SR-BI
82'
protein: adrenal and ovary steroidogenic cells
moderate: liver, mammary gland
low: testis, intestine, epididymal fat
adipocytes, mammary epithelium
liver sinusoidal endothelial cells,
most capillary endothelial cells
Liver: estrogen decreases protein and mRNA
Testis: HCG increases protein and mRNA
pre-adipocytes < adipocytes
capillary endothelial cells:
IFN-gamma
hi fat diet
phorbol esters
TNF-a, IL-1, TGF-B
transiently increases surface expression
increases surface expression
decreases surface expression
no effect on surface expression
monocytes
peritoneal macrophages
B cells
platelets
sickled reticulocytes
No expression observed in:
Most tissue macrophages
Large artery endothelial cells
monocvtes < macrophages:
mRNA , total and surface protein levels transiently increase,
then decrease during maturation
monocvte derived macrophages:
M-CSF increases mRNA, total and surface protein levels
adherence to TNF-a activated EC increases surface protein level
GM-CSF, IFN-y, IL-18, TNF-a, TGF-1 no effect
monocvtes:
IL-4, IL-6, M-CSF, PMA
M-CSF, PMA
dexamethasone, LPS
increase mRNA
increase total and surface protein levels
decrease mRNA, total, surface protein
dSR-CI
170r
macrosialin/CD68
87-116 n
usually about 95
mRNA: embryonic hemocytes
Protein: S2 and mbn-2 hemocyte-like cell lines
Most tissue macrophages. including:
Lymph gland: T cell zone, not B cell zone
Liver Kupffer cells
Peritoneal macrophages
Elicited/activated macrophages
Dendritic cells/Langerhans cells
Primarily expressed in endosomes,
low levels on surface
Largely unknown
LPS, laminarin increase protein levels in mbn-2 cells
unstimulated < stimulated (thioglycollate, BCG) macrophages
stimulation results in glycoform changes
M-CSF decreases levels in elicited macrophages
CD36
78W88r'n
Chapter Two
Polynucleotide Binding to Macrophage Scavenger
Receptors Depends on the Formation of Base-quartet-
stabilized Four-stranded Helices
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As discussed in the Chapter 1, the class A scavenger receptors exhibit an
unusually broad, but circumscribed, polyanionic ligand-binding specificity. These
ligands include modified proteins such as Ac-LDL and M-BSA, certain
polynucleotides, certain polysaccharides, and a variety of other molecules. Class A
scavenger receptors do not bind all polyanions, however. For example, the
polyribonucleotides poly(l) and poly(G) are ligands but poly(A) and poly(C) are not.
The experiments presented in this chapter were aimed at elucidating the nature of this
polynucleotide ligand specificity. The results of these studies indicated that, in order to
bind to the class A scavenger receptors, oligo- and polynucleotides must adopt a four-
stranded, or quadruplex, helical structure analogous to that formed by telomeric DNA
sequences. All of the experiments described in this chapter were performed by me.
This work was originally published in February 1993 in The Journal of Biological
Chemistry (Pearson et al, 1993). The following modifications have been made to the
original text: 1) the figures have been re-numbered with the prefix "2"; 2) footnotes
describing papers submitted for publication have been changed to references since
these papers have now been published; 3) the references have been merged with
those of other chapters in the "references" section of this thesis.
Since the publication of this work, there have been several developments of
note. First, it is now apparent (see Chapter 1), that there are at least three distinct
classes of scavenger receptors. The experiments in this chapter were described as
having been performed using CHO cells transfected with the bovine type I scavenger
receptor (thus the cells were called CHO[bSR-I] cells). This receptor is now known as
the class A type I receptor, or bSR-AI. Second, for at least one of the molecules used
in these studies, dG12, there has been independent confirmation that the
oligonucleotide adopts a parallel stranded quadruplex structure (Miura and Thomas,
1995). Third, I have some unpublished data concerning the ability of
phosphorothioate oligonucleotides to bind to bSR-AI. These data are presented in the
addendum to this chapter. Fourth, there have been some reports which may shed
some light on the possible functional significance of oligo- and polynucleotide binding
to scavenger receptors. These are also reviewed in the addendum.
It was originally concluded that the spatial distribution of negatively charged
phosphates in the quadruplex structure may form a charged surface which is
complementary to the positively charged surface of the collagenous ligand-binding
domain of the class A scavenger receptor. The addendum to this chapter further
explores this idea. As opposed to most known ligand-receptor systems, in which
ligand binding requires very specific interactions between ligand and receptor that are
susceptible to minor alterations in the structure of either the ligand or the receptor(Creighton, 1984), the interactions between the SR-As and their ligands may not be
strictly specified. Receptor-ligand complementarity in this system may be of a
somewhat flexible and dynamic nature.
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Summary
Macrophage scavenger receptors exhibit unusually broad, but circumscribed,
polyanionic ligand-binding specificity. For example, the polyribonucleotides poly I and
poly G are ligands but poly A and poly C are not. To further investigate the molecular
basis of this polynucleotide-binding specificity, we tested the capacity of various
oligodeoxyribonucleic acids to inhibit the scavenger receptor-mediated degradation of
1251-AcLDL by Chinese hamster ovary cells expressing the type I bovine scavenger
receptor. A series of short oligodeoxyriboguanines (dGn, where 5<nS37) were
effective inhibitors. The dG6, dG12 and dA5G37 members of this series were shown
by circular dichroism and UV spectroscopy to be assembled into four-stranded helices
stabilized by G-quartets. [32P]dA5G37 bound directly to scavenger receptors. Partial
or complete denaturation of the quadruplex structures of these oligonucleotides by
boiling destroyed their inhibitory activity. Receptor activity was also inhibited by
d(T4G4)4 , a telomere - like oligonucleotide which forms an intramolecular quadruplex.
In addition, conversion of the four-stranded potassium salt of poly I to the single-
stranded lithium salt dramatically reduced its inhibitory activity. Addition of KCI to the
Li+ salt resulted in the reformation of poly I's quadruplex structure and restoration of its
inhibitory activity. A variety of single-stranded and double-stranded oligo- and
polydeoxyribonucleotides (e.g., dA37, Haelll restriction fragments of OX174) exhibited
very little or no inhibitory activity. Thus, a base-quartet-stabilized four-stranded helix
appears to be a necessary structural determinant for polynucleotide binding to and
inhibition of scavenger receptors. This conformational requirement accounts for the
previously unexplained polyribonucleotide-binding specificity of scavenger receptors.
The spatial distribution of the negatively charged phosphates in polynucleotide
quadruplexes may form a charged surface which is complementary to the positively
charged surface of the collagenous, ligand-binding domain of the scavenger receptor.
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Introduction
Macrophage scavenger receptors are trimeric integral membrane glycoproteins
which have been implicated in the deposition of lipoprotein cholesterol in artery walls
during the formation of atherosclerotic plaques (Brown and Goldstein, 1983; Steinberg
et al. , 1989) and in pathogen recognition for host defense (Krieger, 1992) . Two
classes of macrophage scavenger receptors have been cloned from bovine, murine,
human and rabbit cDNA libraries (Kodama et al., 1990; Rohrer et al, 1990; Freeman et
al, 1990; Matsumota et al, 1990; Bickel and Freeman, 1992; Ashkenas et al, 1993).
The sequence of the type I bovine scavenger receptor cDNA predicts a 453 amino
acid protein with the following domains (Kodama et al, 1990; Ashkenas et al, 1993): I.
N-terminal cytoplasmic (amino-acid residues 1-50), II1. transmembrane (51-76), III.
spacer (77-150), IV. a-helical coiled-coil (151-271), V. collagenous (272-343), and VI.
C-terminal (344-453), which includes a 102 residue SRCR (scavenger receptor
cysteine-rich) domain. The SRCR domain helped to define a previously unrecognized
family of remarkably well-conserved cysteine-rich protein domains (Freeman et al,
1990; Aruffo et all 1991). The type II scavenger receptor is identical to the type I
receptor, except that the 110-amino-acid C-terminus is replaced by a six-amino acid
C-terminus (Rohrer et al, 1990). Despite its truncated C-terminus, the type II
scavenger receptor mediates the binding and endocytosis of ligands with affinities and
specificity similar to those of the type I receptor (Rohrer et al, 1990; Freeman et al
1991; Hampton et al, 1991). The collagenous domain appears to play a critical role in
ligand binding (Kodama et al, 1991; Krieger, 1992; Acton et al, 1993; Doi et al, 1993).
Unlike most cell surface receptors, macrophage scavenger receptors exhibit
unusually broad ligand specificity (Brown and Goldstein, 1983; Krieger, 1992;
Goldstein et al, 1979; Brown et al, 1980; Kodama et al, 1988). Their high affinity
ligands are polyanions, including certain chemically modified proteins such as
acetylated LDL (AcLDL) and maleylated BSA (M-BSA) and certain polysaccharides,
phospholipids (Hampton et al, 1991; Nishikawa et al, 1990), and polyribonucleotides
(see below). Bacterial endotoxin (lipopolysaccharide) is also a ligand for scavenger
receptors, which appear to play an important role in the rapid clearance of endotoxin
from the circulation by the liver (Hampton et al, 1991).
To learn more about the mechanism underlying the scavenger receptors'
unusual broad binding specificity, we have examined the structural basis of the type I
bovine scavenger receptor's specificity for polyribonucleic acids. Poly I and poly G are
ligands and competitive inhibitors of the scavenger receptor whereas poly C, poly U
and poly A are not (Brown and Goldstein, 1983; Brown et al, 1980; Resnick et al,
1993). It is striking that the polyribonucleotides which are ligands form four-stranded
helices under normal physiological conditions while the polyribonucleotides which are
not ligands do not form such quadruplexes (Arnott et al, 1974; Chou et al, 1977;
Zimmerman et al, 1975; Howard et al, 1977; Roy et al, 1979; reviewed in Gushlbauer
et al, 1990).
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A model for a four-stranded deoxyguanosine quadruplex is shown in Figure 2-
1. This model is based on the 2.5 A resolution X-ray crystal structure of the quadruplex
formed by a dimer of the telomere-like oligodeoxyribonucleotide d(G4T4G4) (Kang et
al, 1992). Figure 2-1A shows the hydrogen bonding between the four guanine bases
of adjacent strands in this structure. The bases in this "G-quartet" are roughly planar(shaded region). In the quadruplex, the G-quartets are held together by the sugar-
phosphate backbones and stack with a right-handed twist, resulting in the formation of
a four-stranded helix. Figure 2-1B shows a hypothetical model of a portion of a
quadruplex which is based on the d(G4T4G4) crystal structure and the proposed
quadruplex structure of poly I and poly G (Arnott et al, 1974; Chou et al, 1977;
Zimmerman et al, 1975). Detailed features of quadruplex structures vary depending
on the oligo- and polynucleotide sequences and ionic conditions (Gushlbauer et al,
1990; Kang et al, 1992; Howard and Miles, 1982a; Williamson et al, 1989; Sundquist
and Klug, 1989; Sen and Gilbert, 1990; Sen and Gilbert, 1992; Hardin et al, 1991;
Smith and Feigon, 1992; Guo et al, 1992a; Lu et al 1992; Chen, 1992; Guo et al,
1992b; Balagurumoorthy et al, 1992). For example, quadruplexes can be composed
either of extended oligo- or polynucleotide strands stabilized by intermolecular base-
quartets, or of strands which fold back on themselves to form intramolecular or mixed
intra- and intermolecular base-quartets. In all cases, the four-stranded helices have
very high negative charge densities due to the close proximity of the phosphate
groups.
In the current study we have tested and confirmed the hypothesis that assembly
of polynucleotide ligands into four-stranded helices is a requirement for their binding
to and consequent inhibition of scavenger receptors. We have also demonstrated that
other quadruplex forming molecules not previously known to inhibit scavenger
receptor activity, including telomeric oligodeoxyribonucleotides, are scavenger
receptor ligands.
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Experimental Procedures
Polynucleotides and oligodeoxyribonucleotides: Two independent preparations of the
lyophilized K+ salt of poly I were purchased from Pharmacia LKB (s20,w values 6.2 and
5.1; molecular masses, estimated by the manufacturer, 111 kD and 72.5 kD,
respectively). These are known to be four stranded in a K+ solution (Howard and
Miles, 1982a). Stock solutions of the K+ salt of poly I (5 mg/ml) in deionized water
(with or without DEPC treatment) were stored at 40C. Two double stranded DNA
preparations were used: Haelll digested fragments of OX174 (New England Biolabs)
and pRc/CMV-s-bSR-l (19), a plasmid derived from pRc/CMV (InVitrogen). Most
oligonucleotides were synthesized on an Applied Biosystems Model 380B automated
DNA synthesizer and deprotected in ammonia at 550C by the Biopolymers Laboratory
at MIT. Deprotected oligonucleotides were dissolved in deionized water and de-salted
over NAP10 or NAP25 columns (Pharmacia), or over Sephadex G-10 (Pharmacia)
columns for oligonucleotides 15 residues or shorter. The de-salting step is not
expected to remove counterions, such as Na+ and K+, which are tightly bound to the
dGn oligonucleotides (Hardin et al, 1991). The fractions containing oligonucleotides
were concentrated by evaporation, resuspended at 0.4 - 4 mg/mi in deionized water,
and stored at -200C. The concentrations of the oligonucleotides were determined from
their OD260 values (conversion factor: 30 Igg/ml for OD260 =1.0 (1 cm path length)
(Sambrook et al, 1989). Due to the hypochromic shift accompanying structure
formation, this method underestimates the concentrations of oligonucleotides which
fold into four-stranded helices (Saenger, 1984). The oligonucleotide R101 was a gift
from Mr. Jonathan Wallach (MIT), and the oligonucleotide oSP24 was provided by Mr.
Steven Podos (MIT). Preparations of d(T4G4)4 were independently provided by Drs.Q. Guo and N. Kallenbach (New York University) and Dr. J. Williamson (MIT). They
were synthesized and isolated in the quadruplex forms as described elsewhere
(Williamson et al 1989; Guo et al, 1992a). The dA5G37 was 5' end labeled with [y-
32p]dATP and T4 polynucleotide kinase (IBI) by standard procedures (Sambrook et
al, 1989)
Preparation of the Li+ and Lj+/K+ salts of olyj I - The Li+ and ULi+/K+ salts of poly I were
prepared following the protocol of Howard and Miles (1982a; 1982b). Briefly, stock
solutions of the K+ salt of poly I (0.5 ml) were converted to the Li+ salt by successive
dialysis against 4 liters of the following solutions: 0.5 M LiCI, 1 mM EDTA (3 hours,
room temperature); 0.5 M LiCI (2 hours, 40C); 3 changes of 0.1 M LiCI (19 to 23 hours
total, 40C); and 4 changes of deionized water (74 to 95 hours total, 40C). Any poly I
molecules significantly smaller than the molecular weight cut-off (MWCO) of the
dialysis tubing (6 - 8 kD) were probably lost during dialysis. In some cases, the Li+ salt
of poly I was converted to the Li+/K+ salt by addition of KCI (final concentration: 150 or
200 mM). These preparations were stored at 40C for at least four days before use in
1251-AcLDL degradation assays. The poly I concentration of each sample was
determined spectrophotometrically (conversion factor: 40 gg/ml for OD260 =1.0 (1 cm
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path length) (Sambrook et al, 1989)). In several experiments, the concentrations of
the poly I isoforms were also determined after digesting the specimens to monomers
with Nuclease P1 (Pharmacia; 0.2 units enzyme in 20 ll reaction volume, 4.5 hours at
500C) and using an extinction coefficient for 5'-IMP of 12.2 ml/pmol-cm at 249 nm(Fasman, 1975) (not shown). This method for correcting errors due to the hypochromic
shift did not significantly alter the results.
Other reagents (and sources) include: Na1251 (Amersham), and [y-32P]dATP (New
England Nuclear); LDL (Krieger, 1983; Goldstein et al, 1983), AcLDL (Goldstein et al,
1979), M-BSA (Goldstein et al, 1979), and 1251-AcLDL (Goldstein et al, 1979; Krieger,
1983; Goldstein et al, 1983) were prepared as previously described. Dialysis tubing
was obtained from either Spectrum (MWCO 6-8 kD) or Union Carbide (MWCO 12-14
kD). Care was taken to avoid contaminating the tubing with RNAses during
preparation and storage.
Gel Filtration Chromatographv - Oligonucleotide samples (20 to 50 gg/mi) in Buffer A(10 mM Tris-CI, pH 7.6, 146 mM NaCI, 3 mM KCI, 0.6 mM MgCI2, 0.3 mM CaCI2; salt
composition similar to that of Hams F-12 medium (Ham, 1965) were filtered through a
0.45 pm Millex HA filter (Millipore). The samples were analyzed at 40C using a
Pharmacia LKB 500 FPLC system with a Superose 6 HR 10/30 column (pre-
equilibrated in Buffer A) at a flow rate of 0.5 ml Buffer A/min. The absorbance at 254
nm of the eluted material was continuously recorded using a UV-M II optical unit with a
2 mm path length. There was some variability from preparation to preparation in the
heterogeneity of the size distributions observed (see Results). Poly I isoforms (50
gg/ml) in Buffer B (20 mM Tris-CI, pH 8.0, 150 mM NaCI, 1 mM CaCI2) were subjected
to similar FPLC analysis after clarification by centrifugation (13,000 x g, 15 sec. 40C).
SDectroscopic (UV) Melting Curves - Melting curves in Buffer C (1 mM Na2HPO4, 130
mM NaCI, 3 mM KCI, 0.6 mM MgCI2, 0.3 mM CaCI2, 3 IM FeSO4, 3 pM ZnSO4, 10
nM CuSO4, 10 mM glucose, pH 7.4; formulated to closely match Hams F-12 medium
(Ham, 1965)) of the untreated K+ salt of poly I, its Li+ salt, and its Li+/K + salt (all at 25
gg/ml) were obtained at 247 nm using an Aviv Model 118 DS spectrophotometer.
Absorbance was recorded from 100C to 900C in 20C steps, with an equilibration time
of 1.5 minutes, and an acquisition time of 45 seconds. The absorbance values
presented represent the differences between the values obtained for poly I in Buffer C
and for Buffer C alone. Similar results were obtained for poly I in Hams F-12 medium(data not shown).
Circular Dichroism (CD) - CD spectra of dGn oligonucleotides dissolved in water at
either 35 gg/ml for dG12 and dA5G37 (106 IM in nucleotide residues) or 15.3 lg/ml for
dG6 (46 pM) were collected at 370C on an Aviv Model 60DS equipped with a
thermoelectric controller (1 cm cell, dynode voltage remained below 400 mV).
Spectral scans of untreated samples were taken in 1 nm steps with an acquisition time
of 5 seconds/datum. Each sample was then placed in boiling water for 15 minutes,
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cooled at room temperature for 30 minutes, and re-scanned. The ellipticity values
presented represent the differences between the values obtained for the
oligonucleotide solutions and for a water blank and are corrected for specimen
concentrations as previously described (Cantor and Schimmel, 1980). UV spectra
were recorded concurrently.
Cell Culture: All incubations with cells were performed at 370C in a humidified 5%
C02/95% air incubator. Stock cultures of wild-type CHO cells were maintained in
medium A (Ham's F-12 supplemented with 100 units/mi penicillin, 100 Ag/ml
streptomycin, 2 mM glutamine, and 5% (v/v) FBS). The isolation of transfectants
expressing the type I bovine scavenger receptor (CHO[bSR-I], clone I-B2) and the type
II bovine scavenger receptor (CHO[bSR-II], clone 11-5) was described previously(Freeman et al, 1991). Transfectants were maintained in MAC3 medium (medium A
containing 3% new born calf lipoprotein deficient serum in place of the FBS, and
supplemented with 0.5 mg/mi geneticin (G418, Gibco), 250 AIM mevalonate, 40 AM
compactin and 3 Ig protein/mi of AcLDL), which provides selective pressure for the
expression of scavenger receptor activity as previously described (Freeman et al,
1991). Media components, including sera, were obtained or prepared as previously
described (Freeman et al, 1991; Krieger, 1983).
Assays: Scavenger receptor activity at 370C was assessed by measuring cellular
degradation of 1251-AcLDL in 24 well culture dishes as previously described
(Goldstein et al, 1979; Krieger, 1983; Goldstein et al, 1983). Unless otherwise noted,
CHO[bSR-I] cells were seeded at a concentration of 60,000 cells/well in medium B(medium A supplemented with 0.5 mg/mi G418) on day 0. On day 2, 5 pg protein/mi of
1251-AcLDL (153-630 cpm/ng protein) were added to the wells in 0.5 ml of culture
medium in the absence (triplicate determinations) or presence (duplicate
determinations) of the indicated additions. The culture medium used for these assays
was either medium A or medium C (medium A containing 10 units/ml of E. Coli RNAse
inhibitor (Calbiochem) and 1% (v/v) ITS+ (an insulin, transferrin, selinium and linoleic
acid/albumin supplement from Collaborative Research) in place of FBS). After a 5 or
5.5 hour incubation at 370C, the amounts of 125 1-AcLDL degradation products
released into the media were measured and are presented as ng of 125 1-AcLDL
protein degraded per 5 (5.5) hours per mg of cell protein. Cellular binding and uptake
of [32p]dA5G37 after an incubation for 5 hours at 370C was measured by washing the
monolayers 6 times at 40C as previously described (Goldstein et al, 1983), solubilizing
each monolayer with 500 I1 of 0.1 N NaOH for 15 min at room temperature,
neutralizing each sample with 50 jIl of 1 N HCI, and counting 110 •l aliquots in 5 ml of
Ultrafluor scintillation fluid (National Diagnostics). The binding plus uptake values are
given as cpm bound plus internalized per 5 hours per mg of cell protein. Protein
concentrations were determined by the method of Lowry et. al. (Lowry et al, 1951).
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Results
To test the hypothesis that polynucleotide ligands bind to and inhibit scavenger
receptors when the ligands are assembled into four-stranded helices, we synthesized
and analyzed the properties of an oligodeoxyribonucleotide, dA5G37. Guanine-rich
oligo- and polynucleotides have been shown to adopt four-stranded, or quadruplex,
structures via the formation of inter- and/or intramolecular G-quartets (Zimmerman et
al, 1975; Balagurumoorthy et al, 1992; Gray and Bollum, 1974; Panyutin et al, 1990;
Bonazzi et al, 1991). The five adenosine residues at the 5' end were included to
facilitate 32P-end-labeling with polynucleotide kinase (see below). Figure 2-2 shows
that this oligonucleotide inhibited scavenger receptor activity, as measured by the
degradation of 1251-AcLDL by CHO cells expressing the bovine type I scavenger
receptor (CHO[bSR-I] cells). The 50% inhibitory dose (ID50) was 1.1 ± 0.5 Igg/ml(average ± standard deviation from seven experiments) and virtually all of the
scavenger receptor activity was inhibited at an oligonucleotide concentration of 25
Lg/ml. The control molecule dA37, which is not expected to form quadruplex
structures, did not significantly inhibit 125 1-AcLDL degradation at this concentration
(95 ± 11% of control activity, from four experiments).
These inhibition data suggested that dA5G37 might bind directly to the
scavenger receptor and competitively inhibit 1251-AcLDL degradation. This
conclusion was supported by experiments which showed that dA5G37, but not dA37,
could also block the specific binding of a soluble form of the type I bovine scavenger
receptor to M-BSA beads (Resnick et al, 1993; and data not shown). Thus, it is
unlikely that the dA5G37 was interfering with 1251-AcLDL degradation because of
binding to 125 1-AcLDL rather than to the receptor.
To more directly examine oligonucleotide binding to the receptor, we end-
labeled dA5G37 with [32p]phosphate and measured it's binding and uptake by
CHO[bSR-I] cells. Figure 2-3A shows that specific [32P]dA5G37 binding and uptake
(open circles) at low concentrations (<10 gg/ml) was saturable and was characterized
by a dissociation constant of approximately 1 gg/ml. This Kd was similar to the ID5o
determined by inhibition of 1251-AcLDL degradation. The specific binding plus uptake
shown in Figure 2-3A was calculated by subtracting the "nonspecific" cell associated
[32p]dA5G37 measured in the presence of a large excess of the scavenger receptor
inhibitor M-BSA (400 gg/ml, solid squares, Figure 2-3B) from the total cell associated
[32p]dA5G37 (Figure 2-3B, solid circles). The nonspecific binding plus uptake was
relatively high and increased linearly with increasing [32P]dA5G37 concentrations.
The relationship of this non-specific binding plus uptake to the previously reported
cellular uptake of oligonucleotides is not clear (Loke et al, 1989; Yakubov et al, 1989).
To verify that the specific cell association of [32p]dA5G37 (Figure 2-3A) was due to
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scavenger receptor expression, we measured the binding plus uptake of [32P]dA5G37
by untransfected CHO cells, which express essentially no scavenger receptor activity(Freeman et al, 1991; Hampton et al, 1991; Goldstein et al, 1979). The untransfected
CHO cells exhibited little or no M-BSA competable [32P]dA5G37 binding and uptake
over the concentration range shown in Figure 2-3 (data not shown). Figure 2-3C
shows the transfection-dependent binding plus uptake of [32P]dA5G37 (open
triangles), which was calculated by subtracting the values for the total binding plus
uptake for untransfected cells (panel D, solid triangles) from those for the cells
expressing the type I bovine scavenger receptor (panel D, solid circles). The shapes
of the curves for the transfection-dependent data (panel C) and the M-BSA-
competable ("specific") data (panel A) were remarkably similar. Taken together, these
data clearly establish that [32P]dA5G37 bound to scavenger receptors in a saturable
manner with high affinity.
We next examined the effect of varying the length of dGn oligonucleotides on
their inhibition of 1251-AcLDL degradation by CHO[bSR-I] cells. The monomers
5'dGMP and 3'dGMP and the dimer dGpG at concentrations of up to 100 gpg/ml failed
to inhibit receptor activity (data not shown). However, all dGn oligonucleotides tested
with n > 5 were inhibitors (Figure 2-4A, dG3 and dG4 were not examined). Essentially
complete inhibition was observed at 53 gig/ml for n>12. The level of maximal inhibition
decreased as the oligonucleotide length decreased from n=10 to n=5. However, the
apparent affinity for the receptor for at least one of these shorter oligonucleotides, dG6,
did not appear to be substantially less than that for dG12 or dA5G37 (Figure 2-4B).
The molecular basis for this length dependence of maximal inhibitory activity has not
yet been determined. We have recently observed that a form of bacterial endotoxin,
ReLPS (lipopolysaccharide), can only partially inhibit scavenger receptor mediated
degradation of 1251-AcLDL by transfected CHO cells expressing the bovine type II or
murine type I scavenger receptors (Ashkenas et al, 1993). The relationship, if any,
between the partial inhibition of activity by the short dGn's and the partial inhibition of
activity by ReLPS has not yet been established.
The relationships of the structures of several dGn compounds to their inhibitory
activities were assessed using CD spectroscopy at 370C and denaturation by boiling
in deionized water. Figure 2-5 shows the CD spectra of dG6, dG12 and dA5G37,
before and after boiling. All three spectra of the untreated materials show maxima
centered near 261 nm and 209 nm, minima near 241 nm, and distinctive shoulders
near 230 nm (Figure 2-5A). The spectra of these untreated oligo dGn's were similar to
previously reported spectra of quadruplex polynucleotides, including dG5 (Gray and
Bollum, 1974), dG6 (Bonazzi et al, 1991), and dG12 (Balagurumoorthy et al, 1992),
poly G (Howard et al, 1977), poly dG (Gray and Bollum, 1974), and telomeric (Guo et
al, 1992a; Lu et al, 1992; Chen, 1992; Lu et al, 1993; Guo et al, 1995) and model
telomeric sequences (Hardin et al, 1991; Hardin et al, 1992). Furthermore, the
location of the maxima near 261 nm suggests that these oligo dGn quadruplexes were
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composed of parallel rather than antiparallel oligonucleotide chains, presumably with
all anti- glycosidic bond conformations (see Discussion). Boiling in water for 15
minutes reduced the size of the peaks, shifted the minima near 241 nm and the
maxima near 261 nm to shorter wavelengths by 2 to 5 nm, and eliminated the shoulder
near 230 nm (Figure 5B). These effects, which were most pronounced for dG6, have
previously been seen in similar molecules as a result of heating, and have been
ascribed to the melting of G-quartet stabilized four-stranded structures into single
stranded oligonucleotides (Gray and Bollum, 1974; Hardin et al, 1991; Guo et al,
1992a; Lu et al, 1992). Concurrent UV scans showed that the absorbances were
significantly greater at 290-310 nm for the untreated specimens than for the boiled
samples, and that there were significantly more pronounced shoulders near 275 nm in
the spectra of the boiled samples than those near 280 nm in the spectra of the
unboiled samples (data not shown). Similar results have been reported for dG5 (Gray
and Bollum, 1974), poly G (Pochon and Michelson, 1965) and for telomeric four-
stranded G-quartet structures (Zahler et al, 1991). Therefore, these CD and UV
spectroscopic results provide strong evidence that dG6, dG12, dA5G37, and
presumably the other dGn compounds, formed G-quartet-stabilized parallel stranded
quadruplexes, and that boiling for 15 minutes in deionized water, followed by re-
equilibration for 30 minutes at room temperature, resulted in the partial or complete
denaturation of the quadruplexes.
Further characterization of these oligo dGn's by FPLC analysis supported these
conclusions. Superose 6 chromatography at 40C (Figure 2-6) showed that the
untreated dG6, dG12 and dA5G37 preparations exhibited extremely heterogeneous
size distributions and included material with very large stokes radii (small elution
volumes near the void volume of the column). Similar FPLC profiles were seen at
370C (data not shown). In every case, boiling in deionized water substantially reduced
the apparent sizes of these oligonucleotide complexes (data not shown). Therefore, it
is likely that intermolecular G-quartets non-covalently crosslinked the oligonucleotides
into large and heterogeneous aggregates. These results are consistent with the
previously reported G-quartet-mediated formation of aggregates by guanine rich
oligonucleotides (Ralph et al 1962; Gray and Bollum, 1974; Frank-Kamenetskii, 1989;
Chung and Muller, 1991; however see Bonazzi et al, 1991)
Denaturation of the four-stranded dG6, dG12 and dA5G37 complexes by boiling
dramatically reduced their capacity to inhibit scavenger receptor activity (Table 2-1).
We assume, but have not shown, that the denatured oligonucleotides did not renature
in the culture medium during the assay of receptor activity. Taken together, these
spectroscopic, chromatographic and inhibition data, along with structural data from
other laboratories, provide strong support for the proposal that the formation of G-
quartet-stabilized four-stranded structures was responsible for dGn binding to and
inhibition of the scavenger receptor.
Additional evidence for the importance of four-stranded structures in mediating
the binding to and inhibition of scavenger receptors by polynucleotide ligands was
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obtained in studies of the structure and activity of the polyribonucleotide poly I. X-ray
fiber diffraction and other methods have shown that, under normal physiologic
conditions, poly I chains form parallel four-stranded helices held together by
hydrogen-bonded inosine-quartets (Rich, 1958; Arnott et al, 1974; Chou et al, 1977;
Zimmerman et al, 1975). Inosine bases lack the N2 group of guanine; therefore,
unlike G-quartets which are stabilized by 2 hydrogen bonds between each pair of
bases (Figure 2-1A), inosine-quartets contain only one hydrogen bond between each
pair of bases. Formation of poly I quadruplexes has a striking dependence on the type
of monovalent cation available. Na+ and K+ promote the formation of and stabilize the
four-stranded helical structure by forming coordination complexes with the bases. In
contrast, the Li+ salt of poly I in the absence of such stabilizing cations is primarily
single stranded (Miles and Frazier, 1978; Howard and Miles, 1982a). Miles and co-
workers have shown that preparations of poly I can be cycled between the "denatured"
single-stranded form (prepared by extensive dialysis with buffers containing Li+ as the
only monovalent cation) and the four-stranded form (by subsequent addition of Na+
and/or K+) (Howard and Miles, 1982a).
The untreated K+ salt of poly I exhibited a heterogeneous size distribution and
included material with very large stokes radii as determined by FPLC (Figure 2-7A).
Extensive dialysis against LiCI in water converted the poly I to a homogeneous
preparation of presumably single-stranded molecules with substantially smaller
apparent mass (smaller stokes radius) than the K+ salt form (Figure 2-7B). Based on
the elution volume, the single-stranded Li+ salt of poly I was approximately 19
nucleotides in length. Therefore, it appears that the large apparent mass and the
heterogeneity of the untreated K+ salt was due to the formation of inosine-quartet-
stabilized aggregates, as was the case for the G-quartet-stabilized oligo dGn
molecules described above. After addition of 200 mM KCI to the Li+ salt of poly I, and
subsequent incubation at 40C for several days, the heterogeneous mixture of large
aggregates was reformed (Figure 2-7C), although the average apparent size was
somewhat less than that of the initial K+-form prior to the salt exchange (Figure 2-7A).
To confirm that the structures of these poly I preparations were undergoing the
expected cation-dependent quadruplex/monomer transitions, we examined the
temperature-dependence of their UV absorbances at 247 nm (Howard and Miles,
1982a, 1982b) As shown in Figure 2-8, both untreated poly I (solid circles) and the
Li+/K + salt (open diamonds) displayed cooperative melting transitions between 300-
450C in a buffer containing a variety of salts at physiologic concentrations (see
Experimental Procedures). In contrast, the Li+ salt of poly I (open circles) did not
exhibit a similar temperature-dependent shift in absorbance at 247 nm between 1 00C
and 750C; indeed, it's absorbance at all temperatures was similar to those of the high
temperature (melted) forms of the untreated and Li+/K+ salts of poly I. Together with
the FPLC data described above, these results indicate that our preparation of the Li+
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salt of poly I consisted predominantly of denatured, single-stranded molecules, while
the untreated and Li+/K + preparations were predominantly aggregated quadruplexes.
Figure 2-9 shows a comparison of the abilities of the quadruplex and
predominantly single stranded poly I isoforms to inhibit 1251-AcLDL degradation by
CHO[bSR-I] cells. The untreated K+ salt of poly I (open squares) inhibited scavenger
receptor activity with an ID50 of ~1.0 gg/ml, and the inhibition was essentially complete
at 4 gg/ml. In contrast, the Li+ salt of poly I (open triangles) was a much less efficient
inhibitor; there was 50% inhibition at -7 gg/ml and the activity was not fully inhibited
even at the highest concentrations of poly I tested (18% of control activity at 71 gg/ml).
Although we were unable to detect, using FPLC, the formation of poly I aggregates
during the course of this experiment (data not shown), the relatively low residual
activity of the Li+ salt may have been due in part to the presence of small amounts of
residual quadruplex structure after dialysis and addition to the assay medium (Miles
and Frazier, 1978; Howard and Miles, 1982a). The addition of 200 mM KCI to the Li+
salt of poly I (solid squares) restored it's inhibitory activity: the ID50 was -1.2 gg/ml,
and inhibition was essentially complete at 6 gg/ml. Three other independent Li+-
dialysis/KCI-addition experiments, each using either one or two different commercial
preparations of poly I, gave similar results. The inhibitory activity of the Li+/K + salt of
poly I at 370C was somewhat greater than might be expected based on the melting
curve in Figure 2-8. This may be due to differences in the experimental conditions of
the spectroscopic and receptor-activity assays which might alter the stability of the
four-stranded form of poly I. For example, the Na+ concentration in the degradation
assay was approximately 146 mM, while it was 132 mM in the spectroscopic assay.
Small differences in ion concentrations can have a significant effect on poly I stability(Howard and Miles, 1982a). Also, BSA and other proteins were present in the Ham's
F12 medium used in the receptor activity assays but not in the UV melting experiments(see Experimental Procedures).
In the experiment shown in Figure 2-9, an RNAse inhibitor from E. Coli was
used to protect all three poly I isoforms and poly C (used as a negative control, not
shown) from extensive RNAse degradation during the 5 hour incubation with cells. We
have found that the inclusion of an RNAse inhibitor to the cell culture assay media was
essential to prevent the virtually complete hydrolysis of poly C to mono and
dinucleotides. The quadruplex polyribonucleotides appeared to be resistant to this
degradation, as assessed by FPLC analysis (data not shown). The enzymatic and
chemical lability of polyribonucleotides such as poly C should be considered when
using these molecules as negative controls in scavenger receptor studies.
All of the quadruplex-forming oligonucleotide and polyribonucleotide molecules
described above aggregated into heterogeneous, higher order structures as
determined by FPLC analysis (for example, see Figures 2-6 and 2-7). To determine if
oligonucleotides which form small, homogeneous, quadruplex structures could also
inhibit scavenger receptor activity, we tested the inhibitory activities of several
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telomere-like oligonucleotides. Unlike the heterogeneous four-stranded dGn and poly
I molecules described above, many model telomeres fold into well-defined
intramolecular G-quartet-stabilized monomeric structures (Williamson et al, 1989;
Sundquist and Klug, 1989; Kang et al, 1992; Smith and Feigon, 1992; Guo et al,
1992a). Two preparations of d(T4G4)4 were obtained in the monomeric,
intramolecularly folded four-stranded form from two independent sources (Williamson
et al, 1989; Guo et al, 1992a) Both of these oligonucleotides exhibited moderate
scavenger receptor-inhibitory activity (the average receptor activity in the presence of
25 Itg oligonucleotide/ml was 43% of control), which was similar to those of dG5 and
dG6 (Figure 3 and data not shown). We synthesized the related oligonucleotide
d(G4T4)5 and found using FPLC (not shown) that it was composed of a mixture of two
discrete species with Stokes radii approximately equivalent to those expected for
dA22 and dA67. The d(G4T4)5 was an effective inhibitor of scavenger receptor activity
(22 ± 9% of control activity at 25 gg/ml, average from three experiments), with activity
approaching that of dG12. We therefore conclude that at least some oligonucleotides
with model telomeric sequences can inhibit scavenger receptors, presumably due to
their binding directly to the receptors. Thus, short oligonucleotides with well-defined
G-quartet structures, as well as longer polynucleotides and the heterogeneous dGn
complexes described above, can be effective inhibitors of scavenger receptors.
We have examined the capacity of several other oligo- and polynucleotides to
inhibit scavenger receptors. Table 2-2 shows that those molecules not expected to
form quadruplexes, including double stranded DNA, were very poor inhibitors of
scavenger receptor activity, while those expected or previously shown to form base-
quartet stabilized four-stranded molecules were effective inhibitors. In combination
with previous reports of the polynucleotide specificity of scavenger receptors (Brown et
al, 1980; Brown and Goldstein, 1983), the current studies provide strong support for
the proposal that the formation of quadruplex structures is an important determinant in
the binding to and inhibition of scavenger receptors by oligo- and polynucleotides.
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Discussion
The broad ligand binding specificity of macrophage scavenger receptors has
been well-defined but is poorly understood. A large number of polyanions inhibit
scavenger receptor-mediated binding, uptake and degradation of AcLDL (Goldstein et
al, 1979; Brown et al, 1980; Brown and Goldstein, 1983; Kodama et al, 1988;
Nishikawa et al, 1990; Hampton et al, 1991 Krieger, 1992). These inhibitors include
certain modified proteins, carbohydrates, lipids and polyribonucleic acids. In many
cases, these inhibitors have been shown to be ligands for the receptor and thus
competitive inhibitors. However, there are many other polyanionic proteins,
carbohydrates, and polyribonucleic acids that do not inhibit AcLDL degradation. For
example, poly I and poly G are good inhibitors but poly A, Poly C, and poly U are not.
After determining the primary structures of the type I and type II bovine macrophage
scavenger receptors, we suggested that their common extracellular collagenous
domain, which is highly cationic and well conserved among mammalian scavenger
receptors (Ashkenas et al, 1993), was a likely site of polyanionic ligand binding(Kodama et al, 1990; Rohrer et al, 1990). Recent experiments have confirmed this
proposal (Acton et al, 1993; Doi et al, 1993; Kodama et al, 1991). It seems likely that
the spatial distribution of the positively and negatively charged side chains in this
domain plays a critical role in distinguishing between polyanionic ligands and
polyanions that do not bind (Krieger et al, 1993).
In the current study, we have extended the list of scavenger receptor inhibitors
to include specific types of oligodeoxyribonucleic acids, and we have determined the
structural basis of the type I bovine scavenger receptor's specificity for particular
polyribonucleic and oligodeoxyribonucleic acids. Short dGn oligonucleotides, where
5<n<37, and certain telomere-like oligonucleotides (e.g., d(G4T4)5) effectively
inhibited type I bovine scavenger receptor activity. Experiments using transfected
CHO cells expressing the type II bovine scavenger receptor gave similar results,
although oligonucleotide inhibition of the type II receptors was generally not as potent
as was inhibition of the type I receptors (A. Pearson and M. Krieger, unpublished data).
Cell binding studies with [32P]dA5G37 established that this oligonucleotide, and
presumably the other dGn 's, bound directly to the type I scavenger receptor and
suggest that these molecules functioned as competitive inhibitors. These
oligonucleotides and all of the previously described polyribonucleotide inhibitors can
form four-stranded helices stabilized by either inter- or intramolecular hydrogen-
bonded base-quartets (e. g., "G-quartets" see Figure 2-1) (Brown et al, 1980; Brown
and Goldstein, 1983; Rich, 1958; Arnott et al, 1974; Chou et al, 1977; Zimmerman et al,
1975; Howard et al 1977; Roy et al, 1979; Williamson et al 1989; Panyutin et al, 1990;
Bonazzi et al, 1991; Guo et al, 1992a)
The inhibitory activities of these molecules were dramatically reduced when
their four-stranded helical structures were disrupted, either by boiling in deionized
water in the case of the dGn's or by Li+ denaturation in the case of poly I. The
coordinate denaturation and loss of activity of poly I were reversible; its quadruplex
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structure and its inhibitory activity were restored by the addition of KCI to the Li+ salt.
A set of control oligo- and polynucleotides which do not form, or are not expected to
form, four-stranded helices (e.g., dA37, OX DNA) did not inhibit scavenger receptor
activity. Thus, the formation of a base-quartet-stabilized four-stranded helix appears to
be a necessary structural determinant for the activity of oligo- and polynucleotide
inhibitors of scavenger receptors.
It has recently been reported that dGlo aggregates, which were presumably
four-stranded, but not dC10, dA1o or boiled dGlo, can bind to topoisomerase II and
inhibit its activity (Chung and Muller, 1991). A comparison of the bovine scavenger
receptor amino acid sequence with that of the human (Tsai-Pflugfelder et al, 1988) or
yeast (Giaever et al, 1986) topoisomerases showed no significant homology(unpublished observations). The topoisomerase II sequences do contain many
clusters of basic residues which might interact with the phosphates in aggregated
dGlo.
Three other proteins have been reported to bind to guanine-rich
oligonucleotides. The Oxytricha telomere-binding protein (Raghuraman and Cech,
1990), the Oxytricha telomerase (Zahler et al, 1991), and an avian telomere-binding
protein (Gualberto et al, 1992) bind to oligonucleotides with telomeric sequences (e. g.
d(T4G4)4). The two invertebrate proteins appear to differ from the scavenger receptor
since they bind to the unfolded form of this telomeric oligonucleotide, rather than to the
folded quadruplex form (Raghuraman and Cech, 1990; Zahler et al, 1991). It has been
suggested that the vertebrate binding protein recognizes G - G base pairs in telomere-
like oligonucleotides (Gualberto et al, 1992). The scavenger receptor may provide an
additional tool for the analysis of telomeric structures in natural nucleic acids. For
example, the scavenger receptor may be able to detect quadruplex conformations in
chromosomes.
It is important to note that the detailed three dimensional structures of
quadruplex oligonucleotides and polynucleotides can vary. The quadruplexes can be
stabilized by intermolecular base-quartets between either parallel (Rich, 1958; Arnott
et al, 1974; Chou et al, 1977; Zimmerman et al, 1975; Gushlbauer et al, 1990; Sen and
Gilbert, 1988; Gupta et al, 1993) or antiparallel (Gushlbauer et al, 1990; Jin et al, 1990;
Hardin et al, 1991; Wang et al, 1992) extended polynucleotide strands. Alternatively,
the strands can fold back on themselves to form quadruplexes stabilized by
intramolecular or mixed intra- and intermolecular base-quartets (Williamson et al,
1989; Sundquist and Klug, 1989; Gushlbauer et al, 1990; Panyutin et al, 1990; Kang et
al, 1992; Smith and Feigon, 1992). The orientations of the bases with respect to the
sugar-phosphate-backbones can be all anti in the case of parallel strands (Arnott et al,
1974; Chou et al, 1977; Zimmerman et al, 1975; Gupta et al, 1993), or they can
alternate between syn and anti when the strands fold back on themselves and/or are
antiparallel (Henderson et al, 1987; Gushlbauer et al, 1990; Kang et al, 1992; Smith
and Feigon, 1992; Wang et al, 1992). The four polynucleotide chains are equidistant
from each other when the strands are parallel. However, when the chains fold back on
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themselves, some of the sugar-phosphate chains are closer together and others are
further apart, as in the d(G4T4G4) dimer (Kang et al, 1992) (Figure 1A), so that the
helical grooves are alternately wide or narrow. Quadruplex structures can also vary
depending on the ionic environment, the method of sample preparation, and sample
concentration and history (compare Howard and Miles, 1982a; Sen and Gilbert, 1988,
1990, 1992; Sundquist and Klug, 1989; Williamson et al, 1989; Gushlbauer et al,
1990; Panyutin et al, 1990; Jin et al, 1990; Hardin et al, 1991; Zahler et al, 1991; Kang
et al, 1992; Smith and Feigon, 1992; Guo et al, 1992a; Lu et al, 1992; Chen, 1992;
Guo et all1992b; Balagurumoorthy et al, 1992; Wang et al, 1992; Gupta et al, 1993; Lu
et al, 1993; Guo et al, 1995). For example, the telomeric oligonucleotide d(G4T4G4)
has been reported to form a quadruplex with Na+ counterions whose structure differs
in a number of ways from that of the quadruplex formed with K+ counterions (Kang et
al, 1992; Smith and Feigon, 1992).
The detailed structures of the quadruplexes used in this study varied
considerably. Some consisted of large aggregates of non-covalently associated
oligo- and polynucleotides, while others were clearly small monomeric structures. The
poly I quadruplex comprises four individual and parallel polyribonucleotide strands(Rich, 1958; Arnott et al, 1974; Chou et al, 1977; Zimmerman et al, 1975). It is likely
that the individual strands are not in register. As a consequence, the ends of the
quadruplexes might be free to fold-back to form intramolecular, antiparallel structures.
The telomere-like oligonucleotide d(T4G4)4 repeatedly folds back on itself to form an
intramolecular quadruplex containing G-quartets and T loops (Williamson et al, 1989;
Guo et al, 1992a). Adjacent guanine segments are therefore oriented in an
antiparallel fashion in this quadruplex. The telomere-like oligonucleotide d(G4T4)5
apparently forms at least two different quadruplex species whose detailed structures
have not been determined.
The dGn oligonucleotides used in this study could have formed either parallel
quadruplexes, like poly I and poly G, or folded back antiparallel quadruplexes, like the
telomeric oligonucleotides, or perhaps a mixture of both. Recent studies of telomere-
like oligonucleotides have demonstrated that circular dichroism provides a sensitive
technique for distinguishing between parallel and antiparallel quadruplex
conformations (Chen, 1992; Balagurumoorthy et al, 1992; Lu et al, 1993; Gupta et al,
1993). A strong positive band centered near 260-265 nm in the CD spectrum
correlates with a parallel quadruplex conformation (Hardin et al, 1991, 1992; Guo et al,
1992a; Lu et al, 1992; Chen, 1992; Balagurumoorthy et al, 1992; Gupta et al, 1993;
Guo et al, 1995). On the other hand, a strong positive band centered near 295 nm
accompanied by a weak negative band near 265 nm correlates with an antiparallel
conformation (Williamson et al, 1989; Jin et al, 1990; Hardin et al, 1991; Kang et al,
1992; Smith and Feigon, 1992; Guo et al, 1992a; Chen, 1992; Balagurumoorthy et al,
1992; Wang et al, 1992; Lu et al, 1993; Guo et al, 1995). These recent results are
supported by CD studies of dG5 and poly G (Howard et al, 1977; Gray and Bollum,
1974), as well as more recent studies of several oligo dGn's (Bonazzi et al, 1991).
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Thus, our CD results indicate that the oligo dGn molecules used here were
predominantly parallel-stranded quadruplex structures.
We have not yet determined whether all or only a subset of the many possible
quadruplex conformations can inhibit scavenger receptor activity. Therefore, even
though a four-stranded structure appears to be necessary for nucleic acid inhibition of
the scavenger receptor, it may not be sufficient. There may be quadruplex-forming
oligonucleotides which cannot inhibit scavenger receptor activity.
The results of this study suggest the possibility that the spatial distribution of
negatively charged phosphates in oligo- and polynucleotide quadruplexes can form a
charged surface which is complementary to the positively charged surface of the
collagenous domain of the scavenger receptor. This could account for the previously
unexplained, striking polynucleotide binding specificity of this receptor (Brown et al,
1980; Brown and Goldstein, 1983) and our recent finding that the collagenous domain
of complement factor Clq exhibits polyanionic ligand binding whose specificity is
similar, but not identical, to that of scavenger receptors (Acton et al, 1993; Raepple et
al, 1976). These results suggest that further analysis of the known structures of
collagen and quadruplexes will provide additional insights into the binding properties
of scavenger receptors.
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Figure 2-1. Structure of a G-Quartet (A) and model of a segment of an extended base-
quartet stabilized four-stranded helix (B).
Panel A shows a molecular model of a G-quartet, adapted from the x-ray crystal
structure of a d(G4T4G4) dimer (Kang et al, 1992). The oxygen, nitrogen, and
phosphorus atoms are shown as open, solid, and hatched circles, respectively.
Hydrogen bonds are indicated by dashed lines. In the structure of the d(G4T4G4)dimer the oligonucleotide chains fold back on themselves to form an antiparallel
quadruplex (not shown). As a consequence, the base conformations around the G-
quartet alernate between syn and anti and the quadruplex has wide and narrow
helical grooves (see Discussion). Panel B shows a hypothetical model of an extended
parallel, four-stranded helix, based in part on the X-ray fiber structures of poly I and
poly G (Arnott et al, 1974; Chou et al, 1977; Zimmerman et al, 1975). The shaded
planes represent the base-quartets (see text).
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Figure 2-2. Inhibition of cellular 125 1-AcLDL degradation by dA5G37.
CHO[bSR-I] cells, which express bovine type I scavenger receptors, were plated on
day 0 in medium B in 24-well dishes (80,000 cells/well). On day 2, the cells were
incubated for 5 hours at 370C in medium A containing 5 Igg protein/mi 1251-AcLDL in
the absence (triplicate incubations) or presence (duplicate incubations) of the
indicated amounts of dA5G37. The degradation values represent the results from a
single experiment and were measured as described in experimental procedures.
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Effect of dA5G37 on 1251-AcLDL
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Figure 2-3. Binding plus uptake of [32p]dA5G37 by CHO[bSR-I] cells.
Untransfected CHO and CHO[bSR-I] cells were plated on day 0 in medium B in 24-
well dishes (60,000 cells/well). On day 2, the cells were incubated for 5 hours at 3700C
in medium A containing the indicated concentrations of [32P]dA5G37 (4580 cpm/ng) in
the absence (duplicate incubations) or presence (single incubations) of 400 lg/ml of
M-BSA. Binding and uptake were measured as described in experimental
procedures. The values for the specific binding plus uptake of [32p]dA5G37 (panel A,
open circles) represent the differences between total binding plus uptake (panel B,
solid circles) and nonspecific binding plus uptake determined in the presence of M-
BSA (panel B, solid squares). The values for the transfection-dependent binding plus
uptake (panel C, open triangles) represent the differences between the total binding
plus uptake values for the transfected CHO[bSR-I] cells (panel D, solid circles) and for
the untransfected CHO cells (panel D, solid triangles).
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Saturation Kinetics of [32P]dA5G37
Binding and Uptake by CHO[bSR-l] Cells
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Figure 2-4. Effect of dGn length on the inhibition of 1251-AcLDL degradation by
CHO[bSR-I] cells.
Panel A: CHO[bSR-I] cells were plated on day 0 (30,000 cells/well). On day 3, the
cells were incubated at 370C for 5.5 hours in medium A containing 5 plg protein/mi of
1251-AcLDL in the absence (triplicate incubations) or presence (duplicate incubations)
of the indicated dGn oligonucleotides at concentrations of either 5.3 gg/ml (open
circles) or 53.0 lg/ml (solid circles). Degradation was measured as described in
experimental procedures. For n=37, dA5G 37 was used in place of dG37. Panel B:
Cells were plated on day 0 at 60,000 cells/well. On day 2, the cells were incubated at
37 0C for 5 hours in medium A containing 5 pg protein/ml of 12 51-AcLDL in the absence
(triplicate incubations) or presence (duplicate incubations) of the indicated
concentrations of oligo dG6, dG12 or dA5G37. Degradation was measured as
described in experimental procedures.
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Figure 2-5. CD spectra of untreated and boiled dGn oligonucleotides.
The indicated oligonucleotides were dissolved in 3 ml of deionized water at 15.3 to 35
pgg/ml (46 to 106 pM in nucleotide residues). CD spectra for each oligonucleotide
were recorded at 370C before (panel A) and after (panel B) boiling as described in
experimental procedures.
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CD Spectra of Untreated and Boiled dGn's
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Figure 2-6. FPLC analysis of dG6, dG12 and dA5G37.
The dG6 (panel A), dG12 (panel B) and dAsG37(panel C) oligonucleotides (20 to 50
gig/ml in Buffer A, 200 pl/sample) were subjected to Superose 6 column
chromatography as described in experimental procedures. The locations of the void
volume (globular proteins with masses > 5x106 are excluded) and dAn standards (50
gig/ml; n = 5, 10, 20, 40) are shown. For the dAn standards, the peak-widths at half-
height were approximately 1.5-2 fractions.
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FPLC Analysis of Oligo dG's
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Table 2-1: Effect of Boiling on the Ability of Oligo dGn's to Inhibit
12 5 1-AcLDL Degradation in CHO[bSR-I] Cells
Scavenger Receptor
Oligonucleotide Concentration Activity*
Untreated Boiled
(Lig/ml) (% of control)
none - 100% 100%
dG6 5.0 53 ± 5% 92 + 9%
dG12 5.0 29 ± 6% 85 + 10%
d(A5G37) 5.0 23 + 6% 82 ± 13%
25.0 12 ± 3% 85 ± 9%
Cells were plated on day 0 (20,000-60,000 cells/well) and scavenger receptor
activity (1251-AcLDL degradation) was assayed on day 2 or 3 as described in
experimental procedures. The 100% control values measured in the absence of
added oligonucleotides ranged from 565 - 2640 ng /5 hr/mg protein. For each
oligonucleotide, the values are the averages ± standard deviations determined in 5 - 7
experiments, using 2 or 3 independently synthesized preparations of each
oligonucleotide.
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Figure 2-7. FPLC analysis of poly I isoforms.
The untreated (panel A), the Li+ salt (panel B) or the ULi+/K+ salt (panel C) of poly I (50
I•g/ml in Buffer B, 200 pl/sample) were subjected to Superose 6 column
chromatography as described in experimental procedures. The locations of the void
volume and dAn standards (25 pg/ml; n = 5, 10, 20, 40) are shown.
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Effects of Li+ and K+ on the Structure of Poly I:
FPLC Analysis
I"" IO Io U iU 2•24 26 28 30 32 34 36 38 40 42 4
4
Fraction Number Superose 6
EC)I-`
C.)
o3
C
-D
Co
0.0G
0.c
0.04
0.02
0.0
C
0.02
0.01
C
I'
Figure 2-8. Effects of Li+ denaturation and K+ renaturation on the temperature-
dependent UV absorbance of Poly I.
The untreated K+ salt (solid circles), the Li+ salt (open circles) , or the Li+/K + salt(open diamonds) of Poly I were prepared in buffer C and the temperature-dependent
UV spectra were recorded as described in experimental procedures.
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Figure 2-9. Effects of Li+ denaturation and K+ renaturation on the inhibition by poly I of
125 1-AcLDL degradation by CHO[bSR-1] cells.
On day 2 of culture, degradation of 5 pgg protein/mi 125 1-AcLDL in medium C was
assayed in the absence (triplicate incubations) or presence (duplicate incubations) of
the indicated concentrations of the untreated K+ salt (open squares), the Li+ salt (open
triangles), or the Li+/K+ salt (solid squares) of poly I as described in experimental
procedures.
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Table 2-2: Effective and Ineffective Oligo- and Polynucleotide Inhibitors
of Macrophage Scavenger Receptorsa
Effective Inhibitors: Four-
stranded moleculesb
Compound
poly I
poly G
polyriboxanthinylic acid
dGn (n=5-8,10,12,16,20,23,37,60)
dA5Gn (n=1 2,37)
d(T4G4)4
d(G4T4)5
Ineffective Inhibitors: one- or
two-stranded moleculesc
Compound
poly A
poly C
poly U
GMP, GTP, GpG
dA37
oSP24d
dAP1d
d(CG)gC(CG)g
TH1 d
R101d
pRc/CMV
bX174 (Haelli digest)
a The inhibition of scavenger receptor activity was measured using cellular 1251-AcLDL
degradation assays. All of the compounds listed were examined in this study except
for poly A, poly U, poly G, polyriboxanthinylic acid, and GTP, which, along with poly I,
poly C , were tested previously (Brown et al, 1980; Brown and Goldstein, 1983).
b These molecules are expected to be four-stranded under the conditions of this
assay, based on experiments reported in this work or in the literature (Rich, 1958;
Gray and Bollum, 1974; Arnott et al, 1974; Chou et al, 1977; Zimmerman et al, 1975;
Howard et al, 1977; Roy et al, 1979; Williamson et al 1989; Panyutin et al, 1990;
Bonazzi et al, 1991; Guo et al, 1992a; Balagurumoorthy et al, 1992; Saenger, 1984).
c Ineffective inhibitors are defined as molecules which, at 25 gg/ml, decreased 1251.
AcLDL degradation by CHO[bSR-I] cells by less than 10% for single stranded
molecules or less than 20% for double stranded molecules. These molecules are
assumed to be single or double stranded under the conditions of this assay
(Saenger, 1984; Sklenar and Feigon, 1990).
d Sequences of oligonucleotides: dAP1, 5'ATCCCACTGTGCCAT3'; oSP24,
5'AGAAATGGGCCTGAGTG3'; TH1 (Sklenar and Feigon, 1990),
5'GAGAGAACCCCTTCTCTCTTTCTCTCTT3'; R101,
5'GTCAGTCGACACACTAGTTCAGACGTAGTGTCTGATGAGGCCGAAAGGCCGAA
ACGCGATCGGCATAACGCGTGGATCCTAGC 3 '
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Chapter 2 - Addendum
-- page 76 --
While the studies presented here were in press, Doi et al (1993) proposed a
model for poly(G) binding to the SR-As in which a single stranded form of the
polynucleotide ligand wraps around the collagen triple helix of the receptor such that
the phosphodiester backbone lies in a channel formed by the lysine residues of three
consecutive Gly-X-Y repeats. The results presented in this chapter clearly negate this
model by demonstrating that the quadruplex structure is required for the binding of
homopolymeric oligo- and polynucleotides to bSR-AI and bSR-AII. This serves as a
good reminder of the fact that, while model building can be quite informative, it must
take into account the known properties of the various components of the system being
modeled, and it must be backed up by experimental data.
How can the binding specificity of the SR-As for quadruplex nucleic acids be
explained? dA37 is not significantly degraded during the course of these assays and
inhibiting the RNAse mediated degradation of poly(C) and Li'-poly(l) does not confer
scavenger receptor inhibitory activity on these molecules. Thus, the nuclease
resistance of quadruplex nucleic acids (unpublished observations) relative to single
stranded and double stranded nucleic acids can not account for the observed results.
In our original publication, we proposed that "the spatial distribution of the negatively
charged phosphates in polynucleotide quadruplexes may form a charged surface
which is complementary to the positively charged surface of the collagenous, ligand-
binding domain of the scavenger receptor" (Pearson et al, 1993). Whatever this
structure is, it might not be formed by a linear determinant in the quadruplex, but
rather, might be formed by phosphate groups from multiple strands of the quadruplex.
This seems reasonable since the phosphate backbone structure of any single strand
in the quadruplex is fairly similar to that of any single strand in B-form DNA duplexes
(Smith and Feigon, 1992; Kang et al, 1992; Cheong and Moore, 1992; Miura and
Thomas, 1995) while the relative arrangement of the adjacent backbones differs in
these two forms.
The binding of nucleic acids to SR-As may require a rather specific phosphate
group conformation which the quadruplex structure can provide. Alternatively, within
certain limits, the phosphate groups may be able to adopt a variety of conformations all
of which are loosely complementary to the receptor's ligand binding domain. This
possibility is suggested by the finding that both parallel and anti-parallel quadruplexes
can inhibit bSR-AI activity with approximately equal efficacy, even though their spatial
distributions of phosphate groups differ significantly from each other. Thus, the
different phosphate group conformations displayed by various quadruplex structures
might all fall within a set of negative charge distributions which are adequate for high
affinity binding.
The parameters which define this set of spatial distributions might be governed
by the length and flexibility of the lysine residues in the three consecutive Gly-X-Lys
repeats which form the collagenous ligand binding domain of the SR-As. The
extended side chains of these residues project away from the collagen helix and may
not be involved in strong interactions within the protein. Thus, they may have a large
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amount of free rotation which would allow them to occupy a variety of different spatial
positions around the collagen helix. Quadruplex nucleic acid structures may cluster
enough phosphate groups close enough together to allow for multiple and specific
interactions with these lysines. Since the lysine side chains may be relatively flexible,
a variety of different quadruplex structures, all of which bring multiple phosphates into
close proximity, would be capable of binding. Duplex structures, on the other hand,
may not bring enough phosphate groups close enough together to allow for multiple
interactions with the lysine side chains. Indeed, the distances separating adjacent
strands of either parallel or anti-parallel quadruplex's are as short, and usually shorter,
than the distance which separates adjacent strands across the minor groove of duplex
DNA (Kang et al, 1992; Smith and Feigon, 1992; Wang and Patel, 1993; Miura and
Thomas, 1995; Patel and Wang, 1995). It should be noted that there are conserved
negatively charged residues in the SR-As, and that these may in some manner
modulate ligand binding specificity (Ashkenas et al, 1993).
The model I have suggested is rather different from the conventional view of
ligand-receptor interactions, in which ligand binding requires very specific interactions
between ligand and receptor that are susceptible to minor alterations in the structure of
either the ligand or the receptor (Creighton, 1984). This is not necessarily surprising
since Class A scavenger receptors (and for that matter, class B and C SRs as well),
with their broad ligand binding specificities, are rather different than most other
receptors. The interactions between the SR-As and their ligands may not be strictly
specified, and receptor-ligand complementarity in this system may be of a somewhat
flexible and dynamic nature. This model could explain the promiscuous binding
properties of the SR-As: all of the various SR-A ligands may form structures in which
negatively charged moieties are constrained within the set of spatial distributions
defined by the positions that the SR-A collagen domain lysine side chains can occupy
in space. Indeed, M-BSA, all of the nucleic acid ligands, and at least some of the
polysaccharide ligands (Millane et al, 1988; Piculell and Rymddn, 1989) form ordered
structures which place constraints on the relative distribution of negative charges.
LPS aggregates can also form regular ordered structures (Hayter et al, 1987; Wang
and Hollingsworth, 1996) which might restrict the distances separating individual LPS
molecules to within the set of spatial distributions compatible with SR-A binding. This
model might also explain the binding promiscuity of quadruplex forming
oligonucleotides for a variety of different, structurally unrelated proteins (Stein, 1995),
including CD36 and dSR-CI (see Chapter 1). By placing phosphate groups very close
together, quadruplex nucleic acids may be able to complement a variety of different
positive charge distributions displayed on protein surfaces.
A detailed comparison of the ligand binding capabilities and structures of
different quadruplex oligonucleotides would be very useful in defining the set of
negative charge spatial distributions which the SR-As require for ligand binding. This
model for SR-A ligand binding predicts that a wide range of quadruplex structures
could be accommodated within the SR-A ligand binding domain. An interesting test of
this model would be to see if spatially different protein - nucleic acid contacts are
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observed in the crystal structures of synthetic SR-A collagen domains (Tanaka at al,
1996). complexed with a variety of quadruplex ligands.
Recent findings suggest that binding of quadruplex DNA to scavenger receptors
may be biologically significant (Kimura et al, 1994; Stacey et al, 1996). Bacterial DNA
is highly immunogenic (Pisetsky, 1996; Stacey et al, 1996;), at least in part due to the
common occurrence of unmethylated CpG dinucleotides which are rare in mammalian
DNA (Krieg et al, 1995; Ballas at al, 1996). Macrophages and/or dendritic cells appear
to mediate at least some of the immune responses to both bacterial DNA and CpG
containing oligonucleotides (Stacey et al, 1996; Ballas et al, 1996). In studies using
splenocyte cultures, it has been found that the immunogenicity of such
oligonucleotides can be enhanced by embedding the CpG motifs within quadruplex
forming guanine tracts (Kimura at al, 1994; Ballas et al, 1996). Interestingly, this
increased immunogenicity is completely eliminated by the addition of scavenger
receptor ligands to the assay medium (Kimura et al), suggesting that scavenger
receptors may be involved in this process. The role of the quadruplex structure may
simply be to enhance the cellular uptake of the oligonucleotides, and that the CpG
motifs in these oligonucleotides then stimulate the immune system via scavenger
receptor independent mechanisms (Peyman et al, 1995). Consistent with this
hypothesis, it has recently been demonstrated that maleylation of proteins, which
converts them to SR ligands, enhances their ability to elicit antibody and T cell
responses in the absence of adjuvant in vivo, and enhances their presentation to T
cells by macrophages in vitro (Abraham et al, 1995). Alternatively, it has been
suggested that quadruplex DNA itself may be immunogenic or may potentiate the
immune response (Pisetsky and Reich, 1993 ;Pisetsky, 1996), although whether this
immunogenicity is due to binding to any of the molecularly identified scavenger
receptors is unknown.
In the introduction to this chapter, a mention was made of some studies I
performed using phosphorothioate oligodeoxyribonucleotides. During attempts to use
scavenger receptors to facilitate the uptake of antisense oligonucleotides coupled to
quadruplex forming sequences, I chose to use phosphorothioate oligonucleotides
because of their greater nuclease resistance relative to phosphodiester
oligonucleotides (Stein, 1995). In initial experiments, it was found that the
oligonucleotide dBGTAS1 was an excellent inhibitor of bSR-AI activity (Figure 2A-1).
This oligonucleotide comprises 15 phosphorothioate-linked residues followed by 27
phosphodiester-lined residues which include a stretch of 12 guanines. Unexpectedly,
the control oligonucleotide dBAS1, which comprises only the first 15 phosphorothioate
linked residues of dBGTAS1, was also a good inhibitor (Figure 2A-1). However, the
oligonucleotide dAP1, identical in sequence to dBAS1 but having phosphodiester
linkages, had no inhibitory activity. A second phosphorothioate, dAP2, also inhibited
scavenger receptor activity. Phosphorothioate oligonucleotides appear to bind directly
to the receptor, and not to the AcLDL ligand, since dBAS1 blocked the specific binding
of a soluble form of bSR-AI to M-BSA beads (D. Resnick and M. Krieger, unpublished
observations). Unlike normal phosphodiester bonded oligonucleotides, the
-- page 79 --
phosphorothioates do not require oligomerization in order to bind to bSR-AI, since
dBAS1 is single stranded in solution as determined by FPLC analysis (not shown).
The apparent ability of non-quadruplex-forming phosphorothioate
oligonucleotides to bind to bSR-AI is surprising. Interestingly, recent studies have
reported that phosphorothioates can bind with high affinity to a large number of
structurally unrelated proteins, all of which have regions of high positive charge
density (Wyatt et al, 1994; Stein, 1995; Guvakova et al, 1995; Benimetskaya et al,
1995; Beltinger et al, 1995). This binding ability is not due to the increased nuclease
resistance of the phosphorothioates. Rather the phosphorothioate backbone is
mechanistically required for the tight binding of these oligonucleotides to proteins
(Wyatt et al, 1994). Thus, the phosphorothioate moiety appears to confer some
distinctive property on nucleic acids which enables them to bind to a variety of proteins
with a significantly higher affinity than their phosphodiester counterparts. Consistent
with this conclusion, the phosphorothioate analog of dG12 has greater bSR-AI
inhibitory activity than the phosphodiester analog (84.8% inhibition versus 57.1% at 5
Igg oligonucleotide/ml, 93.0% versus 75.7% at 25 Ig oligonucleotide/ml). The
converse result has also been demonstrated: proteins interact more avidly with
phosphorothioates which can form quadruplex structures than with phosphorothioates
which cannot form such structures (Wyatt et al, 1994; Stein, 1995; Guvakova at al,
1995).
It is not clear why phosphorothioate oligonucleotides have such a strong affinity
for numerous proteins. Two models have been suggested. In one model, the
substitution of a sulfur atom for one of the non-bridging oxygen atoms of the backbone
results in a more rigid oligonucleotide structure. Since this molecule has already lost
a significant degree of entropy, the entropic cost of binding to a protein is not as great
and high affinity binding is possible (Benimetskaya et al, 1995). The fact that
phosphorothioate quadruplexes bind to numerous proteins with a significantly greater
affinity than phosphodiester quadruplexes would seem to argue against this model,
since quadruplexes are already very rigid structures. In the second model, the
phosphorothioate backbone has a looser counterion shell than the phosphodiester
backbone. Thus, it is easier to remove the counterions and to make ionic bonds
between protein residues and the backbone (Cho et al, 1993). This model might
account for the higher affinity of phosphorothioate quadruplexes relative to their
phosphodiester analogs. Quadruplex structures may enhance the binding of
phosphorothioate oligonucleotides because they change the mechanism of binding
from one involving primarily non-specific electrostatic interactions between ligand and
protein to one in which specific electrostatic interactions between ligand and protein
moieties can occur due to the tighter packing of phosphorothioate groups. Regardless
of the mechanism by which proteins bind to phosphorothioate oligonucleotides, this
sequence-non-specific binding has been problematic for researchers attempting to
use anti-sense oligonucleotides to modulate protein expression (Stein). The
possibility of interactions with scavenger receptors must now be added to the list of
potential causes which have been proposed for the non-sequence-specific effects of
anti-sense phosphorothioate oligonucleotides (Stein, 1995).
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Figure 2A-1. Phosphorothioate oligonucleotide inhibition of 1251-AcLDL degradation
by CHO[bSR-AI] cells.
CHO[bSR-AI] cells were plated on day 0 in medium B in 24-well dishes (60,000
cells/well). On day 2, the cells were incubated for 5 hours at 370C in medium A
containing 51g protein/mi 125 1-AcLDL in the absence (triplicate incubations) or
presence (duplicate incubations) of the indicated concentrations of oligonucleotides.
Degradation of 125 1-AcLDL was measured as described in experimental procedures,
and the amount of degradation relative to control (no additions), determined in from 1
to 3 experiments is indicated. The sequences of the oligonucleotides used are:
dBGTAS1 (phosphorothioate/phosphodiester),
5'ATCCCACTGTGCCATGGGGGGGGGGGGTTATTATTATTATATA 3 ; dBAS1
(phosphorothioate), 5'ATCCCACTGTGCCAT 3'; dAP1 (phosphodiester),
5'ATCCCACTGTGCCAT 3'; dAP2 (phosphorothioate), 5'CATCGTCATCTAGCC3'.
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Introduction
It has been over 100 years since Metchnikoff's observations of phagocytosis led
him to propose the cellular theory of immunity (Metchnikoff, 1884). Since that time,
numerous studies have shown that phagocytes, including circulating monocytes and
tissue macrophages, neutrophils, and dendritic cells, play a key role in the adaptive
immune system, both as effector cells and as activators and regulators of the immune
response (Janeway, 1989, 1992; Matzinger, 1994; Ibrahim et al, 1995; Fearon and
Locksley, 1996). In addition, monocytes, macrophages and neutrophils are key
components of the innate, or non-adaptive, immune system which provides an
important and immediate first line of host defense prior to the activation of the adaptive
immune system (Gordon et al, 1988; Janeway, 1992; Fearon and Locksley, 1996).
The ability of monocytes and macrophages to activate and regulate adaptive immune
responses may be inseparable from their earlier participation in the innate immune
response (Janeway, 1992; Ibrahim at al, 1995; Fearon and Locksley, 1996).
As discussed in Chapter One, macrophages and other phagocytic cells can
recognize and bind pathogens directly (i.e., independent of pathogen opsonization),
and this direct form of self/non-self discrimination may play a crucial role in the
activation and regulation of both the innate and adaptive immune responses (Gordon
at al, 1988; Janeway, 1989, 1992; Ibrahim at al, 1995). It has been proposed that the
direct recognition of pathogens by phagocytic cells is mediated by non-clonally
distributed "pattern recognition receptors" which exhibit broad ligand binding
specificity for molecular structures common among microbial pathogens, but absent
from the host (Janeway 1989, 1992; Ibrahim et al, 1995). In addition to activating the
immune response, these pattern recognition receptors may also play a role as effector
molecules in the immune response (Krieger at al, 1993; Krieger and Herz, 1994;
Pearson 1996).
Both innate immunity and the key role of phagocytes in host defense appear to
be evolutionarily ancient, predating the development in vertebrates of the adaptive
immune system (Janeway, 1989, 1992; Fearon and Locksley, 1996). Indeed,
invertebrate immunity, which comprises both humoral and cellular components (Rizki
and Rizki, 1984; Lackie, 1988; Hultmark, 1993; Habicht, 1994; Hoffmann, 1995), is
strikingly similar to vertebrate innate immunity (Hultmark, 1993; Habicht, 1994;
Hoffmann, 1995). One of the most obvious similarities is the crucial role played by
macrophages and other hemocytes (blood cells) during the invertebrate response to
infection (Rizki and Rizki, 1984; Lackie, 1988; Iwanaga at al, 1992; Jomori and Natori,
1992; S6derhall, 1992; Hultmark, 1993; Habicht, 1994).
As with mammalian macrophages, the immune responses of invertebrate
macrophages, and other hemocytes, are induced both by contact with intact
microorganisms and by exposure to isolated microbial surface constituents, including
LPS and the 8-glucan laminarin (Samakovlis et al, 1992; Iwanaga et al, 1992;
SSderhall, 1992; Hultmark, 1993). The mechanisms by which invertebrate
macrophages become activated in response to infection is not yet understood.
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However, it is clear that in Drosophila and other invertebrates, macrophage activation
induces the nuclear translocation of transcription factors homologous to the
mammalian Rel/NF-KB family of transcription factors which play a crucial role in
mediating vertebrate innate immune responses (Sha et al, 1995). Furthermore, many
of the transcriptionally activated immune response genes contain upstream NF-kB
binding sites which are essential for their activation (Sun and Faye, 1992; Engstrim et
al, 1993; Kappler et al, 1993; reviewed in Hultmark, 1993 and Hoffmann 1995).
It has been proposed that, as in vertebrates, the direct recognition of pathogens
and their surface constituents by invertebrate macrophages (Rizki and Rizki, 1984;
Lackie, 1986) is mediated by pattern recognition receptors (Hultmark, 1993; Hoffmann
1995). Several invertebrate proteins have been proposed as candidate pattern
recognition receptors (Sun et al, 1990; Iwanaga et al, 1991; Iwanaga et al, 1992;
Jomori and Natori, 1992; Hultmark, 1993; Cerenius et al, 1994; Theopold et al, 1996).
Included among these are the Drosophila protein 18-wheeler (Eldon et al, 1994; Eldon
and Williams, 1996.), and a B. mori protein GNBP (Lee et al, 1996). Both 18-wheeler
and its homolog, Toll, have leucine-rich repeats reminiscent of CD14, coupled to
intracellular domains homologous to the IL-1 receptor which are involved in Rel
transcription factor activation (Schneider et al, 1991; Rosetto et al, 1995). 18-wheeler
has been shown to recognize non-self molecules and 18-wheeler mutants are
immune compromised, but a direct role in inducing an immune response has not yet
been demonstrated for this protein. Interestingly, Toll has recently been found to play
a direct role in the induction of immune responses in Drosophila , although it does not
appear to act as a pattern recognition receptor in doing so (Lemaitre et al, 1996). Two
additional Toll/18-w homologs have also recently been identified (Mitcham et al,
1996). GNBP is a secreted protein which has pattern recognition receptor like
properties (Lee et al, 1996). Interestingly, it is also homologous to CD14, may have a
GPI-anchored cell surface isoform, and cross-reacts with polyclonal CD14 antibodies.
A homolog has also been detected in Drosophila (Lee et al, 1996). However, the
involvement of GNBP in immune activation has not yet been explored.
Among the various mammalian proteins which may be pattern recognition
receptors are the macrophage-specific class A scavenger receptors (see Chapter
One). These receptors exhibit broad polyanionic ligand binding specificity (Brown and
Goldstein, 1983; Krieger and Herz, 1994), and among their high affinity ligands are the
bacterial surface constituents lipopolysaccharide (LPS) and lipoteichoic acid
(Hampton et al, 1991; Krieger et al, 1993; Doi et al, 1993; Dunne et al, 1994;).
However, as discussed in Chapter One, the actual non-pathological functions of the
SR-As are, to a large extent, still unknown. Given the notion that innate immunity
based on pattern recognition receptors might be evolutionarily ancient, it seemed
reasonable to suggest that scavenger receptors might also exist in an invertebrate
such as Drosophila. Indeed, Abrams and colleagues (1992) recently demonstrated
that Drosophila embryonic macrophages and the macrophage-like Drosophila
Schneider S2 cell line exhibit a scavenger receptor activity similar to that of the
mammalian SR-As (Abrams et al, 1992).
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To follow up on this observation, I set out to clone a Drosophila homolog of the
mammalian SR-As. It was hoped that the identification of such a gene, when coupled
with the power of Drosophila genetics, would yield insight into the normal functions of
these SR-As. This chapter first describes my initial demonstration of S2 cell scavenger
receptor activity which established the basis for the S2 cell studies published by
Abrams and colleagues (1992). This is followed by a description of attempts to clone a
scavenger receptor cDNA from S2 cells. Interestingly, rather than isolating a homolog
of the mammalian SR-As, a new scavenger receptor gene, dSR-CI, was isolated. This
chapter describes the characteristics of dSR-CI, and discusses the potential functions
of this receptor in Drosophila host defense and development.
Portions of the work presented here were originally published in April, 1995 in
The Proceedings of the National Academy of Sciences, USA (Pearson et al, 1995).
Alison Lux performed the expression screening of cDNA pools in COS cells, and
generated the CHO[dSR-CI] cell line. The 4 OC and 37 OC saturation binding
experiments shown in Figure 3-4 were performed by Marsha Penman and Shangzhe
Xu. Under my supervision, Shangzhe Xu also performed some of the CHO[dSR-CI]
competition experiments shown in Figures 3-5 through 3-8, and most of the
sequencing of the dSR-CI cDNA clone. All other work presented in this chapter was
performed by me. The original publication is included in this thesis as Appendix B.
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Experimental Procedures
cDNA Library Construction and Expression Cloning of dSR-C!: Poly A+ RNA (30 gIg)
was prepared from Drosophila S2 and Kco cells as described (Libermann at al, 1987),
except that cells were homogenized and DNA was sheared with a Brinkmann Polytron
disrupter (PT10S probe, three times 5 s, setting 4). cDNAs, synthesized from S2 cell
mRNA using an oligo(dT) primer, were ligated to phosphorylated BstXI linkers (pCTTT
AGAGCACA and pCTCTAAAG (Research Genetics)), size selected into >1.5 kbp and
>2.0 kbp fractions, and ligated into the BstXI site of the expression plasmid pcDNAI(InVitrogen) (Aruffo and Seed, 1987). MC1061/p3 cells (InVitrogen) were transformed
with this library by electroporation and DNA pools (1600 - 4000 clones/pool) were
transfected into COS-M6 cells. The transfected cells were visually screened for uptake
of fluorescent Dil-AcLDL (1,1 '-dioctadecyl-3,3,3',3'-tetramethylindocarbocyanine
perchlorate labeled acetylated low density lipoprotein), and a single clone
(S0o24.11 c) was isolated from one positive pool, all as previously described (Lin et al,
1991; Acton et al, 1994). This clone, designated pdSR-CI, was sequenced on both
strands using the Sequenase 2.0 (US Biochemicals) and the Gibco-BRL PCR-based
sequencing kits. Sequence comparisons and database surveys were performed
using the GCG Sequence Analysis Software Package (versions through 7.3)
(Devereux et al, 1984), and BLAST from NCBI (Altschul et al, 1990).
Southern Screening of S2 cDNA Library: 1 gg of DNA from each cDNA pool analyzed
was doubly-digested with Hindlll and Xbal, electrophoretically separated on a 1%
agarose gel, and transferred to Genescreen membranes (Dupont NEN) following
standard protocols. The filters were hybridized to 32P random prime labeled
(Sambrook et al, 1989) probes at 50 OC overnight in 0.5 M phosphate buffer, 1 mM
EDTA, 7% SDS, 1% BSA, 100 pIg/ml denatured salmon sperm DNA. The filters were
then washed six times at 50 OC -54 OC in 0.3 M phosphate buffer, 1 mM EDTA, 0.5%-
1.0% SDS (0.5% BSA included in first two washes). The following probes, generously
provided by A. Karson, were used: 1) AK817, generated by PCR amplification of the
first 817 coding base pairs of mSR-AI, encoding all but the collagen and SRCR
domains of this protein; 2) AKN1A, generated by Styl/Xbal digestion of the mSR-AI
cDNA clone, comprising that portion of the cDNA encoding the collagen and SRCR
domains, plus a small portion of the mSR-AI 3' UTR (Ashkenas et al, 1993).
Northern Analysis: Northern blot analysis of S2 and Kco poly A+ RNA (Sambrook et al,
1989) was performed using a random primed labeled PCR amplified, gel purified, full-
length dSR-CI cDNA probe. Developmental Northern analysis of dSR-CI expression
in strain Canton S was performed using a mixture of gel purified, random primed
labeled probes 1101p (generated by PCR amplification of the 5' terminal 1101 bps of
the dSR-CI cDNA) and 428p (generated by PCR amplification of the 3' terminal 428
bps). An elongation factor 1 a probe was used for normalization of mRNA loading.
The developmental Northern blot was generously provided by Patrick McCaw.
In situ Hybridization to DrosoDhila Embrvyo's: Clone p6-5, containing the 5' terminal
815 bps of the dSR-C1 cDNA, was constructed as follows: pdSR-CI was doubly-
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digested with EcoRV and Xbal and blunted with Klenow, and the large vector-
containing fragment was purified and re-circularized. Two digoxygenin labeled RNA
probes were generated from Apal (sense strand) and Spel (antisense strand) digested
p6-5 DNA by in vitro transcription from the T7 (sense) and SP6 (antisense) promoters
using DIG-dUTP (Genius 2.0 DIG RNA labeling kit, Boehringer Mannheim). Canton S
embryo's (0-16 hr) were collected and processed, in situ hybridizations were
performed, and embryos were staged, as previously described (Campos-Ortega and
Hartenstein, 1985; White et al, 1994).
Cell Culture: Cells were maintained at 37 OC in a humidified 5% CO02/95% air
incubator (mammalian cells), or at 25 OC in tightly capped flaskettes (Drosophila cells).
Wild type CHO cells were grown in medium A (Hams F-12 supplemented with PSG(100 units/mi penicillin, 100 pg/ml streptomycin, 2 mM glutamine), and 5% (v/v) FBS
(fetal bovine serum)). COS-M6 cells were grown in medium B (DME supplemented
with PSG and 10% (v/v) FBS). Drosophila S2 cells were grown in medium C
(Schneider's media supplemented with PSG and 10% heat-inactivated FBS), and
Drosophila Kco cells were grown in medium D (D22 medium supplemented with PSG
minus glutamine). CHO[mSR-AII] cells, which express murine SR-A type II (Ashkenas
et al, 1993), were grown in medium E (medium A containing 0.5 mg/mi geneticin
(G418, Gibco)). A stable transfectant (clone 2.6a) expressing dSR-CI, designated6CHO[dSR-CI], was isolated by transfecting 1 x 10 CHO cells with 0.5 pg pSV2neo and
9.5 gg pdSR-CI using the polybrene method (Sambrook et al, 1989; Penman et al,
1991), selecting transfectants in medium E and cloning a receptor positive (uptake of 1
gg protein/mi Dil-AcLDL) colony by dilution plating (Penman et al, 1991)
Assays and reagents: Scavenger receptor activities in mammalian cells at 4 OC
(measured in 6-well dishes) and 37 OC (24-well dishes) and in Drosophila S2 cells at
25 OC were determined as previously described (Abrams et al, 1992; Ashkenas et al,
1993; Pearson et al, 1993; Chapter 2), with minor modifications for S2 cells. Briefly,
after incubation of S2 cells for 5 hours at 25 OC with medium containing 12sI-AcLDL, the
cells were washed two times rapidly with BSA/Tris-CI buffer, once slowly (10 minutes)
with the same buffer, and then once rapidly with Tris-CI buffer. Cell surface binding of
12 5I-AcLDL (2 hours, 4 OC), and its binding plus internalization (5 hours, 37 OC), are
125
expressed as ng cell associated I-AcLDL protein per mg cell protein. Degradation
125
activity is expressed as ng I-AcLDL protein degraded in 5 hours per mg cell protein.
Protein determination was by the method of Lowry (Lowry et al, 1951). For competition
125
experiments, cells were incubated with 2-AcLDL for 5 hours in the absence (triplicate
incubations) or presence (duplicates) of competitors during the assay. Stock solutions
of competitors (e.g., laminarin (Sigma)) were prepared in Dulbecco's complete
phosphate buffered saline (at 4 - 10 mg/ml). These and other reagents (e.g., sodium
butyrate from Pfaltz and Bauer) were obtained and/or prepared as indicated or as
previously described (Abrams et al, 1992; Pearson et al, 1993; Acton et al, 1994;
Rigotti et al 1995). Phosphatidylserine vesicles were generously provided by A Rigotti.
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Results
Initial experiments reported elsewhere (Abrams et al, 1992) indicated that
embryos from the Canton S strain of Drosophila melanogaster exhibit scavenger
receptor like activity. To facilitate the analysis of this activity, the Drosophila S2 cell
line (Cherbas et al, 1994), was examined for scavenger receptor activity. As shown in
Figure 3-1, this cell line exhibits specific degradation and binding plus uptake activities
for the classical scavenger receptor ligand I-AcLDL. These scavenger receptor
activities were high affinity, saturable processes, having Km values of approximately
3.0 and 5.0 lig protein/ml, respectively. Subsequent studies reported elsewhere have
confirmed and extended these results, and have demonstrated that the Kco embryonic
cell line lacks this scavenger receptor activity (Abrams et al, 1992).
Two approaches were taken to identify the gene responsible for the
macrophage scavenger receptor-like activity in Drosophila S2 cells. In the first
approach, a cDNA expression library was prepared from S2 cell poly A+ mRNA,
divided into small pools, and screened for SR-AI homologs by low stringency
Southern hybridization using probe AK817, as described in Experimental Procedures.
In this way, over 40 pools were identified which gave hybridization signals, 19 of which
are shown in Figure 3-2. Some of these pools contained cDNAs which gave very
strong hybridization signals in this experiment. Ten of these positive pools were
chosen for subsequent analysis using the non-overlapping 5' and 3' mSR-AI probes
AK817 and AKN1A. The two probes hybridized to similarly sized fragments in four of
the pools (data not shown). Although these cDNA pools have not yet been further
analyzed, the results obtained thus far suggest that there may indeed be Drosophila
homologs of the mammalian class A scavenger receptors.
In the second approach, COS-M6 cells were transfected with the cDNA pools
and visually screened for endocytosis of fluorescent AcLDL (Dil-AcLDL). A single
receptor-positive pool was identified (-350,000 clones screened) and was subdivided
repeatedly to obtain a single functional plasmid (designated pdSR-CI for glasmid
encoding Drosophila scavenger receptor Class C, type 1; (for nomenclature, see Acton
et al, 1994). Northern blot analysis of poly A+ RNA demonstrated that the level of the
dSR-CI message (-2.1 kb) was at least 50-fold higher in S2 cells than in Kco cells(Figure 3-3). As the expression cloning strategy yielded a scavenger receptor cDNA,
the homology cloning approach was discontinued.
A CHO cell line stably transfected with pdSR-CI was generated. These cells,
called CHO[dSR-CI] cells, exhibited high affinity, saturable 1251-AcLDL binding at 40 C
(Kd ~ 2 •ig protein/ml, Figure 3-4A) and, at 370 (Figure 3-4B), high affinity and saturable
binding plus internalization (open circles) and degradation (solid squares, Kd ~5.5 •g
125protein/mi). The degradation of bound and internalized I-AcLDL by CHO[dSR-CI]
cells, which was chloroquine-sensitive (not shown) and thus presumably lysosomal,
was more efficient than that in S2 cells (Abrams et al, 1992). This difference may be
-- page 89 --
due to differences in the assay conditions (e.g., temperature, media) or in the
fundamental properties of the cultured cells. The affinity of dSR-CI for 125I-AcLDL was
comparable to the affinities of the receptors in Drosophila S2 cells and of mammalian
SR-A (Kodama et al, 1990; Rohrer et al, 1990; Abrams et al, 1992;). Thus, CHO[dSR-
CI] cells express a scavenger receptor-mediated endocytic pathway which is similar to
those of S2 cells and mammalian macrophages (Brown and Goldstein, 1983; Kodama
at al, 1990; Rohrer et al, 1990; Abrams at al, 1992; Krieger and Herz, 1994).
A hallmark of SR-A and S2 cell scavenger receptors is their broad polyanion
binding specificity, usually assessed by measuring inhibition of 1251-AcLDL binding,
and subsequent uptake and degradation (Brown and Goldstein, 1983; Krieger et al,
1993). Using such an assay, it was found that numerous SR-A polyanionic ligands, in
125
addition to AcLDL itself, were effective inhibitors competitors of I-AcLDL degradation
by both CHO[dSR-CI] and S2 cells (Figure 3-5). These included the modified protein
M-BSA, the four-stranded polynucleotides poly(l) and dAsG37, and the polysaccharide
dextran sulfate. At concentrations of 400 Igg/ml (100 gig/ml for dAsG37) all of these
molecules reproducibly inhibited scavenger receptor activity by > 85% in both cell
types. Furthermore, M-BSA, poly (I), dAsG37, and dextran sulfate were all high affinity
competitors for both cell types: their concentrations which gave half-maximal inhibition
ranged from -0.1 to 5 •ig/ml (for example, Figure 3-6). As with SR-A, single stranded
dA37 (100 pg/ml), unmodified LDL and BSA (400 Ipg/ml) and phosphatidylserine
vesicles (500 pg/ml) did not compete (< 15% inhibition). Surprisingly, poly D-glutamic
acid inhibited dSR-CI (see below), although it is not an SR-A inhibitor (Brown and
Goldstein, 1983; Krieger and Herz, 1994). These results suggest that expression of
dSR-CI could account for at least some of the S2 cell-scavenger receptor activity.
While there were many similarities in the scavenger receptor activities of
CHO[dSR-CI] and S2 cells, two notable differences were observed. First, the apparent
Ki values for poly(I) and dAsG37 were ~10-fold lower for CHO[dSR-CI] than S2 cells
(Figure 3-6). Second, poly D-glutamic acid inhibited both cell types with relatively high
affinities (apparent K1's: CHO[dSR-CI] - 7 gg/ml, S2 - 18 pg/ml), but with substantially
different maximal levels of inhibition (measured using 400 gg/ml) (Figure 3-7). While
125poly D-glutamic acid inhibited most of the I-AcLDL degradation by CHO[dSR-CI]
cells (80%), it inhibited only about 20% of the activity in S2 cells. These disparities
between the CHO[dSR-CI] and S2 cells may be due to differences in the assay
conditions or in the properties of the receptors expressed in dissimilar cells from
different species. Alternatively, they raise the possibility that S2 cells may be like
mammalian macrophages (Krieger and Herz, 1994) and express multiple types of
scavenger receptors, some of whose specificities may differ from that of dSR-CI (e.g.,
insensitive to poly D-glutamic acid).
Because of the broad polyanion specificity of CHO[dSR-CI] and S2 cell
scavenger receptor-mediated I-AcLDL degradation, it was surprising to find that
laminarin, an uncharged, 131-3 glucose polymer, was also a highly effective inhibitor of
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both the CHO[dSR-CI] and S2 cell scavenger receptor activities (Figure 3-8, apparent
K['s of ~ 2 and 8 gg/ml, respectively). In contrast, dextran (400 gg/ml), another
uncharged glucose polymer, did not inhibit 251-AcLDL degradation (not shown).
Laminarin does not appear to inhibit dSR-CI activity by binding to the AcLDL ligand,
125
since it has virtually no effect on the degradation of I-AcLDL by CHO cells
expressing bovine SR-AII (data not shown). The precise mechanism of laminarin
inhibition of dSR-CI activity and its relationship to laminarin induced immune
responses in cultured Drosophila cells (Samakovlis et al, 1992) have not yet been
established.
The 2032 bp dSR-CI cDNA (Figure 3-9; Genbank Accession #U17693)
encodes a 629 residue polypeptide (Figure 3-9B). The cDNA has a 39 bp 5'
untranslated region (UTR) (Figure 3-9A) containing a sequence (ACCGT) which
closely matches the canonical Drosophila transcription initiation start site (Cherbas
and Cherbas, 1993). The presence of this sequence and the estimated message size
of 2.1 kb (Figure 3-3) suggests that the cDNA clone is probably close to full length. The
5' UTR also contains an in frame stop codon 15 bps upstream of the putative initiator
methionine codon. The 106 bp 3' UTR (Figure 3-9A) contains a polyadenylation signal
84 bps downstream of the termination codon. The predicted dSR-CI protein is a
multidomain type I transmembrane protein (Figure 3-9C) which has no significant
homology to the mammalian SR-A or SR-B molecules (Ashkenas et al, 1993; Acton et
al, 1994). Its N-terminal 20 residues represent a putative signal sequence (see also
Chapter 4) which is followed by a 609 amino acid (67.6 kD) mosaic protein comprising
nine domains with six potential N-linked glycosylation sites (underlined in Figure 3-
9B). Domains I (54 residues) and 11 (53 residues) (Figure 3-9B) are members of the
complement control protein (CCP) family of domains (Reid and Day, 1989). Their
sequences conform to the overall CCP consensus sequence (69% and 65% identities,
respectively) about as well as other randomly selected CCP sequences (not shown).
Over 160 CCP domains have been found in more than 30 proteins, including many
complement proteins (e.g., C1 r, C2, DAF, CRI), and other proteins in vertebrates (e.g.,
clotting factors, selectins (Bevilacqua and Nelson, 1993), proteoglycans (Yamada et
al, 1994)) and invertebrates (the Drosophila hikaru genki gene product (Hoshino et al,
1993) and Limulus Coagulation Factor C (Iwanaga et al, 1992)). In many cases, these
~60 residue domains participate directly in binding interactions with other proteins.
Domain III (185 residues) is the first known invertebrate member of the MAM (for
Meprin, A5 antigen and receptor protein tyrosine phosphatase Mu) family of
extracellular domains (Beckmanm and Bork, 1993). This domain appears to modulate
homophilic binding interactions between receptor protein tyrosine phosphatases
(Zondag et al, 1995). A 25 residue spacer (domain IV) separates the MAM domain
from domain V, which is a 48 amino acid somatomedin B-like domain (Baughman et
al, 1992). This motif was first described as a fragment of the extracellular matrix
molecule vitronectin, in which it acts as the binding site for plasminogen activator
inhibitor-1 (Deng et al, 1996).
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Domain VI is a 129 residue Ser/Thr-rich domain. Threonine and serine
comprise 55% and 12%, respectively, of all amino acids in this domain. Within an 87
residue sub-region (positions 381 - 467), they account for 79% of all residues, while
Lys, Arg, and Pro compose all but one of the other 18 residues. This domain is thus
reminiscent of both vertebrate and Drosophila mucins (Martin et al, 1988; Toribara et
al, 1993). However, unlike the mucins, domain VI contains no identifiable internal
repeat units at the DNA or protein sequence levels. By analogy with the mucins and
other cell surface proteins, such as the LDL receptor, this domain is presumably
heavily O-glycosylated and highly extended (Jentoft, 1990). Indeed, Western analysis
indicates that, in contrast to its predicted unmodified molecular weight of 68 kD, in S2
cells this protein has a molecular weight of approximately 170 kD in S2 cells (D.
Trigatti, S. Xu, A. Pearson and M. Krieger, unpublished observations). Furthermore,
the protein is sensitive to both N-glycanase and O-glycanase treatments, indicating
that it contains N-linked and O-linked oligosaccharides. In fact, the protein is heavily
O-glycosylated, since O-glycanase treatment alone results in a substantial decrease in
its mass to 95 kD (D. Trigatti, S. Xu, A. Pearson and M. Krieger, unpublished
observations).
The remainder of the protein is composed of a 29 residue spacer segment
(domain VII), a 22 residue putative transmembrane domain (domain VIII), and a 64
residue cytoplasmic domain (IX), none of which show significant sequence similarity to
other proteins. The cytoplasmic domain contains several potential sites for
phosphorylation by various kinases (Figure 3-9B) (Feramisco et al, 1980; Glass and
Smith, 1983; Woodgett et al, 1986; Pinna, 1990).
To begin to explore the physiological functions of dSR-CI, in situ hybridization
was used to examine its expression during Drosophila embryonic development
(Figure 3-10). Throughout the stages of development examined, the expression
pattern of dSR-CI was essentially identical to the distribution of
hemocyte/macrophages (Nelson et al, 1994; Tepass et al, 1994). For example, dSR-
CI expression was first seen during developmental stage 10 (4-5 hours after egg
laying (ael)) in the procephalic mesoderm (panel A), which gives rise to all of the
embryonic hemocytes (Tepass at al, 1994). During stage 11 (5-7 hours ael, panel B),
the stained cells appeared to migrate posteriorly into the gnathal buds and into the tail
end of the germ band (which is adjacent to the head due to germ band elongation),
and anteriorly into the head and clypeolabrum. During stage 12 (7-9 hours ael), germ
band retraction carried the tail region cells to the posterior end of the embryo (panel
C). In addition, dSR-CI expressing cells appeared to migrate both posteriorly and
anteriorly along the ventral and dorsal surfaces of the ventral nerve cord (not shown),
so that by late stage 12 (panel C), punctate single cell staining could be seen in the
grooves of the ventral nerve cord. By stages 13/14 (10-11 hours ael, panel D), stained
cells appeared to have migrated not only throughout the head and tail regions of the
embryo, but also around the gut. By stage 11, some dSR-CI positive cells were found
in cavities (panel E), where hemocyte/macrophages accumulate (Abrams et al, 1993;
Tepass et al, 1994). In later stages, stained cells, rather than being integrated into
defined tissues, were found scattered throughout the hemocoel. Here, macrophages
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both deposit extracellular matrix (Nelson et al, 1994) and phagocytose the apoptotic
cells which begin to appear during stage 11 (Campos-Ortega and Hartenstein, 1985;
Abrams et al, 1993; Tepass et al, 1994). Expression of dSR-CI precedes the onset of
apoptosis in stage 11 (Tepass at al, 1994). Finally, it was observed that dSR-CI was
expressed in multi-vesicular macrophage-like cells, which presumably contained
apoptotic corpses (panel F and Abrams et al, 1993; Tepass et al, 1994). These results
demonstrate that dSR-CI expression in embryos is primarily, if not exclusively,
restricted to hemocyte/macrophages. Occasionally unstained cells with a
macrophage-like morphology were observed. It is not clear whether this was due to
low sensitivity of the staining assay or to the presence of a distinct population of dSR-
CI-negative macrophages.
Developmental Northern analysis was undertaken in order to determine the
pattern of dSR-CI expression during Drosophila development (Figure 3-11A). The
results of this analysis demonstrated that the dSR-CI message is first expressed in 2-5
hour embryo's, in agreement with the in situ results above. dSR-CI mRNA expression
is subsequently maintained throughout development, with a significant increase in
expression during the early pupal stage (Figure 3-11B). The dSR-CI message is also
expressed in adults, although at lower levels. Interestingly, however, there is a very
high level of expression in adult heads. It is not yet known which cell types in the late
embryonic and post-embryonic stages express the dSR-CI message.
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Discussion
Previous work clearly demonstrated the existence of receptors in Drosophila
having properties which are strikingly similar to the mammalian class A scavenger
receptors (Abrams et al, 1992). Scavenger receptor activity was found both in
Drosophila embryos and in the S2 cell line (Figure 3-1; Abrams et al, 1992).
Therefore, a cDNA expression library was constructed from S2 mRNA in order to clone
the scavenger receptor gene responsible for this activity. Two cloning strategies were
followed: 1) functional cloning was used to isolate a cDNA which would confer
scavenger receptor activity on an otherwise receptor negative mammalian cell line,
and 2) homology cloning was used to isolate SR-AI homologs. Expression cloning
yielded a scavenger receptor cDNA first, and so the homology cloning strategy was
discontinued. While a scavenger receptor gene has been successfully cloned, it is not
yet known whether it is responsible for any or all of the scavenger receptor activity
which has previously been observed. Resolution of this issue awaits the generation of
flies lacking a functional dSR-CI gene product.
The newly identified Drosophila scavenger receptor exhibits a broad ligand
binding specificity for polyanionic ligands (Figures 3-4 and 3-5). In addition, it appears
to recognize at least one microbial surface constituent, laminarin (Figure 3-8). The
dSR-CI message is expressed specifically in embryonic hemocytes until at least 11
hours of development (stage 13/14) (Figure 3-10). The dSR-CI message is expressed
throughout all subsequent stages of development, and is highly expressed in the adult
head (Figure 3-11). Although the cell types expressing dSR-CI in the head remain to
be determined, they may be glial cells since: 1) in mammals, certain microglia share a
common origin with macrophages (Theele and Streit, 1993), and 2) in Drosophila
embryos, certain microglia (the subperineurial glia) are derived from the mesoderm
rather than from the neuroectoderm, as was previously believed (Edwards et al, 1993;
Ito et al, 1995). These particular glial cells are not yet present in the embryos
examined for dSR-CI expression.
In both its ligand binding properties and its expression pattern, the newly
identified Drosophila scavenger receptor is very similar to the mammalian class A
scavenger receptors. However, the Drosophila receptor defines a new class of
scavenger receptors, the class C receptors, which share absolutely no homology with
the SR-As. While this may be striking case of convergent functional evolution, it is also
possible that class A and class C receptors exist in both mammals and invertebrates.
At least for the class B scavenger receptors, homologs have been identified in
organisms as divergent as mammals, Drosophila and C. elegans (Hart and Wilcox,
1993; Endemann et al, 1993; Acton et al, 1994; Franc et al, 1996; Genbank accession
number 728534). The inability of poly D-glutamic acid to fully inhibit the S2 cell
scavenger receptor activity (Figure 3-7) suggests that dSR-CI may not be the only
scavenger receptor expressed by these cells. Given the preliminary results from the
homology screens of the S2 cell cDNA library, the putative additional receptors may
include an SR-A homolog.
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The dSR-CI gene encodes a multi-domain putative transmembrane protein(Figure 3-9). Disregarding those regions of the protein which seem to be spacers or
transmembrane segments, only the cytoplasmic domain of dSR-CI is nondescript. All
of the other domains have homologs in other mammalian and invertebrate proteins.
Interestingly, three of these domains (CCP, MAM, and mucin) are adhesive domains in
mammalian proteins (Springer, 1994; U et al, 1994; Zondag et al, 1995). The
serine/threonine-rich mucin domain VI appears to be heavily glycosylated and, based
on analogy with the vertebrate mucins (Jentoft, 1990), may extend more than 320 A
from the cell surface. This would significantly project the N-terminal domains (I-V) out
into the extracellular space, potentially facilitating their interactions with ligands.
The function(s) of dSR-CI remain to be determined by genetic, physiological,
and biochemical studies. However, based on what is already known about the dSR-CI
and about Drosophila biology, several hypotheses can be formulated.
As with the mammalian scavenger receptors, the broad polyanionic binding
specificity of dSR-CI, coupled with its mosaic structure and hemocyte/macrophage-
specific expression, make it an attractive candidate for a pattern recognition receptor
which can help confer the polyspecificity and self/nonself discrimination required for
innate immunity in Drosophila (Janeway, 1992; Abrams et al, 1992; Hultmark, 1993;
Krieger et al, 1993; Hoffman, 1995; see also Chapter One). In support of this
hypothesis is the finding that dSR-CI recognizes the B-glucan laminarin (Figure 3-8),
which is a potent stimulator of the Drosophila immune response (Samakovlis at al,
1992). Furthermore, dSR-CI protein expression appears to be upregulated in the
Drosophila mbn-2 hemocyte cell line upon LPS and laminarin treatment (D. Trigatti, A.
Pearson and M. Krieger, unpublished observations). It is conceivable, but still wholly
untested, that dSR-CI might cooperate with other putative pattern recognition
receptors, such as 18-wheeler and GNBP (see above), during the immune response.
The presence of CCP domains in dSR-CI places this receptor in a superfamily
of proteins, many of which are involved in both vertebrate and invertebrate host
defense. In mammals, CCP domains serve to mediate interactions between C3, the
central component of complement, and many C3 receptors and complement
regulatory proteins (Reid and Day, 1989). This suggests that, in addition to its
potential capability to recognize pathogens directly, dSR-CI might also be able to
recognize pathogens which have been opsonized by invertebrate a-2-macroglobulin,
a protease inhibitor which is both structurally and functionally ancestral to C3 (Sottrup-
Jensen et al, 1985; Armstrong et al, 1992; Melchior et al, 1995). Likewise, dSR-CI
might recognize pathogens opsonized by products of the prophenoloxidase
melanization cascade, a complement-like serine protease cascade important to insect
and crustacean immunity (Ashida, 1990; S6derhall, 1992). Indeed, studies of the
Manduca sexta and Drosophila prophenoloxidase genes have demonstrated
structural and functional similarities between these proteins and C3 (Hall et al, 1995b;
Fujimoto et al, 1995; Beck et al, 1996).
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Subsequent to recognizing pathogens by one or more of these mechanisms,
dSR-CI may participate as a major effector molecule in the immune response. Several
effector functions for dSR-CI can be envisioned. Most obviously, by binding to
pathogens, dSR-CI may facilitate their phagocytic clearance from the host.
Additionally, dSR-CI might participate in clot formation when the infectious load is too
great for efficient phagocytic clearance (Rizki and Rizki, 1984; Lackie, 1986; Iwanaga
et al, 1992; S6derhall, 1992; Hultmark, 1993; Hoffmann, 1995) by recognizing some of
the secreted adhesion molecules and clotting factors which are known to bind to both
pathogens and hemocyte membrane receptors (S6derhall, 1992; Iwanaga et al,
1992). For example, as described earlier, dSR-CI might recognize invertebrate C3-
like clotting factors whose existence is suggested by the existence of both a-2
macroglobulin and the presence of CCP domains in Limulus coagulation Factor C
(Iwanaga et al, 1992; Armstrong et al, 1992) . Further, since invertebrate lipoproteins
bind to microbial surface constituents and are hemolymph clotting factors (Lackie,
1988; Hall et al, 1995a), dSR-CI could participate in clot formation by acting as a
lipoprotein receptor.
dSR-CI mediated pathogen binding might also be important for the initial stages
in the formation of cellular capsules around very large pathogens such as the eggs of
parasitic wasps (Rizki and Rizki, 1984; Lackie, 1988). Alternatively, or perhaps
additionally, dSR-CI could conceivably play a role in the later stages of this process,
when well-ordered and multi-layered capsules are formed via extensive hemocyte-
hemocyte adhesive interactions, and in which the outer layers of cells never contact
the pathogen (Rizki and Rizki, 1984; Lackie, 1988). Since dSR-CI contains a MAM
domain and several other potentially adhesive domains (Springer, 1994; Li et al,
1994; Zondag et al, 1995), it could be an adhesion molecule which contributes to the
growth and strengthening of the cellular capsules by binding to proteins either
expressed on or adherent to the surfaces of already adherent hemocytes (Rizki and
Rizki, 1984; SWderhall, 1992). It is important to note, however, that even though MAM
domains can modulate homophilic binding interactions in mammalian proteins, the
MAM domain of dSR-CI does not appear to do so in normal, resting, S2 cells, since
these cells are not aggregated in tissue culture.
In all of the responses discussed so far, dSR-CI plays an effector function.
However, the components of the clotting and prophenoloxidase cascades must be
released from intracellular stores in hemocyte/macrophages before they can perform
their functions (Rizki and Rizki, 1984; Lackie, 1988; S"derhall, 1992; Iwanaga et al,
1992; Hultmark, 1993; Hoffmann, 1995). Drosophila hemocytes also release a battery
of antibacterial peptides (such as the cecropins) in response to infection and may send
signals to the fat body to do the same (Hultmark, 1993; Hoffmann, 1995). Thus, a very
early event in the immune response must be the activation of hemocyte/macrophages
in response to pathogen recognition. Rel domain transcription factors homologous to
NF-kB are probably crucial for this initial activation event (Hultmark, 1993; Hoffmann,
1995). However, little is currently known about the mechanisms by which the activities
of these and other transcription factors are themselves regulated in response to
infection. Given its ligand binding properties, dSR-CI clearly has the potential to be
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involved in the initial detection of pathogens and the subsequent activation of
hemocyte/macrophages. Again, dSR-CI could mediate cellular activation following
either direct detection of microbes and/or indirect detection of microbes which have
been opsonized by endogenous serum components such as a-2 macroglobulin. While
the cytoplasmic domain of dSR-CI contains several potential serine/threonine
phosphorylation sites, its lack of homology with other proteins provides no insight into
how dSR-CI might activate hemocyte/macrophages.
It is important to note that the Drosophila fat body is the major site of
antibacterial peptide synthesis in response to infection (Hultmark, 1993; Hoffmann,
1995). As in the hemocytes, rel domain transcription factors, and other transcription
factors, are probably required for this response. However, again as in the hemocytes,
little is currently known about the mechanism by which the fat body is activated. As
mentioned above, the process may depend on signals generated by previously
activated hemocytes. Alternatively, the fat body may contain receptors which
themselves recognize soluble microbial surface constituents (Hultmark, 1993;
Hoffmann, 1995). Since terminally differentiated fat body cells have not yet appeared
at the stages of embryonic development examined for dSR-CI mRNA expression, it is
not yet known whether dSR-CI has the potential to contribute to fat body activation.
The expression, ligand binding properties, and domain structure of dSR-CI also
suggest functions for this protein in processes distinct from host defense. For example,
Drosophila hemocyte/macrophages migrate throughout the tissues and interstitial
spaces of the developing and adult fly (Rizki and Rizki, 1984; Nelson et al, 1994;
Tepass et al, 1994). Migration along the embryonic ventral nerve cord appears to be
dependent upon tissue-specific guidance cues, since the migration does not occur in
single-minded mutant embryos lacking CNS midline and ventral epidermal cells (Zhou
et al, 1995). Since dSR-CI is expressed prior to the onset of hemocyte/macrophage
migration, and since it contains several potentially adhesive domains, it may play a
role in these migratory processes.
Apoptotic cells are efficiently recognized and engulfed by macrophages during
both mammalian and Drosophila development (Abrams et al, 1993; Savill et al, 1993).
Both the class A and class B scavenger receptors may participate in apoptotic cell
engulfment in mammals (see Chapter 1), and it has been proposed that the
Drosophila scavenger receptors may participate in apoptotic cell engulfment during
embryonic development (Abrams et al, 1992; Abrams et al, 1993). The broad binding
specificity of dSR-CI suggests that it might recognize apoptotic cells, since these cells
express molecular patterns on their surface which are not found on normal cells (Savill
et al, 1993). Indeed, apoptotic cells can be considered to be "altered self" cells
somewhat analogous to non-self microbial pathogens (see Chapter 1). While these
findings have all been made studying mammalian apoptotic cells, given the
conservation of the apoptotic cell death program across the animal kingdom (Steller,
1995), it seems likely that they will hold true for Drosophila as well. Several findings
are consistent with the possibility that dSR-CI might participate in apoptotic cell
engulfment during Drosophila development: 1) dSR-CI expression in the embryo
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precedes the onset of apoptosis (Abrams et al, 1992); 2) dSR-CI expression is
upregulated during the early stages of pupal metamorphosis, a time of extensive cell
death; and 3) COS cell transfectants expressing dSR-CI (but not untransfected cells)
are able to bind and engulf apoptotic thymocytes in vitro (N. Franc and A. Ezekowitz,
personal communication). Importantly, PS vesicle do not appear to be dSR-CI ligands
(Figure 3-5). It seems possible that the CD36 homolog croquemort might recognize
PS on apoptotic cells, and the dSR-CI might act as a phagocytic receptor subsequent
to this initial recognition event. Interestingly, however, croquemort is expressed
coincidentally with the onset of apoptosis (Franc et al, 1996). This suggests that an
alternative role for dSR-CI might be to mediate the initial recognition of apoptotic cells
by hemocyte/macrophages, which would then lead to the upregulation of croquemort
and the subsequent engulfment of the dying cells. Finally, the potential expression of
dSR-CI in subperineurial glia, if confirmed, is consistent with this receptor playing a
role in the reported participation of these cells in the engulfment of apoptotic cells
arising in the central nervous system (Sonnenfeld and Jacobs, 1995). For the moment,
the hypothesis that dSR-CI participates in apoptotic cell engulfment remains
speculative. However, this possibility seems great enough to warrant experimental
exploration of this issue in the future.
Many different functions for dSR-CI have been suggested here. It will be
interesting to determine the actual function of dSR-CI. This is particularly interesting
since, to date, dSR-CI and 18-wheeler are the only molecularly identified invertebrate
membrane receptors which directly recognize microbial surface molecules. The
application of genetic techniques, along with additional molecular and physiologic
studies, should soon begin to provide information on the roles of dSR-CI in Drosophila
development and host defense.
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Figure 3-1. Concentration dependence of the 12sl-AcLDL interaction with S2 cells.
1.5 x 106 S2 cells were incubated in medium C containing the indicated amounts of
125I-AcLDL for 5 hours at 25 OC, and cell association (binding plus internalization, solid
circles) and degradation (solid squares) were determined as described in
Experimental Procedures. The high affinity values shown represent the specific
binding plus uptake and degradation of the ligand, determined as the difference
between measurements made in the absence (duplicate incubations) and presence(single incubations) of excess unlabeled AcLDL (400 gg protein/mi).
-- page 99 --
Concentration Dependence of the
1251-AcLDL Interaction With S2 Cells
C
500 .
000 O
0,
500 -
000 I
00
oo
12 5 1-AcLDL
C4
O
*o)
Q0)
O )
-c
(%J
Tm
2500
2000
1500
1000
500
0
EL0)o
Lu
0)
CD
C
m
(Cg/ml)
Figure 3-2. Southern hybridization screening of S2 cDNA pools for SR-Al homologs.
1 gtg of DNA from each of 19 S2 cDNA pools was screened by Southern hybridization
for cDNA clones containing sequences homologous to mSR-AI as described in
Experimental Procedures. There was incomplete digestion of the DNA in these cDNA
pools (data not shown), which may account for some of the fragments greater than 4
kbp in size which were detected. DNA size standards, in kbp, are indicated (,BstElII
digest, New England Biolabs).
-- page 101 --
Hybridization Screening of S2
cDNA Pools with an mSR-AI Probe
5.69 kbp-
4.32 -
3.67 -
2.32 -
1.93 -
1.26
Figure 3-3. Northern hybridization analysis of dSR-CI expression in S2 and Kco cells.
Approximately 4 gg of polyA+ mRNA from S2 and Kco cells was analyzed using a PCR
generated dSR-CI probe and an elongation factor 1 a probe as described in
Experimental Procedures. A single band of approximately 2.1 kb was detected in the
S2 lane. Only a very weak signal can be detected from Kc, cells.
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Figure 3-4. Concentration dependence of the 125I-AcLDL interaction with CHO[dSR-
Cl] cells at 40C and 370C.
On day 1, CHO[dSR-CI] cells were plated in medium E into either 6-well dishes(125,000 cells/well, panel A) or 24-well dishes (60,000 cells/well, panel B). On day 3,
the indicated amounts of 1-AcLDL in medium A were added and binding for 2 hours
at 40 C (panel A, solid circles) or binding plus internalization (open circles) and
degradation (solid squares) for 5 hours at 370 C (panel B) were determined as
described in Experimental Procedures. The high affinity values shown represent the
differences between measurements made in the absence (duplicate incubations) and
presence (single incubations) of excess unlabeled AcLDL (400 gg protein/mi).
Untransfected CHO cells exhibit virtually no scavenger receptor activity (Freeman et al,
1991).
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Figure 3-5. Specificity of the CHO[dSR-CI] and Schneider S2 scavenger receptors.
CHO[dSR-CI] cells were plated on day 0 in medium E in 24-well dishes (60,000 or
30,000 cells/well). On days 2 or 3, respectively, the cells were incubated for 5 hours at
37 0C in medium E lacking G418 and containing 5 gg/ml 12I-AcLDL in the absence
(triplicate incubations) or presence (duplicate incubations) of 400 gg/ml of the
indicated competitors, except that dA37,and dAsG37,were used at 100 pg/ml and
phosphatidylserine vesicles were used at 500 pg/mI. S2 cells (750,000 cells/tube)
were incubated for 5 hours at 25 OC in medium C containing 5 pg/ml 12I-AcLDL in the
absence (triplicate incubations) or presence (duplicate incubations) of the same
concentrations of the same competitors. The degradation values, expressed as a
percent of the control degradation levels observed in the absence of added
competitor, were measured as described in Experimental Procedures and represent
the results from a single experiment. Similar results have been observed in multiple
experiments, except for dA37 and phosphatidylserine vesicles, which were only tested
once. The control degradation values in these experiments ranged from 1163 - 1571
ng/5 hours/mg protein for CHO[dSR-CI] cells, and 2965 - 4313 ng/5 hours/mg protein
for S2 cells. Abbreviations: MBSA - maleylated BSA; pl - poly(l); DSO4 - dextran
sulfate; CSO4 - chondroitan sulfate; pD-E - poly D-glutamic acid; PS -
phosphatidylserine vesicles (1:1 phosphatidlyserine:phosphatidlycholine).
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Figure 3-6. Inhibition of 1251-AcLDL degradation in CHO[dSR-CI] and S2 cells by
dA5G37 and poly(l).
A. CHO[dSR-CI] cells (solid circles) were plated on day 0 in medium E in 24-well
dishes (60,000 or 30,000 cells/well). On days 2 or 3, respectively, the cells were
incubated for 5 hours at 37 OC in medium E lacking G418 and containing 5 Ig/ml I-
AcLDL in the absence (triplicate incubations) or presence (duplicate incubations) of
the indicated concentrations of either dAsG,3 (part A) or poly(l) (part B). S2 cells (solid
squares, 750,000 cells/tube) were incubated for 5 hours at 25 OC in medium C
containing 5 pg/m 1251-AcLDL in the absence (triplicate incubations) or presence(duplicate incubations) of the same concentrations of these competitors. The
degradation values, expressed as a percent of the control degradation levels
observed in the absence of added competitor, were measured as described in
Experimental Procedures and represent the averages of the results from one to three
experiments per concentration. The control degradation values in these experiments
ranged from 586 - 1032 ng/5 hours/mg protein for CHO[dSR-CI] cells, and 510 - 1335
ng/5 hours/mg protein for S2 cells.
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Figure 3-7. Inhibition of 1251-AcLDL degradation in CHO[dSR-CI] and S2 cells by poly
D-glutamic acid.
CHO[dSR-CI] cells were plated on day 0 in medium E in 24-well dishes (30,000
cells/well). On day 3, the cells were incubated for 5 hours at 37 OC in medium E
lacking G418 and containing 5 pg/ml 125I-AcLDL in the absence (triplicate incubations)
or presence (duplicate incubations) of the indicated concentrations of poly D-glutamic
acid. S2 cells (750,000 cells/tube) were incubated for 5 hours at 25 OC in medium C
containing 5 pg/ml 1I-AcLDL in the absence (triplicate incubations) or presence
(duplicate incubations) of the same concentrations of poly D-glutamic acid. The
degradation values, expressed as a percent of the control degradation levels
observed in the absence of added competitor, were measured as described in
Experimental Procedures. The control degradation values in this experiment were
1163 ng/5 hours/mg protein for CHO[dSR-CI] cells, and 4313 ng/5 hours/mg protein for
S2 cells.
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Figure 3-8. Inhibition of 1251-AcLDL degradation in CHO[dSR-CI] and S2 cells by
laminarin.
CHO[dSR-CI] cells were plated on day 0 in medium E in 24-well dishes (60,000 or
30,000 cells/well). On days 2 or 3, respectively, the cells were incubated for 5 hours at
37 OC in medium E lacking G418 and containing 5 gg/ml 1251-AcLDL in the absence(triplicate incubations) or presence (duplicate incubations) of the indicated
concentrations of laminarin. S2 cells (750,000 cells/tube) were incubated for 5 hours
at 25 OC in medium C containing 5 Ig/ml 12sI-AcLDL in the absence (triplicate
incubations) or presence (duplicate incubations) of the same concentrations of
laminarin. The degradation values, expressed as a percent of the control degradation
levels observed in the absence of added competitor, were measured as described in
Experimental Procedures and represent the averages of the results from one to three
experiments per laminarin concentration point. The control degradation values in
these experiments ranged 582 - 727 ng/5 hours/mg protein for CHO[dSR-CI] cells, and
510 - 1335 ng/5 hours/mg protein for S2 cells.
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Figure 3-9. Predicted protein sequence and domain organization of the Drosophila
scavenger receptor type Cl (dSR-CI).
Panel A: The sequences of the 5' and 3' untranslated regions (UTR) of the dSR-CI
cDNA. The putative transcription start site (underline) and an in frame stop codon (***)
in the 5' UTR, and the putative polyadenylation signal (AAAAAA^^^^^^) in the 3' UTR, are
indicated.
Panel B: The cDNA for dSR-CI was cloned and sequenced as described in
Experimental Procedures. The predicted protein sequence is numbered from -20 for
the first in-frame Met in the putative signal sequence; the first residue (Arg) after the
predicted cleavage site (von Heijne, 1986) is designated +1. Cysteines are boxed and
potential N-linked glycosylation sites are underlined. Potential phosphorylation sites
in the cytoplasmic domain are indicated (* casein kinase II (Pinna, 1990), t protein
kinase C (Woodgett et al, 1986), A cAMP/cGMP dependent protein kinase (Feramisco
et al, 1980; Glass and Smith, 1983)). The protein is divided into nine domains, some
belong to previously described motif families (see text). Consensus sequences for
those motifs are indicated below the corresponding sequences in dSR-CI. The CCP
consensus sequence is from Perkins, et al. (1988). The MAM and somatomedin B
consensus sequences were generated from 13 MAM sequences (7 independent
sequences and 6 sequences of homologs from different species), and 15
somatomedin B sequences (8 independent sequences from 6 proteins, and 7
sequences of homologues). MAM consensus criteria: single amino acids or
combinations with aromatic (x=F,W,Y), hydroxyl (o=S,T), or positive or negative(+=H,K,R; -=D,E) side chains must be present in a 5 independent sequences, aliphatic(a=A,V,L,I) or charged (c=+,-) residues in > 6, and hydrophobic residues (h=a,x,M) in
all 7. At positions in which only two amino acids occur in at least 6 of the sequences,
both are shown. Somatomedin B consensus residues occur a 5.67 of the 8
independent sequences. For these calculations, residues were assigned an
appropriate fractional occupancy weight if they occurred in a sequence represented by
several species homologues. The MAM consensus sequence differs somewhat from
that assembled by Beckmann and Bork (1993) when fewer cloned sequences were
available.
Panel C: Schematic diagram of the domain structure of dSR-CI. The signal sequence(Sig Seq), complement control protein (CCP), MAM, somatomedin B (Som B), spacer(Sp), ser/thr rich putative O-glycosylated (Ser/Thr), transmembrane (TM), and
cytoplasmic (Cyto) domains and the potential N-linked glycosylation sites (ball and
stick symbols) are indicated. The domains are numbered as in part A.
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Figure 3-10. Expression of dSR-CI mRNA in Drosophila embryos.
In situ hybridization in embryos was performed using a digoxygenin labeled dSR-CI
antisense RNA probe as described in Experimental Procedures and was visualized
using Nomarski optics. The stage ("St.") of embryonic development is indicated and
the bars in panels E and F represent 10 pm. Panel E is a high magnification view of a
portion of the ventral nerve cord of a stage 11 embryo. Panel F is a high magnification
view of a portion of the posterior region of a stage 12 embryo. Abbreviations: cl,
clypeolabrum; gb, germ band; pm, procephalic mesoderm; vnc, ventral nerve cord.
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Figure 3-11. Developmental Northern analysis of dSR-CI mRNA expression.
A. A developmental Northern blot was analyzed using the dSR-CI probe 1101p and
an elongation factor 1 a probe as described in Experimental Procedures. The lack of
a dSR-CI signal in late pupa is due to insufficient loading of these lanes.
B. The level of dSR-CI expression was determined at every stage of development
relative to the level observed in 8 - 24 hour embryos. dSR-CI message levels were
normalized to each other by correcting for loading differences using the elongation
factor la signal. Note that elongation factor la is known to be expressed at higher
levels in embryos than in subsequent developmental stages (Walldorf et al, 1985).
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Chapter Four
Identification and Analysis of a Family of dSR-CI - Related
Genes in Drosophila melanogaster
-- page 121 --
Introduction
In Chapter 3, the cloning and characterization of the Drosophila dSR-CI gene
was described. The initial goal of the cloning project was to identify a gene
responsible for the scavenger receptor activity which had been previously observed in
Drosophila embryos and S2 cells. While it was hoped that this gene would be an SR-
A homolog, the expression cloning approach taken was not biased toward the
isolation of one particular class of SR, and indeed, the gene which was identified
which defined a completely new and distinct SR class. In retrospect, this is not
necessarily surprising since, as discussed in Chapter one, there are now at least three
distinctly different classes of proteins which have scavenger receptor activity and
pattern recognition receptor like broad binding specificity, and there are numerous
other proteins which also exhibit pattern recognition receptor characteristics.
The expression pattern of the dSR-CI message, and the sequence and ligand
binding properties of the dSR-CI protein, make this gene interesting in its own right. In
the preceding chapter, a number of potential developmental and host defense
functions for dSR-CI were discussed. The next step toward determining the actual
functions of this gene in vivo was to identify and/or generate mutants lacking dSR-CI
function. Therefore, in situ hybridization to polytene chromosomes was used to
localize the gene within the Drosophila genome. Following this localization, it was
decided that genomic clones containing the dSR-CI gene should be isolated. These
genomic clones were desired for several reasons. First, analysis of the region
containing the dSR-CI gene indicated that the best way to obtain mutants might be to
use P element mediated mutagenesis (Zhang and Spradling, 1993). To do so would
require a source of genomic DNA which could be used for analysis of P element
insertions into or near the dSR-CI gene. Second, genomic clones could be used for
breakpoint analysis of the various chromosome aberrations affecting the dSR-CI
region. Third, genomic clones containing dSR-CI with all of its regulatory elements
could be used to generate P element rescue constructs. Successful rescue of a
mutant phenotype with cloned DNA is the best way to demonstrate that the phenotype
is due to a mutation in the gene of interest. Fourth, the upstream regulatory sequences
of the dSR-CI gene could be used to express altered forms of the dSR-CI protein in a
tissue-specific manner for functional studies. Finally, these clones would also be
useful for studying the regulated expression of the dSR-CI gene.
In the process of isolating genomic clones, a new family of Drosophila genes
homologous to dSR-CI was discovered. This chapter describes the identification and
characterization of these new dSR-CI homologs, as well as the current state of
knowledge regarding the location and organization of these genes within the
Drosophila genome. Most of the work described herein was performed by me. Some
of the genetic analysis of the deficiency and single mutant strains shown in Figure 4-2
was performed by Y. Yu under my direction and supervision. C. Bae gave some
assistance in the PCR analysis of various deficiency strains (Figure 4- 12), and D.
Trigatti subcloned a piece of one of the dSR-CII genomic lambda clones for sequence
analysis (Figure 4-9).
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Experimental Procedures
Reagents and sources. The standard molecular biology techniques used throughout
this work can be found in Sambrook et al (1989). Labeling of probes with 32P-
nucleotides, obtained from DuPont NEN, was sometimes performed using the
Amersham Megaprime labeling kit.. Agarose (SeaKem GTG, and LE grades) was
from FMC Bioproducts. The following filters were used: Genescreen (DuPont NEN)
and Zetabind (CUNO Inc.) for Northern and Southem blotting, and Nitrocellulose HA
(Millipore) for genomic and cDNA library screening.
In situ hybridization to polytene chromosomes. Salivary glands were dissected from
wandering third instar larva in 45% acetic acid, and their chromosomes were spread
and squashed between a glass slide and a siliconized glass coverslip in 3:2:1 acetic
acid:deionized water:lactic acid. After incubation at 4 OC overnight, the slides were
dipped into liquid nitrogen, the coverslips were removed, and the slides were washed
twice in 100% ethanol and allowed to dry. Slides were stored at RT. Just before use,
the slides were acetylated for 10 minutes in 0.1M triethanolamine containing 355 pCl
acetic anhydride/300 ml, and, after washing and drying in ethanol, the chromosomes
were denatured for 3 minutes in 0.07 N sodium hydroxide. A biotinylated dSR-CI
probe was prepared by nick translation of 450 ng of clone pdSR-CI (Chapter 3,
Pearson et al, 1995) using Bio-16-dUTP (ENZO Diagnostics). Incorporation was
approximately 12% as determined by spiking the nick translation mixture with 32p_
dATP. Unincorporated Bio-16-dUTP was removed by ethanol precipitation, and the
probe was resuspended in 75 gI1 of hybridization buffer (0.5 M sodium phosphate, pH
6.8, 0.6 M sodium chloride, 5 pM magnesium chloride, 1X Denhardt's). The probe was
then boiled and 15 gI1 were added to the slide. After sealing the hybridization mixture
under a glass coverslip, the probe was allowed to hybridize to the chromosomes at 58
OC overnight. Subsequently, the slides were washed with hybridization buffer three
times for 20 minutes at 58 0C, and were then incubated with a 1:250 dilution in
phosphate buffered saline (PBS) of streptavidin-biotinylated peroxidase (ENZO
Diagnostics) for 1 hour at 37 OC. After several PBS washes, a diaminobenzidine(DAB) reaction was performed for 20 minutes at RT in using 0.5 mg/mi DAB in PBS
containing hydrogen peroxide (2 pl per ml). Prior to examination in the microscope ,
the chromosomes were stained for 30 seconds using a 1:20 dilution of Giemsa in 10
mM sodium phosphate, pH 6.8.
Genetic techniques. All deficiency (D) strains used in this work are embryonic lethal.
For complementation analysis, males and virgin females of various Df/Balancer and
single lethalVBalancer strains were crossed and the progeny in each phenotypic class
were scored. For Southern blot and PCR analyses of deficiency strains, Df/Balancer
flies were outcrossed to Canton-S flies. The Df/+ F1 males and virgin female siblings
were then mated, and eggs were collected on yeasted molasses egg laying plates.
Eggs were aged for 48 to 72 hours, during which time any hatched larva were
removed. After de-chorionation in 50% bleach, homozygous Df embryos were
collected by selecting unhatched eggs exhibiting visible signs of development and,
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usually, melanization. The Balancer chromosome allows for the easy maintenance of
recessive lethal mutations as heterozygous stocks (Ashburner, 1989).
Preparation and Southern blot hybridization analysis of DrosoDhila genomic DNA.
Genomic DNA was isolated from Drosophila embryos or adults as follows: embryos or
adults were homogenized in 0.1M EDTA, 1% SDS, 1% DEPC, 0.1 M Tris-CI, pH9.0
and incubated for 30 minutes at 70 OC. 14 I1 8M potassium acetate/100 p.
homogenate was then added and proteins and debris were precipitated on ice for 30
minutes and removed by centrifugation. DNA was then precipitated by adding 0.5
volumes of isopropanol followed by RT centrifugation. After washing in 70% ethanol
and air drying, the DNA pellets were resuspended in 10 mM Tris-CI, 1 mM EDTA, pH
7.4. Following standard protocols, 0.5 - 2.0 ig of genomic DNA was digested with
restriction enzymes, electrophoretically separated on 1% SeaKem GTG agarose (FMC
Bioproducts), and transferred to membranes. Hybridization to the membranes used
the following probes: 1) gel purified dSR-Clp, generated by PCR from pdSR-CI using
the primers sdSR1.1 and asdSR1.1 (Table 1); 2) mixed Xel.1b/Xg2.1a probe (see
below); and 3) an elongation factor 1 a probe (Walldorf et al, 1985) generously
provided by C. Wilson and H. Steller. Probes were random primed labeled with 32P-
radiolabeled nucleotides, sometimes using the Megaprime labeling kit.
PCR Analysis of dSR-CI intron/exon structure. Analysis of the intron/exon structure of
dSR-CI was performed using the primer pairs sdSRl.1/asdSR1.1,
sdSRl.1/asdSR1.36, sdSR1.5/asdSR1.30, sdSRl.10/asdSR1.25,
sdSR1.17/asdSR1.23, sdSR1.25/asdSR1.15, and sdSR1.40/asdSR1.1 in PCR
reactions containing 8 pmol of each primer, 1.5 mM magnesium chloride, 1X PCR
buffer (10 mM Tris-CI, pH 8.3, 50 mM potassium chloride, 0.001% gelatin), 0.2 mM of
each dideoxynucleotide triphosphate (dNTP) - dATP, dCTP, dGTP, dTTP, 0.1 to 0.3 gl
Amplitaq DNA polymerase, and either approximately 100 ng of Canton-S genomic
DNA prepared from adult flies as described above, or less than 10 ng of clone pdSR-
CI (Chapter 3). The reaction parameters were 1 minute each at 94 OC and then 42 °C -
63 OC, depending on the primer pair, followed by 1 or 2 minutes at 72 OC, for 35 or 40
cycles. PCR products were analyzed on a 1% LE agarose gel (FMC Bioproducts)
following standard procedures. Primer sequences are listed in Table 1.
Isolation and analysis of genomic clones. Filter lifts from a Canton-S genomic library
prepared in the lambda dash II vector (generously provided by M. Brodsky and H.
Steller) were probed with the random primed 32P-radiolabeled 1101p 5' dSR-CI probe
previously described (Chapter 3). Following standard protocols, plaques
corresponding to the 26 positive signals so identified were picked and used to infect E.
coli strain Q358 (Sambrook et al, 1989) for preparation of secondary plates and filters
lifts. Upon secondary screening, four (Xc4, Md5, Xel, Xg2) of the 26 plaques were
confirmed positive. Single plaques (denoted Xd5.1a, el.1 b, Xg2.1a) were isolated
from Md5, Xel and Xg2 by tertiary screening and used to generate frozen stocks and
for DNA isolation. Although two secondary .c4 plaques were both confirmed by
tertiary screening, it was never possible to grow the tertiary phage generated from
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either of these secondaries. Genomic DNA was prepared from isolated lambda clones
as follows: 40 ml overnight liquid cultures were started from frozen phage stocks. The
next day, bacterial debris was removed by centrifugation and the supernatant was
treated with 1200 units of DNase (Boehringer Mannheim) and 4 pRg of boiled RNAse(Sigma). The lambda phage were precipitated on ice in 10% PEG/1M sodium chloride
and were then resuspended in TM10 buffer (10 mM magnesium sulfate, 50 mM Tris-
CI, pH 7.5). Phage were lysed at 70 OC in the presence of 0.25% SDS, 20 mM EDTA,
0.2 M Tris-CI, pH 8.5, and the DNA was precipitated on ice for several hours by the
addition of potassium acetate to 0.5 M and two volumes of ethanol. After a 70%
ethanol wash, DNA was resuspended in 10 mM Tris-CI, 1mM EDTA, pH 7.4.
Restriction mapping of lambda genomic clones followed standard protocols. For
Southern analysis, 10 ng - 2 Igg of the digested genomic clones were
electrophoretically separated on a 1% agarose gel, transferred to filters, and analyzed
by hybridization to the following probes: 1) gel purified 244p, generated by PCR
amplification from pdSR-CI using T7 and asdSR1.35 (Table 1) primers; 2) the
oligonucleotide sdSR1.22, corresponding to dSR-CI sense strand sequence
separating the MAM domain and somatomedin B domain coding sequences (Table 1);
3) dSR-Clp; and 4) an oligonucleotide homologous to the T3 promoter sequence
present in the lambda dash II vector (Stratagene). Probes were either end-labeled or
random primed labeled using 32P-radiolabeled nucleotides, sometimes using the
Megaprime labeling kit. Subcloning of genomic clone restriction fragments into the
vector pBSKSII+ (Stratagene) was performed following standard molecular biology
techniques (Sambrook et al, 1989). DNA was isolated from overnight bacterial
cultures using the Qiagen midiprep system, and was sequence by L. Ziaugra of the
Whitehead Institute Sequencing Facility.
Isolation of cDNA clones. Colony lifts were made from a 4-8 hour embryo cDNA library
(Brown and Kafatos, 1988) generously provided by X. Song and H. Steller. The filters
were subjected to hybridization with the 32P-radiolabeled oligonucleotide leas1.45
(Table 1). This probe corresponds to anti-sense strand sequences located in the
putative signal sequence coding region of dSR-CII (see below) which should be
located near the 5' end of the cDNA based on the genomic DNA sequence. 33
hybridizing colonies were detected out of approximately 50,000 colonies screened.
Secondary screening of 17 of these positive colonies verified that at least 11 were truly
positive. Single colonies corresponding to these clones were grown up for storage.
DNA was isolated from the bacterial cultures using the Qiagen midiprep system. A
single dSR-CII cDNA clone (clone p11-12) was identified by partial sequencing of eight
of these clones. Sequencing was performed by L. Ziaugra of the Whitehead Institute
Sequencing Facility.
PCR analysis of Drosophila Deficiency and Canton-S strains. Single Canton-S
embryos, or dead homozygous deficiency embryos obtained as described above,
were individually placed into 0.3 ml Eppendorf tubes. The embryos were broken open
with a sterile pipette tip containing 10 pI of squishing buffer (SB: 10 mM Tris-CI, pH 8.2,
1 mM EDTA, 25 mM sodium chloride, 200 p•g/ml fresh proteinase K) and the SB was
then released from the tip. The tubes were placed in a PCR machine at 25 OC, and
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were allowed to warm to 37 OC over a 30 minute period. The samples were then
heated to 95 0C for 2 minutes, and subsequently were stored at -20 OC until use. In
preliminary experiments, it was determined that as little as 1.6 Ri1 of embryonic Canton-
S DNA so prepared gave strong PCR amplification signals. Two multiplex PCR
reactions were performed from each embryo as follows: 1) dSR-CI/STSDm0173/ft
PCR - the 60 gI1 reaction volume contains 1.6 pl of template, 4 pmol primers sdSR1.17,
asdSR1.23, sDm0173.15, and asDm0173.25, 8 pmol of primers D1378f and D1378r,
1X PCR buffer, 0.2 mM of each dNTP, 1.23 mM magnesium chloride, and 0.4 pl
Amplitaq DNA polymerase (Perkin-Elmer Cetus); 2) dSR-CII/rp49 PCR - the 40 pCl
reaction volume contains 1.6 gl1 of template, 4 pmol of primers les1.15 and leas1.25,
16 pmol of primers srp49.2 and asrp49.2, 2.43 mM magnesium chloride, 0.2 mM each
dNTP, 1X PCR buffer, and 0.4 p.l of Amplitaq DNA polymerase. 40 PCR cycles of 1
minute each at 94 OC, then 58 OC, then 72 OC were performed. Restriction digests of
the products were at 37 OC overnight using 1 p.l of enzyme added to 9 p.1 of PCR
mixture. PCR and digestion products were analyzed on a 1% LE agarose gel (FMC
Bioproducts) following standard procedures. Primer sequences are listed in Table 1.
RNA preparation and Northern blot hybridization analysis. Poly A+ RNA was prepared
from strain Canton-S at various stages of development. Embryos were dechorionated
in 50% bleach and were stored at -80 OC prior to use. Larva, pupa and adults were
also stored at -80 OC prior to use. Prior to homogenization, larva, pupa and adults
were ground to a fine powder in a mortar and pestle on liquid nitrogen. Embryo's, and
the powdered larvae, pupae and adults were homogenized in 8 M urea, 3 M LiCI, 5
mM EDTA, 5 mM dithiothreitol using a Dounce homogenizer. Debris was removed by
centrifugation and the supernatant was kept on ice overnight to allow the RNA to
precipitate. The RNA was collected by centrifugation, resuspended in TES (10 mM
Tris-CI, pH 7.5, 5 mM EDTA, 0.5% SDS) and extracted twice with
phenovchloroform/iso-amyl alcohol (25:24:1). The RNA was then re-precipitated by
adding 0.1 volume 3 M sodium acetate, pH 5.3 and 2.5 volumes ethanol and was
stored in this state at -20 OC for several days. After centrifugation, the RNA was
resuspended in binding buffer (0.4 M sodium chloride, 5 mM EDTA, 10 mM Tris-CI, pH
7.5) plus 0.5% SDS, and incubated for 1 hour at RT with oligo dT-cellulose. After
extensive washing in binding buffer, the poly A+ RNA was eluted with 10 mM Tris-CI,
pH 7.5, 1 mM EDTA, and was precipitated as before. The poly A+ RNA was recovered
by centrifugation, was resuspended in deionized water and was stored at -80 OC until
use. Following standard procedures, 10 pgg of poly A+ RNA was electrophoretically
separated on a 1% agarose gel, transferred to membranes, and probed with the
following 32P-radiolabeled probes: 1) oligonucleotide leas1.45; 2) gel purified
Dm0173p1, generated by PCR amplification Canton-S genomic DNA using primers
sDm0173.15 and asDm0173.25; and 3) gel purified rp49p (Konugsuwan et al, 1985),
generated by PCR amplification of Canton-S genomic DNA using primers srp49.2 and
asrp49.2 (Table 1).
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Results
As a first step toward isolating mutants lacking dSR-CI function, the cytological
location of the dSR-CI gene was determined by in situ hybridization of a cDNA derived
probe to polytene chromosomes. A single hybridization signal was detected at
cytological location 24D4 - 24D8 on the left arm of chromosome 2 (Figure 4-1). This
was the only signal detected on multiple chromosomes from two larvae.
A physical map of the 24C - 25A region of 2L is shown in Figure 4-2. The
location of the dSR-CI gene, as determined by the in situ analysis, is indicated by the
two-headed arrow. Several deficiency strains have been isolated whose chromosome
have breakpoints within this region (Szidonya and Reuter, 1988). The extent of the
intact chromosomes in these strains are indicated by the solid lines in Figure 4-2. Note
that there is an inherent uncertainty in the assignment of breakpoints, as indicated by
the shaded lines. For example, Df(2L)edsz- and Df(2L)MI 1 appear to have
overlapping breakpoints cytologically, but can clearly be separated genetically since
the former complements fat (ft) mutations but not echinoid (ed) mutations, while the
latter complements ed but not ft. (Szidonya and Reuter, 1988). Several lethal
complementation groups have been identified which lie within the 24D4 - 24D8
interval (Szidonya and Reuter, 1988), which indicated by the solid vertical lines in
Figure 4-2. These lethal complementation groups are listed above the line of the
chromosome, and of these, the ft has been cloned (Mahoney et al, 1991) and is not
dSR-CI. In addition, since 1(2)24Db is a Minute mutation, it unlikely to be dSR-CI , as
these are usually ribosomal proteins (Ashburner, 1989). The previously assigned
positions of ft, 1(2)24Dc, 1(2)24De, and 1(2)24Df were confirmed by testing the ability of
mutants in these genes to complement several of the deficiency strains , which
demonstrated that they could complement Df(2L)edsz-`  and Df(2L)dph28, but not
Df(2L)M11 (data not shown). However, 1(2)24Dd was previously placed incorrectly
between the breakpoints of the Df(2L)edS -1 and Df(2L)dph28 chromosomes. In our
hands, complementation analysis versus this deficiency gave only two
1(2)24Dd/Df(2L)edsz-' progeny out of 114 scored for one allele, and none out of 84
scored for a second allele. Since one of these alleles also failed to complement
Df(2L)M11 (0/131, the other allele was not tested), 1(2)24Dd appears to be located in
the same cytogenetic interval as ed. The ability of 1(2)24Dd to complement ed and
Df(2L)sc19-1 is currently being examined. The assignment of the cytogenetic location
of the 1(2)d and 1(2)g genes (De Belle et al, 1993) has not yet been confirmed.
Finally, two genes have been genetically mapped to the 24D region, angle wing (ang)
(Mittler, 1950) and 1(2)G99 (Golubovsky, 1971). The physical locations of these genes
have not yet been determined.
Southern analysis of genomic DNA was performed in order to more accurately
determine the physical location of the dSR-CI gene with respect to the deficiencies
illustrated in Figure 4-2. In initial experiments using genomic DNA from Canton-S flies,
the dSR-CIp probe detected a single EcoRI fragment of approximately 4.8 kbp and two
EcoRV fragments of approximately 2.6 kbp and 4.2 kbp (Figure 4-3) consistent with the
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presence of an EcoRV site at bp 815 of the dSR-CI cDNA (Chapter 3). Next, genomic
DNA isolated from embryos homozygous for several of the region 24D - 25A
deficiencies was compared to genomic DNA isolated from their heterozygous Df/
Balancer parents by EcoRI and EcoRV digestion and Southern hybridization. As
shown in Figure 4-4, hybridization of the dSR-CI probe to an EcoRI fragment of 4.6 kbp
was observed in genomic DNA prepared from both Canton - S and Oregon-R flies in
this experiment. This EcoRI fragment is similar in size to that observed in the
preliminary experiment shown in Figure 4-3. Interestingly, the CS and OR genomic
DNA did not display the same EcoRV restriction fragment pattern observed previously.
While the 2.6 kbp fragment seen in Figure 4-3 was still observed, the 4.2 kbp fragment
was now missing. In its place, there was a fragment of approximately 10 kbp length.
Thus, there appears to be an EcoRV polymorphism to one side of the dSR-CI gene. In
order to aid in the discussion below, I will call the two polymorphic variants RFLP-A
(2.6 kbp and 4.2 kbp EcoRV fragments) and RFLP-B (2.6 kbp and ~10 kbp fragments).
The reason for the discrepancy between the results of these two Southern analyses is
unclear, but may be related to the fact that the first experiment (Figure 4-3) used
genomic DNA, generously provided by H. Steller, which may have been isolated from
a different CS line than that used for the second experiment.
Upon analysis of the Df strain genomic DNA, it was observed that both the
Df/Balancer parents and the Df/Df embryos from strains Df(2L)edS 1 and Df(2L)dph2
contained the 4.6 kbp EcoRI fragment and the RFLP-B EcoRV fragments (Figure 4-4).
Thus, these two chromosomal deletions do not remove the dSR-CI gene from the
Drosophila genome. Interestingly, the Balancer chromosome appears to be of the
genotype RFLP -A, while the chromosome harboring the deletion is of genotype RFLP
- B, since both RFLP patterns are observed in the heterozygous parents, but only the
RFLP - B pattern is observed in the Df homozygotes.
In contrast to the first two Df strains, there was no detectable dSR-CI signal in
genomic DNA obtained from homozygous Df(2L)M1 1 embryo's (Figure 4-4). Thus, the
dSR-CI gene must be contained within the region of the genome defined by the
breakpoints of this chromosomal deletion. Genomic DNA isolated from homozygous
Df(2L)ed-dph' embryos generated a signal upon hybridization to the dSR-CI probe,
although this signal was weaker than that generated by genomic DNA from the
parental line and also demonstrated a slight mobility shift (Figure 4-4). This result
might indicate that the dSR-CI gene is present on the Df(2L)ed-dph' chromosome.
However, there are two reasons for believing that the gene is actually deleted from this
chromosome. First, it is apparent from the ethidium bromide stained gel used to
prepare this Southern blot that genomic DNA from the Df(2L)ed-dph' homozygous
embryos is vastly overloaded compared to the genomic DNA from their parents (Figure
4-4 bottom). Thus, the hybridization signal detected may result from a low level
contamination of the genomic DNA prepared from the Df homozygous embryos with
DNA non- Df homozygote embryos collected accidentally. Indeed, it is interesting that
the parental Df(2L)ed-dp h' chromosome appears to be of the RFLP-A genotype, while
the weak EcoRV signal detected in embryonic DNA is of the RFLP-B genotype,
suggesting that there was in fact a contamination with RFLP-B containing flies.
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Second, the EcoRI and EcoRV genomic fragments detected in the homozygous
embryonic DNA are mobility shifted to the same degree. This would be unexpected if
the Df(2L)ed-dph' was deleting only part of the genomic DNA near the dSR-CI gene.
Instead, the mobility shift may simply be due to the vast excess of genomic DNA that
was run on the agarose gel. Indeed, the genomic fragments detected by hybridization
to an elongation factor la probe are mobility shifted to the same degree as the
fragments recognized by the dSR-CI probe (data not shown).
The results of this Southern analysis are consistent with the localization of the
dSR-CI gene as determined by in situ hybridization. Further, this analysis
demonstrated that 1(2)24Dc, 1(2)24De, and 1(2)24Df might correspond to the dSR-CI
gene since the are known to complement Df(2L)ed -Szl but not Df(2L)M11 (Szidonya
and Reuter, 1988). In addition, these results indicate that ed, 1(2)d, 1(2)g, and 1(2)24Dd
are not dSR-CI, since these genes can complement Df(2L)M11 , but not Df(2L)ed -SZl
(Figures 4-2 and 4-4).
The identification of only a single 4.6 kbp EcoRI fragment containing dSR-CI
sequences by Southern analysis suggested that the dSR-CI gene was small. PCR
amplification of Canton-S genomic DNA using primers homologous to the 5' and 3'
termini of the dSR-CI cDNA clone yielded a product of approximately 2.3 kbp, when
corrected for the faster than expected mobility of the cDNA derived control reaction
product (Figure 4-5B, see figure legend for explanation). This result is consistent with
the possibility that the dSR-CI gene is small, since the cDNA clone is likely represent
most, if not all, of the dSR-CI message (the cDNA size is 2.03 kbp and Northern
analysis detects a single message of approximately 2.1 kb (Chapter 3)). However, this
result does not eliminate the possibility that there is a small exon in the 5' or 3' UTR
which is distantly removed from the rest of the dSR-CI gene. At least for the region
between the two terminal primers I have used, there appear to be only approximately
250 bps of intronic sequence. Additional PCR analysis has identified two introns in the
dSR-CI gene (Figure 4-5). The first was identified using primers derived from
sequences specifying the middle of the first and the middle of the second CCP
domains, suggesting that each CCP domain may be the product of a separate exon.
The second intron lies between two primers located within the MAM domain coding
region. Interestingly, there appears to be no intron separating the sequences coding
for the second CCP domain and the MAM domain. It is likely that there is at least one
additional intron in dSR-CI, since the two introns have been identified are
approximately 70 and 100 bps in length respectively.
Prior to mapping the dSR-CI gene relative to the 24D - 25A region deletion
breakpoints, three genomic clones, Xd5.1 a, Xel. 1 b, and Xg2.1 a, had been isolated
from a CS library using as a probe the 5' 1101 bps of the dSR-CI cDNA. By digesting
these clones with a panel of seven restriction enzymes, it became apparent that there
was significant overlap between clones Xel.lb, and Xg2.1a (data not shown). These
two clones were therefore subjected to further analysis, as described in Experimental
Procedures, in order to determine an unambiguous restriction map. Some of the data
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used to construct this map is shown in Figure 4-6A, which illustrates the pattern of
fragments obtained from several single and double restriction enzyme digests of clone
Xel.1b. For example, digestion of this clone with EcoRI generates insert-derived
fragments of approximately 0.6, 1.5, 1.7, and 4.6 kbps, and two fragments of
approximately 3.9 kbps, as indicated by the increased intensity and width of this band
relative to the others. The small 0.6 kbp fragment is barely visible on the ethidium
bromide stained gel and did not reproduce well when this figure was generated. Scal
reduces the size of the 4.6 kbp and one of the 3.9 kbp fragments by approximately 1.0
and 0.6 kbps respectively (again, the 0.6 kbp fragment did not reproduce well, but it
was obvious on the ethidium bromide stained gel that its intensity was twice that of the
band observed in the EcoRI only digest). Some of the restriction digested genomic
DNA samples, including those shown in Figure 4-6A, were subjected to Southern
hybridization analysis in order to determine which fragments contained sequences
homologous to the dSR-CI cDNA. As shown in Figure 4-6B, a probe corresponding to
the 5' 244 bps of the dSR-CI cDNA hybridized to the 4.6 kbp EcoRI fragment, and to
the 3.6 kbp fragment generated by the EcoRI/Scal double digest. The same EcoRI,
Scal and EcoRI/Scal fragments were also identified using an independent dSR-CI
probe. The subsequent observation, described above (Figure 4-3 and 4-4), of 4.6 kbp
fragments homologous to a dSR-CI cDNA probe in genomic DNA from several
different fly strains, described earlier was consistent with the results of the Xel. 1 b
restriction and Southern analyses. Ultimately, a 28 kbp restriction map of the
overlapping clones Xel. 1 b and ,g2.1 a was constructed by these types of methods
(Figure 4-7). Upon completion of the map, it was observed that a Pvul/Scal fragment of
approximately 1.4 kbp (the actual Pvul/Scal double digest has never been performed)
should be homologous to the dSR-CI cDNA. Although this prediction was not tested, it
was observed that the dSR-CI cDNA contains each of these sites, separated by a
distance of 1.6 kbp, as determined by the cDNA sequence and intron/exon structure
analysis presented above. Thus, by this criterion, in combination with the observation
of 4.6 kbp EcoRI fragments in both CS and Xel.1 b genomic DNA which hybridized to
dSR-CI probes, the Xel.lb and Xg2.1a clones appeared to contain the dSR-CI gene.
Furthermore, the Pvul and Scal sites helped to define the orientation of the gene within
the X clones.
An unambiguous restriction map for Xd5.1a has not yet been completed, but
both the pattern of restriction fragments and Southern analysis indicate that this clone
does not appear to overlap with either of the other two clones (data not shown). It has
never been possible to obtain PCR amplification products from this clone using
several sets of dSR-CI primers. In addition, sequencing of the 1.3 kbp Xbal fragment
of this clone which is recognized by an oligonucleotide probe on Southern blots
demonstrated no significant homology to dSR-CI (data not shown). These results
indicate that Xd5.1a does not contain dSR-CI sequences, and may have been
fortuitously isolated during the initial screen for genomic clones.
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After the dSR-CI gene was mapped relative to the 24D -25A area chromosomal
deletions by Southern hybridization to Df strain genomic DNA (Figures 4-2 and 4-4),
the kel.1 b and Xg2.1a clones were used as probes on the same Southern blots to
determine if any of the deletion breakpoints were within 28 kbp genomic interval
defined by these clones. Unexpectedly, it was found that every deletion chromosome
tested appeared to contain the entire 28 kbp of cloned genomic DNA (data not shown).
This result immediately suggested that these genomic clones contained a homolog of
the dSR-CI gene, and not the gene itself. This hypothesis was strengthened by
Southern analysis of restriction enzyme digested CS and Xel.1b genomic DNA using
a dSR-CI cDNA derived probe. This probe recognized fragments in CS genomic DNA
that were different from those it recognized in Xel.1 b DNA. For example, the cDNA
probe recognized two EcoRV bands of 2.8 kbp and approximately 11 kbp in CS
genomic DNA (Figure 4-8A, left), consistent with previous results. However, this probe
recognized only a single EcoRV fragment of greater than 14 kbp in the Xel. 1 b DNA
(Figure 4-8A, right). A similar difference was observed with XmnI digestion: fragments
of 1.2 kbp and 1.35 kbp were detected in CS DNA, while fragments of 1.6 kbp and 4.9
kbp were detected in Xel.lb DNA. In fact, the only enzyme for which a difference is
not detected is EcoRI, in which a single 4.6 kbp fragment is detected in both genomic
DNA samples (Figure 4-8A)! This illustrates the importance of using multiple
restriction enzymes to analyze genomic DNA: EcoRI was the only enzyme which was
used for analysis of CS and Df genomic DNA which had been mapped in the X.
clones.
It is unlikely that genomic polymorphism can account for all of the differences
observed between CS and Xel.lb genomic DNA since four of five different enzymes
tested all show these differences. To verify that these differences were not due to
polymorphisms in these restriction site loci, a second blot of the same CS DNA was
prepared and was hybridized to a mixed ;el.1 b/;g2.la probe. Most of the restriction
fragments which gave strong hybridization signals with the cDNA probe did not give
strong signals with the mixed X probe (Figure 4-8B). Thus, the 2.8 kbp and -11 kbp
EcoRV fragments, the 1.2kbp and 1.35 kbp Xmnl fragments, and the ~12 kbp Ncol
fragments detected in CS DNA using the cDNA probe are not detected using the
mixed X probe. Instead, the mixed X probe detected CS DNA restriction fragments
which were similar in size to restriction fragments that were weakly recognized by the
cDNA probe (compare Figure 4-8A left with Figure 4-8B). Interestingly, the mixed X
probe detected only some of the CS DNA restriction fragments that were weakly
detected by the cDNA probe; for example, two Scal fragments of around 3.6 kbp and
3.8 kbp are weakly detected by the cDNA probe, but are not detected by the mixed X
probe. This result suggests that there may be additional dSR-CI homologs in the
Drosophila genome. Low stringency Southern analysis of an isogenized Canton-S
strain should provide a good estimate of the number of homologs.
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To ultimately verify that .el. 1 b and Xg2.1 a do in fact contain a homolog of dSR-
CI, the 1.4 kbp Pvul/Scal fragment predicted by restriction analysis (Figure 4-6) was
subcloned and sequenced. Sequence analysis of this fragment indicated that Xel.1 b
and .g2.1a do contain a dSR-CI homolog. This homolog has tentatively been named
dSR-CII. The 4.6 kbp EcoRI fragment of ,el.1b was subsequently cloned into
pBSIIKS+ and has been partially sequenced (Figure 4-9). Sequence analysis of this
clone predicts that, like dSR-CI, dSR-CII is a small gene which appears to contain
three introns ranging in size from 63 to 126 bps. Small introns are quite common in
Drosophila genes, with 60 to 65 bp introns being the most abundantly represented
size class (Mount et al, 1992).
Sequencing of a 2066 bp (excluding a short poly A tail) dSR-CII cDNA cloned
from a 4 - 8 hr embryonic library (see Experimental Procedures) verified the small size
of the dSR-CII gene and the presence of all three introns (Figure 4-9). A canonical
arthropod transcription start site sequence (Cherbas and Cherbas, 1993) exactly
overlaps the 5' end of the cDNA, suggesting that the cDNA represents the entire dSR-
CII message. In addition, the 84 bp 5' UTR contains an in frame stop codon 69 bps
upstream of the putative initiator methionine codon. There are two polyadenylation
signals in the 185 bp 3' UTR, which also contains two ATTTA sequences that may
confer instability on this message (Shaw and Kamer, 1986). Comparison of the dSR-
Cl and dSR-CII cDNA sequences indicates that the two genes are highly homologous,
their DNA coding sequences being 67% identical. The locations of the first two dSR-
CII introns coincide with the locations of the dSR-CI introns determined by PCR
mapping (Figure 4-5). However, the first dSR-CI intron may be significantly smaller(approximately 70 bps) than the corresponding intron in dSR-CII (126 bps). The dSR-
CII gene also contains a third intron, which is located between sequences coding for
the end of the mucin domain (see below) and the second spacer domain of the dSR-
CII protein.
The dSR-CII protein has the same arrangement of domains as the dSR-CI
protein (Figure 4-10). The two proteins are quite similar at the amino acid sequence
level, having 55% amino acid identity and 70% amino acid similarity overall. A
particularly high degree of homology is apparent in the MAM domain (75% identity/
84% similarity), while the CCP, transmembrane and cytoplasmic domains also share a
significant degree of homology. Cleavage of the putative signal sequence of dSR-CII
would generate a mature, 581 residue protein of 64.9 kD if unmodified. However, the
presence of a serine/threonine rich region indicates that this protein, like dSR-CI(chapter 3), will probably have a greater mass due to significant O-glycosylation. The
mature dSR-CII protein will likely have a significantly smaller mass than its homolog,
however, since the mucin - like domain of dSR-CII is both shorter and less
serine/threonine-rich than the corresponding domain of dSR-CI. The dSR-CII protein
may also be N-glycosylated. Three potential N-linked glycosylation sites are
conserved with dSR-CI in the MAM domain, and there are four additional sites specific
to dSR-CII (Figure 4-10). Both dSR-C proteins have multiple potential
serine/threonine phosphorylation sites in their cytoplasmic termini, but again, there
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does not appear to be any particular conservation of these sites between the two
proteins (Figure 4-10). Finally, it is interesting to note that, whereas an unmodified
dSR-CI protein would be essentially neutral (+1 charge overall), an unmodified dSR-
CII protein would be slightly acidic (-12 charge overall, calculated pl 6.0).
An additional dSR-CI homolog was discovered during a search of the Genbank
database. This homolog is represented by the sequence tagged site STSDm0173,
which has been generated by the Drosophila genome project, and which encodes
part of a MAM domain. Comparison of the predicted amino acid sequence encoded by
the STSDm0173 sequence with the MAM domains of dSR-CI and dSR-CII (Figure 4-
10) shows that the STSDm0173 protein is significantly more divergent than the other
two proteins (46% amino acid similarity/54% identity to dSR-CI and 40%/55% to dSR-
CII). The MAM domain intron in STSDm0173 is located at the same position as an
intron in dSR-CII , but at 60 bps, is shorter than those of dSR-CI (approximately 100
bps) and dSR-CII (111 bps). Given the low quality of the STSDm0173 sequence, an
accurate determination of the level of conservation awaits the isolation of genomic and
cDNA clones containing the complete STSDm0173 sequence. Importantly, there are
no stop codons in the 245 bp of known STSDm0173 sequence. Coupled with the
observation that an mRNA which hybridizes to the STSDm0173 sequence can be
detected by Northern analysis (see below), this suggests that STSDm0173 marks a
functional gene. Confirmation of this hypothesis awaits the isolation and sequencing
of a corresponding cDNA, and ultimately, the detection of an STSDm0173 protein.
STSDm0173 defines the distal end of a contig assembled from overlapping 75 -
100 kbp P1 genomic clones by the Drosophila genome project (Smoller et al, 1991)(Figure 4-11). Interestingly, this contig is located at the 24D region of 2L in the vicinity
of the ft gene. Prior to the identification of the STSDm0173 gene as a dSR-CI
homolog, PCR analysis of several P1 clones from this contig had indicated that the
dSR-CI gene mapped to the same P1 clones as STSDm0173 (data not shown). Since
the primers used for this analysis were homologous to dSR-CII, this assignment was
verified using dSR-CI specific primers. At the same time, the Drosophila genome
project found new STS (STSDm3565) which also mapped to these clones, and which
corresponds to the sequence encoding the cytoplasmic domain of dSR-CII Thus, it is
now very clear that the dSR-CI and STSDm01 73 genes lie close together in the
Drosophila genome. The exact arrangement of these two genes relative to each other
is unknown, and is currently under investigation.
The colocalization of dSR-CI and STSDm01 73 to the same P1 clones indicates
that these two genes are located within approximately 80 kbp of each other in the
genome. Southern analysis had already indicated that dSR-CI was deleted in
Df(2L)ed-dph' and Df(2L)M11 embryos (Figure 4-4). In order to more precisely
determine the location of the dSR-CI and STSDm01 73 genes relative to the
chromosomal deletion breakpoints in the 24D - 25A region, gene-specific primers
were used for single embryo multiplex PCR analysis of deficiency homozygotes as
described in Experimental Procedures. The use of single embryo PCR has two
advantages over Southern analysis for answering this question: 1) since individual
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embryos are analyzed, the PCR method is insensitive to small contaminations of
homozygous Df embryos with their non-homozygous siblings, and 2) it is significantly
easier to obtain 10 dead embryos and prepare their DNA for PCR than it is to obtain
several hundred dead embryos and prepare their DNA for Southern analysis. The
advantage of multiplex PCR is that it allows for the identification of multiple genes from
the same embryo using a minimum number of PCR reactions.
Preliminary PCR experiments established working conditions for the multiplex
PCR reactions and demonstrated that each specific primer pair amplified only its
corresponding gene (data not shown). Upon analyzing three homozygous deficiency
embryos from each deficiency strain, it was found that the control rp49 (the gene
encoding ribosomal protein 49 - Kongsuwan et al, 1985) and dSR-CII primers
amplified products of the expected size in every embryo (Figure 4-12A). Thus, as
already indicated by the Southern analysis (Figures 4-2 and 4-4), the dSR-CII gene is
not deleted in any of the 24D - 25A region chromosomal deletions examined and must
be located elsewhere in the genome. The precise location of dSR-CII will be
determined by in situ hybridization to polytene chromosomes. The ability to amplify
dSR-CII sequences from these Df strain genomic DNAs suggests that cross-
hybridization of the dSR-CIp probe to dSR-CII sequences may have contributed to the
residual hybridization signal detected in the initial Southern analysis of these Df
strains (Figure 4-4).
The dSR-CI, STSDm0173 and ft primers amplified products in all Df(2L)ecdzl,
Df(2L)M-z and Df(2L)dph~ embryos, in two of the three homozygous Df(2L)dpr2
embryos, and in several additional homozygous Df(2L)dp"h2 embryos (Figure 4-12A
and data not shown). Interestingly, weak dSR-CI sized products were also detected in
all of the Df(2L)ed-dp h' and Df(2L)M1 1 embryos (Figure 4-12A). The weak
amplification of these products, coupled with the fact that it has not been possible to
amplify them in subsequent experiments using the same primers and embryos,
suggests that they do not correspond to either the dSR-CI or the STSDm01 73 gene.
Indeed, restriction analysis of these products indicated that they could not be either
dSR-CI or dSR-CII because they were insensitive to digestion by either EcoRV (dSR-
CI specific) or Clal (dSR-CII specific) (Figure 4-12A and 4-12B). Furthermore, the dSR-
CI sized products could not correspond to STSDm0173 since they were the wrong
size. While the origin of these PCR products is not clear, they may represent yet other
members of the dSR-C family of proteins, and I am currently attempting to clone them
for sequence analysis.
Single embryo PCR has confirmed and extended the conclusions of the
Southern analysis regarding the cytological location of dSR-CI (Figure 4-4). The
demonstration that the MAM domain coding sequences of dSR-CI are not deleted in
the Df(2L)dp"2 8 and Df(2L)M-zB chromosomes (Figure 4-12) suggests that it this gene
is not 1(2)24Df. Further, the STSDm0173 gene is not separated from the dSR-CI gene
by any deletion breakpoints, thus indicating that most of the mutants which can not
correspond to dSR-CI also can not correspond to STSDm0173. However, since
STSDm0173 is distal to dSR-CI, and since the STSDm0173 primers may be located
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in the middle of the gene, it is possible that ed, 1(2)24Dd, 1(2)dor 1(2)g may be
STSDm0173 mutants.
In order to begin elucidating the functions of dSR-CII and STSDm0173, their
expression pattems were analyzed by Northern analysis of poly A+ RNA isolated from
various stages of Drosophila development (Figure 4-13). In contrast to dSR-CI, which
is expressed throughout development beginning about 4 hours after egg laying(Figures 3-10 and 3-11), dSR-CII expression is restricted to 0 - 8 hour embryos. As
predicted from the cDNA sequence, the dSR-CII message is approximately 2.0 kb in
length, indicating that the dSR-CII cDNA must be very nearly, if not completely, full
length. The expression of STSDmO1 73 during development differs from both dSR-CI
and dSR-CII. This gene is expressed only during the larval and pupal stages (Figure
4-13). Interestingly, the STSDm0173 message appears to be only approximately 1.25
kb in length, significantly shorter than the messages of the other two dSR-C genes.
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Discussion
As discussed in Chapter 3, the properties of the dSR-CI gene suggest that it
might participate in one or more of several different processes during Drosophila
development and host defense. The isolation of dSR-CI mutants would greatly
facilitate the identification of the actual in vivo functions of this gene. As a first step in
this process, the gene was mapped to the region 24D4 - 24D8 on the left arm of
chromosome 2. This places dSR-CI close to the ft gene (Figure 4-1). Using this
information, dSR-CI was further mapped with respect to several chromosomal
deletions. The results of Southern analysis (Figure 4-4), PCR (4-12) and the
Drosophila genome project are all consistent with the in situ localization of the dSR-CI
gene. These results indicate that dSR-CI is located less than 100 kbp to the distal side
of the ft gene.
In order to facilitate the isolation, analysis and transformation-mediated rescue
of dSR-CI mutants, it is necessary to have genomic clones containing the dSR-CI
gene. Although genomic clones were isolated using the 1101p probe derived from the
dSR-CI cDNA, analysis of two of these clones indicated that they actually harbor a
close homolog of dSR-CI, which has been named dSR-CII. At the same time that dSR-
CII was identified, database searching revealed that a sequenced tagged site
(STSDm0173) generated by the Drosophila genome project was moderately
homologous to part of the MAM domain coding sequence of dSR-CI. While dSR-CII
does not appear to be located in the near vicinity of dSR-CI (i.e. the region from 24A to
25B, based on Southern and PCR analysis), the STSDM0173 gene is located on the
same P1 genomic clones as the dSR-CI gene (Figure 4-11), indicating that it is within
100 kbp of dSR-CI. Both dSR-CII and STSDm01 73 appear to be functional genes,
since the dSR-CII cDNA has no stop codons through its entire region of homology with
dSR-CI, while STSDm0173 contains no stop codons in the partial open reading frame
which has been sequenced. In addition, transcripts corresponding to each of these
open reading frames can be detected by Northern analysis (Figure 4-13).
Two additional genomic clones were identified during the initial screen with the
1101p probe. It has never been possible to isolate DNA from one of these clones, so it
is not known whether this clone contains the dSR-CI gene. The other clone is
distinctly different from the dSR-CII containing clones and does not appear contain the
dSR-CI gene by both PCR analysis and sequencing. Since the sequenced portion of
this clone was isolated using a dSR-CI oligonucleotide probe which may have
hybridized to a different region than the 1101p probe initially used to isolate the clone,
it remains possible that this clone contains yet another dSR-CI homolog.
There are now numerous examples of gene families in Drosophila. In some
cases, the various members of these families are scattered throughout the genome.
Examples include genes encoding secreted proteins (TGF-8 homologs:
decapentaplegic , screw, 60A - Arora et al, 1994; Wharton et al, 1991), receptors (type
II receptors for TGF-8: thick veins, saxophone - Brummel et al, 1994), and cytoplasmic
proteins (kinesin like proteins: kip genes Dalby et al, 1993). Often, these genes are
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less conserved with each other than they are with corresponding homologues in
vertebrates, suggesting that they may have arisen by gene duplication events pre-
dating the divergence of the vertebrate and arthropod lineages during evolution.
Structurally related genes have also been found in Drosophila which are tightly
linked to each other. Examples of such genes include several different transcription
factor families (Antennapedia-complex and Bithorax-complex genes - McGinnis et al,
1984; sloppy-paired 1/slp2 - Grossniklaus et al, 1992; knirps/knirps-
related/Embryonic-gonad - Rothe et al, 1989; invected/engrailed - Coleman et al,
1987; gooseberry/gooseberry-neuro - Baumgartner et al, 1987; BarH1/BarH2
Higashijima et al, 1992; and odd-skipped/sister-of-odd-and-bowel/bowel - Hart et al,
1996) and secreted proteins (BMP-1 homologs: tolloid/tolloid-related-1 - Nguyen et al,
1994; the antibacterial peptide cecropin genes - Samakovlis et al, 1990; L71 genes -
Wright et al, 1996). Two members of a gene pair (e.g. odd/sob or kni/knrl) may be
divergently transcribed (Wright et al, 1996; Baumgartner et al, 1987), convergently
transcribed (Coleman et al, 1987) or transcribed in the same direction (Grossniklaus et
al, 1992; Nguyen et al, 1994; Hart et al, 1996). In the case of the cecropin locus, which
contains three equally spaced genes separated from one another by two
pseudogenes, two of the genes are tandemly transcribed while the third is
convergently transcribed relative to the second (Samakovlis et al, 1990).
The exact organization of dSR-CI, dSR-CII and STSDmO 173 within the genome
is currently under investigation using in situ polytene chromosome hybridization to
localize dSR-CII, and restriction analysis of P1 clones to determine the distance of
separation between and relative orientation of dSR-CI and STSDm0173. It is possible
that these three genes will be organized in a manner similar to the kni/knrl/Egon and
odd/sob/bowlgene families (Hart et al, 1996; Rothe et al, 1987). Two members of
these families are tightly linked to each other (e.g. in the 24A region, < 10 kbp
separates sob from odd), while the third is several lettered divisions away (e.g. Egon is
in 24C). The odd/sob/bowl family is particularly interesting because the two most
closely linked genes, odd and sob, are less related to each other than sob is to bowl,
which is further away in the genome (Hart et al, 1996). This is strikingly reminiscent of
the sequence relationships between dSR-CI, dSR-Cll and STSDm0173 (see below).
Tightly linked homologous genes in Drosophila often have overlapping
temporal and spatial patterns of expression, suggesting that they are regulated by
common cis-- acting sequences. At one extreme, both members of the BarHI/BarH2
and kni/knrl gene pairs have been found to be expressed identically both temporally
and spatially (Rothe et al, 1992; Higashijima et al, 1992). More often, linked
homologous genes have similar, but non-identical, patterns of expression(Samakovlis et al, 1990; Nguyen et al, 1994; Coleman et al, 1987; Grossniklaus et al,
1992; Wright et al, 1996; Hart et al, 1996; Li and Noll, 1994). This suggests that, in
addition to common cis-acting sequences, there may be gene-specific cis-acting
sequences which control the expression of linked homologous genes. It was
previously established that dSR-CI is expressed during throughout development
starting in embryonic stage 10 (Chapter 3). Northern analysis indicates that dSR-CII
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expression, on the other hand, is restricted to 0 - 8 hour embryos (Figure 4-13).
Furthermore, unlike dSR-CI, dSR-CII is not expressed in the mbn-2 hemocyte cell line(data not shown). Thus, the regulation of dSR-CII expression appears to differ
significantly from that of dSR-CI. The lack of detectable dSR-CII message in females
suggests that it is not a maternal gene, and is probably first expressed after
cellularization of the embryo occurs around 2.5 hours after egg laying. In contrast to
dSR-CII, STSDm01 73 expression in larva and early pupa temporally overlaps, but is
more restricted than, dSR-CI expression. Thus, STSDm0173 may be regulated in part
by the same cis -acting elements which control dSR-CI expression. It will be
interesting to determine the cell and tissue specificity of both dSR-CII and
STSDm0173 expression.
The STSDm0173 message is significantly shorter than the dSR-CI and dSR-CII
messages (Figure 4-13). This may suggest that the gene represented by STSDm0173
simply encodes a MAM domain containing protein which is not actually a dSR-CI
homolog. That MAM domains are found in a variety of otherwise functionally and
structurally unrelated proteins demonstrates that they are basically molecular building
blocks which can be used in a variety of functionally unrelated proteins. Alternatively,
this gene may be a homolog in which one or more of the dSR-CI encoded domains
are not present. There are precedents for such a relationship between two or more
members of a tightly linked gene family in Drosophila. For example, one of the L71
encoded proteins contains a 75 residue C-terminal extension which almost doubles its
size relative to the other L71 encoded proteins (Wright et al, 1996). In addition, the tir-
1 encoded protein contains a large N-terminal extension relative to the tid encoded
protein (Nguyen et al, 1994). An interesting possibility in regard to STSDm01 73 is that
it contain sequences homologous to those in dSR-CI which encode the CCP, MAM
and somatomedin B domains, but lacks the more 3' sequences. Such a gene would
generate a 1.2 kb message and would encode a secreted protein. It will be important
to determine the actual sequence of the STSDm0173 gene at the genomic and cDNA
levels in order to determine whether it is a true dSR-CI homolog.
As has already been mentioned, sequence comparison indicates that dSR-CI
and dSR-CII are closely related genes, while STSDm0173 is a more distant relative
(Figure 4-10). The locations of the first two introns in dSR-CI and dSR-CII are very
similar and may be identical. Consistent with this hypothesis, STSDm0173 contains a
putative intron sequence located in precisely the same position as the dSR-CII intron(Figure 4-9). PCR analysis indicates that dSR-CI must contain at least one additional
intron, which may be located in the same region as the third intron of the dSR-CII
gene.
dSR-CI and dSR-CII are also well conserved at the level of amino acid
sequence, with STSDm0173 again being more distantly related. The MAM domains
of dSR-CI and dSR-CII are particularly well conserved, and are more closely related to
each other (75% amino acid identity/84% similarity) than to any other known MAM
domains (best match: 30% identity/45% similarity to the MAM domain of rat apical
endosomal protein (Speelman et al, 1995). The reason for the high level of sequence
-- page 138 --
conservation between the MAM domains of dSR-CI and dSR-CII is not known.
Perhaps these domains play a similar role in both of these proteins. Although less
well conserved than the MAM domains, the CCP domains of dSR-CI and dSR-CII are
also more closely related to each other than to other CCP domains (data not shown).
In addition, even though it is significantly less well conserved, the MAM domain of
STSDm0173 is also more similar to those of dSR-CI and dSR-CII than to any other
known MAM domains. The greater homology between dSR-CI and dSR-Cll than
between either of these genes and STSDm0173 suggests that the duplication event
which distinguished STSDm0173 from dSR-CI/dSR-CII occurred prior to that which
distinguished dSR-CI and dSR-CII from each other. It is also possible that after a
duplication event which generated the dSR-CI/STSDm0173 gene pair, a second
event duplicated both members of this pair and was followed by a translocation event
which moved one of the gene pairs to a different region of the genome. Thus, it is
possible that there is an STSDm0173 homolog tightly linked to dSR-CII which has not
yet been identified. This possibility has not yet been tested.
The existence of a family of genes related to dSR-CI raises the possibility that
some of these genes might be functionally redundant. This is a non-trivial issue,
especially since dSR-CI mutants may have no phenotype if the gene can be
functionally replaced by one of its homologs. Functional redundancy of related genes
has been observed in yeast (for example, see Kataoka et al, 1984) and mammals (for
example, see Lohnes et al, 1993). Functional redundancy has also been observed in
Drosophila among some of the linked homologous gene families described earlier.
For example, BarHI and BarH2 appear to be completely functionally redundant - only
when both genes are deleted from the genome can any phenotypic effect be observed(Higashijima et al, 1992). To a lesser degree, kni and knrl also have redundant
functions: during embryonic development, knrl can compensate for a loss of anterior
kni function, but not for a loss of posterior kni function, in kni mutants. Only when both
gene products are absent is anterior head development affected (Gonzalez-Gaitan,
1994). Similarly, sipi and sip2 are almost, but not completely, functionally redundant
(Cadigan et al, 1994). There may be some degree of functional homology among
unlinked homologous genes in Drosophila as well. For example, it is possible that the
dpp receptor tkv may be functionally redundant with sax in some cell types (Brummel
et al, 1994).
There are several ways in which the issue of the potential functional
redundancy between dSR-CI, dSR-CII and STSDm0173 can be addressed. First,
having cloned the dSR-CII cDNA, it will now be possible to determine if the dSR-CII
protein has scavenger receptor activity in transfected tissue culture cells. This work is
currently in progress, and similar studies will be possible once the STSDm01 73 gene
is cloned. It has been found, however, that genes with similar activities which can
functionally compensate each other under artificial conditions, are not redundant
under normal circumstances due to differences in expression or gene structure (Li and
Noll, 1994; Rothe et al, 1992). Thus, it will also be important to determine the spatial
pattern of dSR-CII and STSDmf0173 expression in the developing fly. That dSR-CII is
expressed only in 0 - 8 hour embryos suggests that it may not compensate for a dSR-
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CI loss except perhaps at this early stage of development. Given the similar temporal
pattern of STSDm0173 and dSR-CI expression, determination of both the spatial
expression pattern of these genes in late embryos, larva and pupa is of particular
importance. Should the STSDm0173 protein turn out to be similar to the dSR-CI
protein in structure, function, and expression pattern, it may be necessary to construct
chromosomes carrying null mutations of both genes, perhaps by generating small
deletions, in order to accurately determine the function of either gene during
Drosophila development and host defense.
In summary, at least one new gene has been identified which shares significant
homology with the entire dSR-CI gene, while a second shares significant homology
with at least a portion of dSR-CI. Are there additional dSR-CI homologs in
Drosophila? There is no a priori reason for believing that the answer to this question
will be either yes or no, and it will be interesting to analyze Drosophila genomic DNA
using both PCR and low stringency Southern hybridization analysis in order to answer
this question.
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Table 4-1. Oligonucleotides used in this study.
Oligonucleotide
asdSR1.1
asdSR1.15
asdSR1.23
asdSR1.25
asdSR1.30
asdSR1.35
asdSR1.36
sdSR1.1
sdSR1.5
sdSR1.10
sdSR1.17
sdSR1.22
sdSR1.25
sdSR1.40
leas1.25
leas1.45
les1.15
asDmOl 73.25
sDm0173.15
D1378f
D1378r
asrp49.2
srp49.2
T3
T7
Seauence (5' --> 31
dSR-CI
dSR-CI
dSR-CI
dSR-CI
dSR-CI
dSR-CI
dSR-CI
dSR-CI
dSR-CI
dSR-CI
dSR-CI
dSR-CI
dSR-CI
dSR-CI
dSR-CII
dSR-CII
dSR-CII
STSDmO0173
STSDmO0173
fat
fat
rp49
rp49
GTTGCATAITITCTTTTATT
CGTTGTTGTTGGCTTCGGCG
GCCACTGGGTTCCCTGCTGA
CGATAGCAGATGGTAGCTTC
GTGGTTGCTCCTTCGACACG
TTTCGCCTCGAAGGCGACCA
CATCTCGATCGCAAGTTTGC
GACCGTATCTATACATTAAG
GCGGCTACACTTTGCAGGGA
ACACAAGAGATCATTCTTGC
CAGATCCCTCACCCTGAAGA
GCACCACCACAGAACCAACG
TCCCTGCCCCCAACGGTCAC
GGCTGTGAGATTCAAGAAGG
GCCATGTGTTCCCTGCGAG
GCGGAATCCAAACTGTAGGC
CGAGATCTCTCTGTTTGAATG
CTTGATCGCCAGACACGGTG
GAACCTCACGGTGGGCCA1T
TTGGACAGGGAGACACAGAAC
ATAACCATTCAGACCCTCAGG
GGAGCGACAGCTGCTTGG
CCCAAGATCGTGAAGAAGCG
AATTAACCCTCACTAAAGGGA
AATACGACTCACTATAGGGC
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Figure 4-1. Polytene chromosome in situ localization of the dSR-CI gene to 24D4 -
24D8.
Polytene chromosomes were prepared and probed with a dSR-CI cDNA derived
probe as described in Experimental Procedures. The dSR-CI gene maps to the 24D4
- 24D8 region of chromosome 2L.
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Figure 4-2 Physical map of the 24D - 25A region of chromosome 2L.
The several known chromosomal deletions, lethal complementation groups, and P
element insertions (vertical arrows) are indicated, as are two genes, angle wing(ang)and 1(2)G99 which have been mapped by recombination to this region of the
genome. The location of the dSR-CI gene as determined by in situ hybridization is
indicated by the two-headed arrow, and the locations of the ft, 1(2)24Db, 1(2)24Dc, and
1(2)24De genes as determined by complementation analysis, and of the dSR-CI and
STSDm0173 genes as determined by PCR analysis of several deficiencies (Figure 4-
12) are indicated by the vertical lines. The distal breakpoint of the Df(2L)edSzl
chromosomal deletion is located in 24A. The proximal breakpoints of the Df(2L)dph25
and Df(2L)sc 19-3 deletions are located in 25B, and that of Df(2L)scl 9-l is in 25C.
Except for Df(2L) M-zB, the indicated deficiency strains were isolated by Szidonya and
Reuter (1988) using either of two chromosomal duplications which cover the four
known haplo-insufficient loci located in the 24D - 26 region. One of these duplications,
Dp(2;1)B19, is indicated by the open horizontal line. This duplication extends to 25F.
Two of the haplo-insufficient loci covered by this duplication, 1(2)Db (M(2)LS2) and
M(2)24F (M(2)z), are also indicated. Alleles of most of the indicated lethal
complementation groups which are proximal to the distal breakpoint of this duplication
were also isolated in the screen of Szidonya and Reuter. Lethal P element insertion
loci are indicated by vertical arrows. Those discussed in the text include a -
1(2)k01102, b - 1(2)k06526, and c - 1(2)14703. This figure was compiled from data in
Szidonya and Reuter, 1988; De Belle et al, 1993; Emmons et al, 1995; the
Encyclopedia of Drosophila (joint project of the Berkeley Drosophila Genome Project
and FlyBase); FlyBase (maintained at Harvard University); and results described
herein.
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Figure 4-3. Preliminary Southern analysis of Canton-S genomic DNA.
Canton-S genomic DNA (0.5 pgg) was digested with the indicated restriction enzymes
and analyzed by Southern hybridization with the dSR-Clp probe as described in
Experimental Procedures. dSR-Clp detects a single BamHI fragment of greater than
14 kbp, a single EcoRI fragment of approximately 4.8 kbp, and two EcoRV fragments of
approximately 4.2 kbp and 2.6 kbp. DNA size standards (,BstEll digest, New England
Biolabs) are indicated on the side.
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Figure 4-4. Localization of the dSR-CI gene by Southern analysis of region 24D - 25A
chromosomal deletions.
As described in Experimental Procedures, genomic DNAs were prepared from adult
Canton-S (CS) and Oregon-R (OR) flies, from Df/Balancer heterozygous adults (p),
and from unhatched homozygous Df embryos (e). Approximately 1.0 pg of each DNA
sample (except embryonic DNA from Df(2L)ed-dph') was digested with EcoRI and
EcoRV and then sequentially analyzed by Southern hybridization using a pdSR-CI
probe. Strong hybridization to fragments of 4.6 kbp (EcoRI) and 10 kbp, 4.2 kbp and
2.6 kbp (EcoRV) (size markers are XBstEll, only some bands are listed) is detected
with the dSR-Clp probe in genomic DNA of from CS, OR and all parental Df strains,
and in the genomic DNA of homozygous Df embryos from strains Df(2L)ed z-l, and
Df(2L)dph2 . A weak and slightly shifted signal was detected in genomic DNA from
homozygous Df(2L)ed-dphi embryos. However, as seen from the ethidium bromide
stained gel (bottom) significantly more Df(2L)ed-dph' DNA tested from the homozygous
embryos than from their heterozygous parents. Thus, the signal may be due to a small
level of contamination of this sample with wild type embryos, rather than to the
presence of the dSR-CI gene in genomic DNA from this strain. No signal was seen in
DNA from homozygous Df(2L)M11 embryos, which were probed independently of the
other Df strains.
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Southern Analysis of Region 24D - 25A Deficiencies
With a dSR-CI Probe
Strain
Enzyme
Df(2L)M11i
Df/Bal Df/DfI V I V
14.4 kbp
6.37
3.68
2.32
1.93
CS OR Df(2L)ed-dphi Df(2L)edsz-' Df(2L)dph25
Df/Bal Df/Df Df/Bal Df/Df Df/ Bal If/DfI v I v I I I V I I V I V
Figure 4-5. PCR analysis of dSR-CI intron/exon structure.
A. A schematic diagram of dSR-CI indicates the positions of the sense (above) and
antisense (below) primers relative to the various dSR-CI protein domains encoded by
the cDNA.
B. PCR amplification of dSR-CI products from Canton-S genomic DNA (CS) and the
cDNA clone pdSR-CI (c) was performed as described in Experimental Procedures. In
most cases, the negative control reactions (no template) are also shown (-). There
appeared to be a small contamination in the sdSR1.5/asdSR1.30 PCR reaction, but
this did not affect the amplification of an intron containing fragment from CS genomic
DNA. A negative control reaction was not performed for the sdSRl.10/asdSR1.25
reaction. The sizes, in bps, of the expected amplification products from pdSR-CI are
indicated. In each case )X174Haelll markers (New England Biolabs) were used to
determine product size, except for the sdSR1.1/asdSR1.1 PCR reaction, which used
XLBstEll markers. It is evident that larger than predicted amplification products were
obtained from the genomic DNA using primers sdSR1.5 and asdSR1.30(approximately 70 bps larger) and sdSR1.17 and asdSR1.23 (approximately 100 bps
larger). These presumably represent introns. The products of the sdSR1.1/asdSR1.1
reaction appear to be running faster than predicted given the size of the cDNA. By
correcting for the difference between the expected and observed migration of the
cDNA amplified product, it can be estimated that the dSR-CI gene contains
approximately 250 bps of DNA not found in the cDNA between these terminal primers.
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Figure 4-6. Analysis of restriction enzyme digestion products of clone e l.1 b.
A. 2 Igg of DNA from the clone lel.1b was cut with the following enzymes and
analyzed on a 1% agarose gel as described in Experimental Procedures: EX -
EcoRI/Xbal; X - Xbal; E - EcoRI; S - Scal; ES - EcoRI/Scal; SX - Scal/Xbal; X - XBstElI
markers; ý - 4XHaelll markers. Unique EcoRI and Xbal sites are located in the
polylinkers of XDashll which flank the cloned genomic DNA. The 9.1 kbp and 20 kbp
fragments observed upon digestion with these enzymes correspond to the X arms.
Scal is not located in either polylinker, and generates . phage DNA fragments of 2.26
kbp and 16.4 kbp, and also fragments containing either 1.3 kbp or 8.8 kbp of X DNA
joined to DNA from the cloned insert. The lengths of the DNA size markers are
indicated.
B. The DNA on the agarose gel shown in part A was blotted onto Genescreen and
probed with 244p, corresponding to the 5' end of the dSR-CI cDNA. Among the
Xel. 1 b restriction fragments which this probe detects is an EcoRI fragment of
approximately 4.6 kbp. The locations of the XBstEII size markers are indicated.
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Figure 4-7. Restriction map of the overlapping genomic clones Xel.lb and Xg2.1a.
The 28 kbp map was constructed by analysis of the products of restriction enzyme
digestion of genomic DNA prepared from clones kel.lb and Xg2.1a as described in
Experimental Procedures. Sample data are presented in Figure 4-7. Restriction
analysis indicates that sequences homologous to the dSR-CI cDNA are contained
within an approximately 4.6 kbp EcoRI fragment of el.1 b. The orientation of these
sequences within the genomic clones was determined by comparing this restriction
map to the restriction map of pdSR-Cl. Note that the precise location of one Ncol site
has not yet been determined.
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Figure 4-8. Comparative Southern analysis of Canton-S and el .lb genomic DNA.
Canton-S (2 gg) and kel. 1 b (10 ng) genomic DNA were cut with the following
enzymes and analyzed by Southern hybridization using either a dSR-Clp probe (A) or
a mixed kel.1b + Xg2.1a probe (B): RI - EcoRI; RV - EcoRV; X - Xmnl; S - Scal; N -
Ncol. The locations of the )BstEll size markers are indicated.
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Figure 4-9. Genomic and cDNA sequence of the dSR-CII gene.
Genomic clone pDT1 5-1, containing a 4.6 kbp EcoRI fragment from Xel. 1 b, was
sequenced. Shown are the 2731 bps of contiguous coding strand sequence from this
clone which have been verified on both the coding and non-coding strands. The
numbering scheme is derived from the complete sequence of the 2066 bp dSR-CII
cDNA clone pll-12. The genomic DNA sequences not included in the cDNA (introns,
146 bps of upstream sequence, 263 bps of downstream sequence) are not numbered.
The locations of the arthropod transcription initiation consensus sequence (AAAA^^^^^), the
5' end of the cDNA (>), the three intron sequences (------), and the two polyadenylation
signals (aaaaaa) and two potential mRNA instability signals (####) in the 3' UTR are
indicated. Also indicated are the positions of the putative start codon (***), the putative
termination codon (TER) and an in frame stop codon in the 5' UTR (STP). Clone pll-12
also contains a 55 bp poly A sequence derived from the dSR-CII poly A tail which is
not indicated in this figure.
-- page 158 --
GTTGATGTACAAAAACGATTTAATGAACGGTAACATCTTTTT
TTTGCAGCTGCGAAAAATCAGCTGGTGACGAACCCGCCCTTAAGGACTCGACTTGAAAAT
>^^^^^ STP
1 GAGTTGAGCATCAGGTAGCAGTCACTGTCCTTTCGAATCTCCTTAATATACATACAAAAT 60
t**
61 TGCAGAACAAAAAAATTCGGAGCTATGCAATTTTTCTTGGCTCTGACATTGATTTTAGCC 120
121 TACAGTTTGGATTCCGCAAACGGAAGCTGCGAAGGATCGTTAGATTTGGAAAATGGACGA 180
181 TTCTTCACACGATCGAACAATTTAGTGATTTTCCAATGCAATCGCGGATTTGTATTGCAG 240
241 GGAAATTCAATACACACCTGCGATCGGGATGGTCGACTTCGCGAGAAGAAACCATTTTGT 300
301 GCCAGTGAGTGTTGACAGTTTTCGAAAATGTACACCCTTTCAAATCGAACATTTCATATC
ATCATACTAGTTATCAACAAAATTTTGATTTTTTTCATTTTAATTTTAAGGGAAAGGATG 314
315 CGATAAGCCTGAGGATCCCACAAACGGATATGTTTTAGATAATCCTGTAAAGGCGGAAAT 374
375 CGTGTGTTTAGATGGTTTCGTTCTATACGGAAGTCGCACTGCCTTCTGCGATGGAGAAAA 434
435 GTGGAGCACACAGCTGGGAGCTTGCCGGAGAAGCAACCACACGATGGACCACTCCTGCGA 494
495 CTTCGAGAGCGAGGATCAGTGCGGCTGGTCTGCGGAGGAGACCATCTGGTTGCCCTGGAA 554
555 GAGGATCAGTGCGGTGACGGATTTTCACCACCCCAGAACAGGACCACGATACGATCACAC 614
615 CTTTGGAAACGCTTCGGGTGGACACTATATGCGCATGGAGACCCAGATCGAGGCTTATGG 674
675 CAGTTACCACTTCGTATCGCCGGTATATCCGAGATCTCTCTGTTTGAATGCCGCCTGCTG 734
735 CTTTCGGTTTCACTACTTCATGTTCGGAGCTGGAGTGGACAGACTGGTGGTGTCCGTGAA 794
795 GCCAGCCTCTCTGCAGATCGATGACATGTGGAACAACTTTAGGTCCAAGTATGTAAACAA
CTCGTTTTAGTTTCGTCAAGAAAATGTTATACGAATGAGCTTCTACAACCATATGGTATA
CTAGCTGCTTTTATATACTGAAAGTTTATTTTCTCCAGTTCCAGCAAATTTGAAATAAC 863
864 TGGCTCGCAGGGAACACATTGGCTGGAGCACAATCACCATCGACAAGATGCATGAGGA 923
924 CTTCCAGGTGGTGTTCACAGCAACGGATGCGAGGTCACAATTCGGGGACATTGCCATCGA 983
984 TGACGTCAAACTGATGACGGGCAGCGAATGTGGAGTGGATGGGTATAGCACCACCACCAC 1043
1044 CACCGAATCAGCATCCTCGGCGATGTCCAGCAGCGAGGAGCCCCTGGTCTTCGACATGAT 1103
1104 GAGCTGTACGTTTCGCTGTGGATCCATTAGTCCGGGCAGTCCACTTTTTTCCGATGAGGG 1163
1164 TATTGTCATGAGCTGCGGCTGTGACGACTCCTGTATTCTAAACAATAATTGTTGTCCCAA 1223
1224 CTATTTCGAAAAGTGTGTGAAGGAGTTGGACATAGGGTCTAATGTTTTTCTAAACTCAGC 1283
1284 GAACACAACAACTACATCAATATCAAGAAATACAACGACGGAAAAAGTATTTAGCATTTC 1343
1344 TTTAGAGGCAAGCAGAAGTTTTACAACACCAAGGACGAGCACAAATTCGACAACATTTCC 1403
1404 AAGAACTCAAATAAGTACTAAAAAGTTACTGAACACCCATGAAACTTCAACAGAAACTTC 1463
1464 AACATTACCAACAAGAAACAAAAAGTTGTCTCAACCTTCAATATTTAGTAGCCAGCACAT 1523
1524 TACAGGTAAGACAAAGAGTTATAATCAATTTTTTTATTACTATATATATATATATATATA
TATTCCAGTTACCACTACAACTGATCGTTCGAGAAAGGATTACCACGAGGACCAGGTCAG 1580
1581 TTGGACATGAACACAAATATTCCCCATCCAGCTTATCGTGATAGTCATGTACCTGCTCAT 1640
1641 CGGCGTAATCCTGGTGATAGTTGTGGCCAATCTCAAACAACTGTGTAAAATTCTTACCAA 1700
1701 GAACTCAAGTCGAGATAACGAGAAGGTGGTTAGTTTCAAAAAGGCATTCGAGGGGCTGAG 1760
1761 AAAACCGAGAAGTCCCAAAATTGCAACGGCATGGATCAGCATTTGTGCAGTGCCATTGTT 1820
1821 CGATGAGGATTTGGATTACTTTGAGGACATGGACATGAACATACGCATGGTGACGGATTT 1880
#TER #####
1881 ATGAGGGGTGATTCCATTTACTACCTACAGCCTTACTCAAATTTGAAACCATATCAAATT 1940
aaaaaa
1941 AAATGGCATATATTGTGACAATAAATATTTTTAAGAAGTTGATTGTAATCTGTGACCAAA 2000
aaaaaa
2001 TAGATAATAAATGAGGTACATAAATACATTTAAATGTGTTTTGGGCATTGGTGACCCAAC 2060
2061 TTTGTG 2066
AAATTCCANATGGGTATTATGTACATTTCAAATTCTCTTTTATTGCCTAAGCTAACCTTT
TTCAAATGAATGATTTCAAACCCATTTAAGGTGACCCTAATGTAACTCACTTTTAGCATG
AGGTAACATACAGGTAACTTACTTTTTTCCAAGTTAAAAGAGACTGCGTTTTAAAATACG
ATTTGTGGCGTTATACTACTTTTACCTATGAGAAAGTATATTAAAGTGTCTTTATCGTTC
AATTAATTCCTGCTAAGGAATTC
Figure 4-10. Comparison of the domain structure and protein sequences of dSR-CI,
dSR-CII and STSDm0173.
The complete sequences of each domain of the dSR-CI, and putative dSR-CII
proteins, and the partial sequence of the putative STSDm0173 protein MAM domain
are aligned. All amino acid identities are boxed. The exact location of the putative
signal sequence cleavage sites in dSR-CI and dSR-CII are unclear. Although they
have been placed at G20/R21 in dSR-CI and A18/N19 in dSR-CII, there is a second
potential cleavage site located at G16/H17 in dSR-CI and G21/S22 in dSR-CII (von
Heijne, 1986). The locations of the potential N-linked glycosylation sites in dSR-CI and
dSR-CII are underlined. The locations of potential phosphorylation sites in the dSR-CI
and dSR-CII cytoplasmic domains are indicated (* protein kinase C, ^  casein kinase 2,
# cAMP dependent protein kinase A).
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Figure 4-11. Diagram of the fat genomic clone contig of Drosophila melanogaster.
This diagram, based on data obtained from the Encyclopedia of Drosophila, shows the
P1 genomic clones located at the distal end of the fat contig which spans the 24D5 -
25A1 region of chromosome 2L (Hartl et al, 1994; Berkeley Drosophila Genome
Project, personal communication). The sequence tagged sites (STS) which have
been used to order the P1 clones within the contig are indicated by circles.
STSDm0173 defines the distal end of this contig. Other STS sites of note correspond
to the dSR-CI gene (STSDm3565), the fat gene (STSD1378) and the lethal P element
insertion 1(2)01085 (STSDm0294, and see Figure 4-2). The physical locations of those
P1 clones which have been mapped by in situ hybridization to polytene chromosomes
are also indicated.
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Figure 4-12. Localization of dSR-CI and STSDm0173 by PCR analysis of region 24D
- 24E deficiency strain genomic DNA.
A. As described in Experimental Procedures, three individual Canton-S (CS) embryos
and three or more individual embryos homozygous for each of several deficiencies
were tested for the presence or absence of sequences corresponding to dSR-CI,
STSDmr0173, and ft (left), and to dSR-CII, and rp49 (right) by multiplex PCR. The
results obtained from a single representative embryo from each strain are shown.
These results have been verified in multiple embryos from each strain. The following
deficiency strains (see Figure 4-2) were examined: Df(2L)ed'z (A), Df(2L)ed-dph' (B),
Df(2L)M11 (C), Df(2L)dp" (D), Df(2L)M-z (E), and Df(2L)dph~ (F). The sizes of the
expected PCR amplification products are: dSR-CI - approximately 280 bp, dSR-CII -
293 bp, ft - 474 bp, STSDm0173 - 225 bp, rp49 - 460 bp. The dSR-CI sized PCR
products obtained from amplification of the Df(2L)ed-dp~' and Df(2L)M1 1 strain
genomic DNA were subjected to restriction digestion with no added enzyme (un) and
with EcoRV (V) or Cla I (I). EcoRV digestion should cut only dSR-CI amplification
products, reducing their size by 25 bps, while Clal digestion should cut only dSR-CII
amplification products, yielding two fragments of 119 bp and 174 bp. Lane M is the
PCR Marker size ladder (Gibco BRL) containing fragments of size 1.0 kbp, 750 bp, 500
bp, 300 bp, 150 bp, and 50 bp. (-) Lanes are the no template negative control PCR
reactions. Note that the two positive control primer pairs did not generate any
amplification products in the CS control embryo shown here. This outcome was
specific to this particular CS embryo, since both products were generated in
subsequent CS control reactions (not shown). Since all of the Df embryos tested in
this experiment gave PCR products of the expected size using these two primer pairs,
the lack of products in this CS embryo, which was simply a control for the efficacy of
the PCR reaction, does not affect the interpretation of the experimental results.
B. Additional restriction analysis of the multiplex PCR reaction products obtained from
Df(2L)e~ ' , Df(2L)ed-dph ' and Df(2L)M11 embryos using the dSR-CI, STSDm0173
and ft primers. This analysis better illustrates the lack of EcoRV digestion of the dSR-
CI sized product obtained by PCR from Df(2L)M1 1, and shows that EcoRV does cut the
dSR-CI sized product obtained by PCR from Df(2L)edSF '.
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Figure 4-13. Northern hybridization analysis of dSR-CII and STSDm0173 expression
during Drosophila development.
Poly A+ RNA was obtained from Canton-S strain Drosophila at various stages of
development and analyzed by Northern hybridization using a dSR-CII specific probe,
an STSDm0173 specific probe, and an rp49 probe as described in Experimental
Procedures. The dSR-CII probe detected a single 2.0 kb message expressed in 0 - 4
and 4 - 8 hour embryos. The STSDm0173 probe detected a single 1.25 kb message
expressed during larval and pupal stages. rp49 (0.6 kb) is included to normalize for
RNA loading. Abbreviations: L1 - first and second instar larva, L3 - wandering third
instar larva, EP - early pupa, LP - late pupa, F - adult female, M - adult male.
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Chapter 5
Concluding Remarks
-- page 169 --
As discussed in Chapter One, the broad ligand binding specificities of the
scavenger receptors, combined with their expression patterns, suggest that one or
more of these receptors might be pattern recognition receptors active in the innate
immune reactions of vertebrates and invertebrates. Many hypotheses have been
offered concerning the potential function(s) of these receptors. Unfortunately, there
have only been a few studies which have actually addressed whether scavenger
receptors play a significant role in any of these processes in vivo. Furthermore,
interpretation of the results from these studies is complicated by the fact that they have
usually involved the use of compounds which can affect the activities of multiple
scavenger receptors.
This situation is likely to change in the near future, as mice deficient in the
expression one or another of the various scavenger receptors are generated. Indeed,
mSR-AI/II deficient mice have already been generated (H Suzuki, Y Kurihara, T
Kodama, personal communication). Since homozygous SR-AI/II deficient mice are
born and live to adulthood, the SR-AI/II gene does not appear to be essential for
normal health and development. However, preliminary data suggest that SR-AI/II
participates at some level in apoptotic cell engulfment and liver-mediated LPS
clearance from the blood. That it does not play an essential role in either of these
processes may indicate that SR-Al/Il simply enhances processes mediated by other
receptors. It is also possible that SR-AI/II may be part of a system of receptors, all of
which provide small but incremental contributions to these phagocytic processes, such
that the loss of any one receptor has only mild phenotypic effects. Thus, it will be
interesting to determine the effects of double and triple knockout combinations
involving SR-AI/II and other genes of interest, such as CD14 and the SR-Bs. In
addition, further scrutiny of the SR-AI/II mice may reveal that this receptor is crucial for
certain very specific and unanticipated functions.
The powerful genetic tools available in Drosophila melanogaster have led me
and others at MIT to investigate the possibility that scavenger receptors also exist in
this organism. If flies did have scavenger receptors, these genetic tools could then be
used to gain a better understanding of scavenger receptor function in vivo. There was
reason to believe that such receptors might exist, since innate immunity is
evolutionarily quite ancient. Indeed, a scavenger receptor activity was identified in
Drosophila embryos and in the hemocyte/macrophage like S2 cell line. Chapter 3 of
this thesis has described the cloning and initial characterization of the dSR-CI gene,
whose protein product can at least account for the scavenger receptor activity.
Although not at all related structurally to the class A or class B scavenger receptors,
the dSR-CI protein does exhibit the type of broad ligand binding specificity that is a
defining characteristic of pattern recognition receptors. Furthermore, the gene is
expressed specifically in embryonic hemocyte/macrophages. These properties, and
especially the ability of the dSR-CI protein to bind the immunostimulatory microbial
surface constituent laminarin, suggest that dSR-CI might participate in Drosophila host
defense reactions. In addition, preliminary studies have indicated that the dSR-CI
protein might participate in the phagocytic engulfment of apoptotic cells during
Drosophila development.
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These findings have made the dSR-CI gene attractive for further study. Having
originally looked for scavenger receptor genes in Drosophila in order to take
advantage of the genetic potential of this organism, the obvious thing to do was to
isolate dSR-CI mutants lacking functional dSR-CI protein. As a first step, the gene was
mapped to the 24D4 - 24D8 region of chromosome 2. For the reasons stated in
Chapter Four, genomic clones containing sequences homologous to the dSR-CI
cDNA were also isolated. However, these clones actually contained a new gene,
dSR-CII, homologous to dSR-CI. In addition, a third dSR-CI homolog was identified as
a sequence tagged site generated by the Drosophila genome project.
Although it is interesting that there is a family of dSR-C genes, for none of these
genes is a function known, and for none of these genes have mutants been identified.
Determining the functions of these genes, and in particular, the function of dSR-CI, is
the goal of ongoing research efforts. For the rest of this Chapter, I would like to discuss
some strategies for achieving this goal.
As with dSR-CI, determining the cytological location of dSR-CII will immediately
identify pre-existing point mutations, chromosomal aberrations, and P element
insertions which should be useful for isolating dSR-CII mutants. At some point,
however, a decision has to be made concerning which of the dSR-C genes should
take priority in future studies. For this reason, it will be necessary both to obtain the
complete sequence of the STSDm0173 gene and to determine the cell and tissue
expression patterns of the dSR-CII and STSDm0173 messages. From the perspective
of being interested in pattern recognition receptors of the Drosophila innate immune
system, it would make sense to prioritize those genes which are expressed in
hemocytes and the fat body. In addition, it will be important to determine if the dSR-CII
and STSDm0173 proteins have scavenger receptor activity.
By these criteria, dSR-CI remains the primary focus for future study. Several
different strategies for determining the function of the dSR-CI protein are currently
either in progress, or are being planned. First, it is important to know where the dSR-
CI message and protein are expressed during later stages of development, and
particularly if they are expressed in the larval and adult fat body. In addition, given the
increased expression of the dSR-CI message during early metamorphosis, and the
preliminary observation that the dSR-CI protein can recognize apoptotic cells, it will be
interesting to determine the pattern of dSR-CI expression in early pupa. Since there is
some evidence that the croquemort transcript is not expressed in the absence of
apoptotic cell death (N Franc, personal communication), it would be interesting to see
if croquemort is expressed in deficiency strains deleted for dSR-CI, since a lack of
croquemort expression in these strains would suggest a role for the dSR-CI protein in
regulating croquemort. Finally, the very high level of dSR-CI message expression in
the adult head remains unexplained and the cell type specificity of this expression
should be examined.
Work is currently in progress which is aimed at defining the ligand binding
domain of the dSR-CI protein. Under my supervision, G. Johnson, an undergraduate in
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the Krieger lab, is constructing a series of truncation mutants which progressively
eliminate the extracellular domains of this protein. The first such mutant, in which the
N-terminal CCP domain is deleted, has already been constructed and will soon be
assayed for receptor activity. Other truncations will be constructed once the binding
activity of this first mutant is known. These will include truncations from the C-terminal
end of the protein, which will generate secreted proteins that can be studied by in vitro
binding assays using scavenger receptor ligands coupled to agarose beads (Resnick
et al, 1993). In addition, if the dSR-CII and STSDm0173 proteins lack scavenger
receptor activity, one can imagine that domain swapping experiments might help
localize those regions of the dSR-CI protein which are important for ligand binding.
While these studies are interesting in their own right, they may be particularly
useful for studying dSR-CI gene function in the fly. For instance, by expressing these
mutant dSR-CI proteins in wild type flies, it may be possible to generate dominant
effects on normal dSR-CI function which will lead to detectable phenotypes such as
incomplete development or increased or decreased susceptibility to bacterial infection.
The power of this type of approach has already been demonstrated in elegant studies
of the Notch, sevenless, breathless and Toll genes (Basler et al , 1991; , Schneider et
al, 1991; Rebay et al, 1993; Reichman-Fried and Shilo, 1995). By placing mutant dSR-
CI constructs under different types of regulatory elements (hsp promotor, UAS
elements, or regulatory sequences upstream of the dSR-CI gene), it should be
possible to express the mutant proteins both ubiquitously and also fairly specifically in
hemocyte/macrophages. It may also be interesting to simply overexpress and/or
ectopically express the wild-type dSR-CI protein in flies, as overexpression and
ectopic expression of wild type genes has been observed to lead to dominant
phenotypes in other systems (Ruohola-Baker et al, 1993; Noordermeer et al, 1992;
Chiba et al, 1995).
It still remains necessary to identify mutants lacking normal dSR-CI function.
Having localized the dSR-CI gene to a small region of the genome by a combination of
in situ hybridization and Southern and PCR mapping of genomic DNA obtained from
deficiency strains, a limited number of candidate mutations have been identified
which might affect the dSR-CI gene (Figure 4-2). In addition to ang and 1(2)G99
(Figure 4-2), 18 additional lethal genes have been mapped genetically to within ± 6
map units of the ed - ft - dp cluster. By determining the ability of these loci to
complement Df(2L)ed-dp ', it has already been possible to eliminate six of these loci
from consideration as dSR-CI mutants (data not shown). The remaining 12 loci, and
also ang and 1(2)G99, remain to be tested in this manner. At the moment, however,
there are two loci which are very good candidates for the dSR-CI gene, 1(2)24Dd and
1(2)24De. It is also formally possible that 1(2)24Dfcorresponds to a regulatory mutation
affecting dSR-CI expression. In order to determine if either of these loci, or any other
loci which don't complement Df(2L)ed-dp h , correspond to the dSR-CI gene, western
blotting is being performed on protein extracts obtained from every known allele of
these loci using an anti-dSR-CI polyclonal antibody (three different antibodies have
now been generated which recognize the dSR-CI protein - Pearson, Trigatti, and
Krieger, unpublished observations). The basis for believing that this approach might
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work is Zucker's recent finding that roughly 75% of all mutations in ninaA and at least
one additional gene lead to protein production at <20% of wild type levels. It is
important to point out however, that a negative Western result would not eliminate the
possibility that a candidate locus corresponds to dSR-CI.
The other approach for isolating dSR-CI mutants, which is currently in the
planning stages, is P element mediated mutagenesis (Tower et al, 1993). Two lethal P
element insertion loci (1(2)k01102 and 1(2)k06526 ) are located near the dSR-CI gene
Figure 4-2). In the case of 1(2)k01102, the lack of complementation with Df(2L)eds 'zl
(data not shown) indicates that it does not affect the dSR-Clgene. However, it is quite
close to dSR-CI since it also fails to complement Df(2L)M1 1. Unfortunately,
1(2)k06526, which physically maps to the same chromosome bands as dSR-CI (Figure
4-1 and Berkeley Drosophila Genome Project, personal communication) does not
appear to contain a functional P element (data not shown). Having identified several
P1 genomic clones which contain dSR-CI sequences (Figure 4-11), efforts are now
underway to isolate a smaller, more usable, clone which can be easily mapped. Once
this is accomplished, it may be possible to determine the location of the 1(2)k06526
and 1(2)k01102 insertions relative to dSR-CI.
Even if the 1(2)k06526 insertion disrupts dSR-CI, since this P element is non-
functional, it will not be possible to rescue dSR-CI gene function by precise P element
excision. Thus, the primary reason for isolating usable genomic clones containing
dSR-CI sequences is that they will enable the isolation of useful P element induced
mutations in the dSR-Cl gene. Basically, by analyzing Southern blots of cloned
genomic DNA using PCR generated probes containing the sequences flanking the P
element insertion sites, it will be possible to accurately map the location relative to
dSR-CI of P element insertions generated by local hopping of the /(2)k01102 element
(and/or other nearby elements) (Dalby et al, 1995). The effects of these P elements on
the expression of dSR-CI, and on the phenotype of the mutant line, will then be
examined. Given the hypotheses that have been presented for dSR-CI function, it will
be important to determine if dSR-CI mutants exhibit altered survival rates and changes
in antibacterial and antifungal gene expression relative to wild type flies when they are
challenged by bacterial and fungal infections. It will also be important to determine if
these mutants exhibit changes in hemocyte migration or apoptotic cell engulfment.
Since STSDmO 173 is close to dSR-CI, the P element mutagenesis approach has the
added advantage that it should allow for the isolation of mutations in both dSR-CI and
STSDmO173 from the same screen. Finally, it may be possible to use the 1(2)k01102
and 1(2)kl4703 P element insertions to generate overlapping chromosomal deletions
that, in trans to each other, specifically delete only the dSR-CI gene (Preston et al,
1996). Should the isolation of dSR-CI point mutations prove to be particularly difficult(which is possible given the apparent small size of the gene), this approach may prove
useful for determining the true function of the dSR-CI protein.
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Scavenger receptors in innate immunity
Alan M Pearson
Scavenger receptors are cell-surface proteins expressed by
mammalian monocytes and macrophages and by invertebrate
hemocytes, among other cell types. They exhibit distinctive
ligand-binding properties, recognizing a wide range of
ligands that include microbial surface constituents and intact
microbes. The ligand-binding properties and expression
patterns of these receptors suggest that they may function
in one or more host-defense-related processes. Significant
advances in scavenger receptor biology have recently been
reported, including the identification of several new scavenger
receptor genes.
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Abbreviations
AcLDL acetylated LDL
CCP complement control protein
EC endothelial cell
LDL low-density lipoprotein
LPS lipopolysaccharides
OxLDL oxidized LDL
PBM peripheral blood monocyte
PS phosphatidylserine
SR scavenger receptor
SRCR SR-cysteine-rich
TSP thrombospondin
VnR vitronectin receptor
Introduction
The circulating monocytes and tissue macrophages of
mammals, and the hemocytes of invertebrates, mediate
many of the innate, or non-adaptive, immune responses
to microbial infection (see [1-3] as well as other reviews
in this issue). In some cases, these evolutionarily ancient
phagocytic cells recognize and engulf pathogens that have
been opsonized by serum proteins such as complement
[1]. Macrophages and hemocytes, however, can also
bind pathogens directly, and this direct recognition plays
a crucial role in host defense [1,3-5]. Janeway [4,5]
has proposed that activation of the innate immune
system (and, importantly, of the adaptive immune system
also) is initiated when pathogens bind to non-clonally
distributed pattern-recognition receptors on immune cells.
It was suggested that these receptors exhibit binding
specificities for structural patterns typically displayed by
the cell-surface molecules of many microorganisms (e.g.
lipopolysaccharides [LPS] and glucans), but not normally
found on the surfaces of host cells [4,5]. The ability to
mediate pathogen binding, should, in principle, enable
pattern-recognition receptors to participate both in the
activation of innate immune cells and in the effector
mechanisms (e.g. phagocytosis) that these cells employ.
Several soluble and membrane-bound mammalian pro-
teins, including the mannose receptor [6], the collectins
(Epstein et al., this issue pp 29-35) and the LPS receptor
CD14 [7"], exhibit the properties of pattern-recognition
molecules. Scavenger receptors (SRs) have also been
suggested to be attractive candidates for such non-self
recognition receptors [2-4,8,90,10,11**,12*']. This sugges-
tion is based on several findings. First, SRs exhibit broad
ligand-binding specificities (Table 1), a characteristic
feature of pattern-recognition receptors. Second, some SRs
can bind both microbial surface molecules and intact
bacteria. Third, SRs are expressed by macrophages, hemo-
cytes and other immunologically relevant cells. Finally, SR
activity is evolutionarily ancient [10]. In addition to their
pattern-recognition receptor-like properties, some SRs also
exhibit activities typical of cell-adhesion molecules.
Until recently, only two SRs were known, both products of
the same gene. Within the past three years, and principally
within the past 18 months, several additional SR genes
have been reported, helping to define at least three
independent SR classes (Fig. 1; see (12"] for a definition
of these classes). Scavenger receptors are defined by their
ability to bind modified low-density lipoproteins (LDLs),
such as oxidized LDL (OxLDL) and acetylated LDL
(AcLDL), and they were initially studied primarily for
their potential role in atherogenesis [90]. This review will
discuss recent developments in the SR field, in particular
as they relate to the potential roles of SRs in host defense.
Scavenger receptor classes
The two class A SRs, SR-AI and SR-AII, were the first
macrophage SRs to be identified [13,14] (for a recent
review, see [90]). These receptors comprise six domains,
including extracellular a-helical coiled-coil and collage-
nous regions which oligomerize to form a trimeric glyco-
protein (Fig. 1). SR-AI has an additional carboxy-terminal
extracellular SR-cysteine-rich (SRCR) domain, which has
now been found in thirteen other proteins ([8,15]; D
Resnick, personal communication). Nonetheless, SR-AI
and SR-AII exhibit nearly identical binding properties,
specifically binding a broad array of polyanionic ligands
with high affinity. Studies with SR-AI have shown that
these ligands include surface constituents of both Gram-
positive and Gram-negative bacteria, as well as the intact
bacteria themselves (Table 1) [90,160,17]. SR-AI and/or
SR-AII are expressed primarily by monocytes and by
peritoneal and most tissue macrophages. Some dendritic
cells, certain specialized endothelial cells, and smooth
muscle cells in atherosclerotic lesions also appear to
express the protein(s) [18,190,20-23]. Substantial progress
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Table 1
Ligand speclficitles of the scavenger receptors
SR-AIIII MARCO SR-BI CD36 dSR-CI
Lipoproteins/proteins
AcLDL + + + +' +
OxLDL + ND + + ND
M-BSA + ND + + +
LDL ND +
BSA ND - -
Poly- and oligonucleotides
Polyl/polyG/oligo dG + ND - - +
PolyC/oligo dA ND - -
Anionic Polysaccharides
Fucoidan + ND - - +
Dextran sulfate + ND - ND +
Chondroitan sulfate - ND - ND ND
Phospholipids
Phosphatidylserine - ND + +
Phosphatidylcholine - ND
Poly D-glutamic acid - ND ND ND +
Lipid IVa/ReLPS + ND ND - ND
Other LTA, S. aureus, S. aureus, HDL P falciparum- Laminarin
other Gram-positive E. coli infected RBCs, (P-glucan)
bacteria, collagen, TSP,
crocidolite-asbestos apoptotic cells,
oleic acid
*The ligand specificities reported in the literature have been determined both by directly testing the ability of a given compound to bind to a particular
SR, and by testing the ability of a given compound to inhibit the binding of a known ligand to SR-transfected cells. It is important to note that SRs
exhibit some unusual binding properties, such as species-specific differences in ligand binding, and non-recipricol cross-competition between two
ligands [91]. Therefore, the inability of compound A to inhibit binding of compound B does not necessarily mean that compound A is not a ligand.
Caution must be exercised in interpreting negative data unless direct binding studies have been performed. The data presented are drawn from
references presented in the text and from AM Pearson, D Resnick, A Rigotti, M Krieger (unpublished data); [90]. 'The binding of AcLDL to CD36 is
controversial [12"*,270,36,48*]. As AcLDL is used as an inhibitor to evaluate the contribution of SRs to various macrophage functions, resolution
of this issue is important. BSA, bovine serum albumin; HDL, high-density lipoprotein; LTA, lipoteichoic acid; M-BSA, maleylated BSA; ND, not
determined; PMN, polymorphonuclear leukocyte (neutrophil); RBC, red blood cell; ReLPS, reduced form of PS.
is being made in defining the regulatory elements that
control the macrophage-specific expression of the SR-AI/II
gene [24,25].
A third SR-A, termed MARCO, has recently been
identified and shown to bind both AcLDL and bacteria
[26"]1. MARCO expression has been detected only in
peritoneal macrophages and in a limited subset of tissue
macrophages in the spleen and lymph nodes [260'].
All of these macrophages also express SR-AI/II. The
carboxy-terminal portion of MARCO is homologous to the
collagenous and SRCR domains of SR-AI, although the
MARCO collagenous domain is much longer than that
of SR-AI/II. MARCO does not share any other domains
with SR-AI/II. In SR-AI/II, and perhaps also in MARCO,
the primary ligand-binding region comprises a cluster of
basic residues located at the carboxy-terminal end of the
collagenous domain [9*,26']1.
The search for additional SRs led to the identification of
the class B SRs, CD36 [27*'] and SR-BI [12"]. These
receptors, together with the lysosomal protein Limp II
[28], the Drosophila emp [29] and croque mort (N Franc.
RAB Ezekowitz, personal communication) proteins, and a
putative Caenorhabditis elegans protein (Genbank accession
number 728534), define the CD36 family [30]. The single
conserved extracytoplasmic domain shows 25-30% homol-
ogy between any two family members and comprises
an amino-terminal region which contains most of the
potential N-glycosylation sites, and a carboxy-terminal
region rich in conserved proline, glycine and cysteine
residues [30]. Non-conserved putative transmembrane and
cytoplasmic domains flank the extracellular domain, but in
CD36 only the carboxy-terminal hydrophobic region ap-
pears to be embedded in the membrane [31]. Interestingly,
croque mort lacks a carboxy-terminal hydrophobic region.
suggesting that the CD36 family proteins, including
the SR-Bs, may use additional mechanisms to effect
association with the cell membrane [28,301. Initial studies
concerning the transcriptional regulation of CD36 gene
expression have recently been reported [32,33].
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Figure 1
Structures of the class A, class B and class C SRs. The class A SRs, SR-AI and SR-AII, are trimeric glycoproteins generated by alternative
splicing of mRNA transcripts from the same gene [91]. They consist of cytoplasmic (50 amino acids), transmembrane, spacer, a-helical
coiled-coil (black) and collagenous (dotted) domains [90]. The collagenous domain mediates ligand binding [91]. In addition, SR-AI contains a
carboxy-terminal scavenger receptor cysteine rich (SRCR) domain (15]. MARCO is a new SR-A protein comprising amino-terminal cytoplasmic(49 amino acids), transmembrane and spacer domains distinct from those of SR-AI/II. These are followed by a long collagenous domain with
carboxy-terminal with homology to that of SR-AI/II, and then a carboxy-terminal SRCR domain [26"1. The model presented for the class B
receptors SR-BI [12"] and CD36 [27"'] is based on current reports regarding CD36 structure. These experiments indicate that CD36 has
a very short carboxy-terminal (<10 residues; 45 residues in SR-BI), a single transmembrane domain, and a single large extracellular domain
comprising an amino-terminal region containing most of the N-glycosylation sites and a carboxy-terminal region rich in proline, glycine and
cysteine residues (the cysteine residues are indicated). The Drosophila class C scavenger receptor, dSR-CI, comprises several domains [11"].
From the amino terminus to the carboxy terminus, these domains are a signal sequence (which is likely cleaved from the mature protein), two
complement control protein (ccp) domains (grey), a large MAM domain (stripes), a smaller spacer domain, a somatomedin B domain (black), a
serine/threonine rich mucin like domain which may be heavily glycosylated (dotted), another spacer domain, a transmembrane domain, and finally
a small cytolplasmic domain (cross-hatched; 64 amino acids). Adapted from figure by M Krieger (unpublished data).
CD36 and SR-BI bind a wide variety of ligands, including
Plasmodium falciparum parasitized red blood cells (Table
1), and in this way they resemble pattern recognition
receptors. At least some of these ligands (for example,
phospholipids such as phosphatidylserine [PS] [3400]),
must contain negatively charged moieties in order to be
recognized by the SR-Bs. Interestingly, the class B recep-
tors (and other CD36 family members?) may primarily be
lipid-binding proteins expressed by tissues and cells in-
volved in host defense and/or lipid metabolism (SL Acton
et al., unpublished data; see also Note added in proof;
[30,35",36]). These cells include monocytes, macrophages
and hemocytes, B lymphocytes, capillary endothelial cells,
platelets and adipocytes ([12-,30,33,3500,37,38]; SL Acton
etal., unpublished data; see also Note added in proof). The
relationship, if any, between host defense and lipid recog-
nition is currently unclear. It has been noted, however,
that both mammalian macrophages and insect hemocytes
internalize anionic phospholipid vesicles (including PS),
and that this may thus be one primitive mechanism by
which phagocytes recognize non-self and damaged-self
[391]. Perhaps surface expression of anionic phospholipids
represents one type of pattern not associated with normal
host cells.
After the striking finding that Drosophila embryonic
hemocytes express SR activity [10], a class C SR gene,
dSR-CI, was cloned from the hemocyte-like L2 cell line
(synonym S2) [1100]. The extracellular portion of the
dSR-CI protein contains two amino-terminal complement
control protein (CCP) domains. In mammals, CCP do-
mains mediate the binding of complement receptors and
complement regulatory proteins to the central component
of the complement cascade, C3 [40]. The extracellular
region of dSR-CI also contains MAM and somatomedin
B domains, and a mucin-like domain which may be
heavily glycosylated. Some of these domains are known to
have adhesive properties in mammalian proteins [41-43].
dSR-CI, like SR-AI/II, exhibits high-affinity binding to
a broad array of polyanionic ligands (Table 1). Unlike
SR-AI/II, however, it also binds uncharged microbial
0-glucans, which are potent inducers of the Drosophila
immune response [3]. These findings suggest that dSR-CI
might be able to mediate the direct recognition of
microbial pathogens by hemocytes. Indeed, dSR-CI is
expressed in the hemocytes of the Drosophila embryo
[11"]; whether it is also expressed in larval hemocytes
and by the larval fat body, an important tissue for the
Drosophila immune response [2,3], is not yet known.
Because dSR-CI does not appear to account for all of the
SR activity found in L2 cells [110"], additional Drosophila
SRs probably exist; these could potentially include both
SR-A and SR-B (e.g. croque mort) homologs.
It is likely that mammals also possess additional, as yet
unidentified, SRs. For example, macrosialin/CD68 [44]
has recently been shown to be able to bind OxLDL
[45]. The roles of this protein as an SR and in host
defense are unclear as it is predominantly a lysosomal
and endosomal protein [44,45]. Several studies have also
suggested the existence in mammals of macrophage and
non-macrophage SR activities which may be distinct from
those of the SR-As, the SR-Bs and macrosialin/CD68
[46,47,48*,49",50,51 ].
Scavenger receptor functions in innate
immunity
The potential involvement of SRs in the activation
of monocytes, macrophages and hemocytes by micro-
bial products and microbes of various types (Gram-
positive bacteria, Gram-negative bacteria, yeast, etc.)
[7-",16-,52,53-,541,55] has not yet been the subject
of extensive investigation. Two findings suggest that
SR-As are probably not involved in LPS (Gram-negative
bacteria)-induced macrophage activation: AcLDL blocks
most of the binding of Lipid IVa (an LPS precursor)
to murine macrophages, but does not appear to effect
Lipid-IVa-induced macrophage activation [17]; and SR-
AII-transfected CHO cells do not respond to 100 ngml-1
LPS whereas CD14-transfected CHO cells do [56].
One of the principal functions of SRs may be their partic-
ipation in the clearance of microbes and highly toxic mi-
crobial surface constituents from the body [9*,10,11**,12*',
16*,17,44,57]. The primary reasons for believing this to
be the case remain the broad ligand-binding specificities
and macrophage/hemocyte expression of the SRs. Several
other findings support the involvement of the mam-
malian SRs in these phagocytic and endocytic processes.
First, LPS and other inflammatory stimuli upregulate
macrophage SR-AI/II, CD36 and macrosialin/CD68 ex-
pression [44,57,58]. Second, peritoneal macrophages from
SR-AI/II knock-out mice exhibit a 50% reduction in
LPS-binding activity (H Suzuki, Y Kurihara, T Kodama,
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personal communication). Third, LPS associates with
high-density lipoprotein [52,530], which binds SR-BI (SL
Acton et al., unpublished data; see also Note added
in proof). Thus SR-BI may facilitate LPS clearance by
the liver. Finally, the co-injection of SR ligands (poly
I, AcLDL) with lipid IVa significantly reduces hepatic
uptake of lipid IVa in mice [17]. SRs may also participate
in the clearance by alveolar macrophages of anionic
environmental particulates from the lung [59,60].
It has been suggested that some SRs, by participating in
microbial clearance processes, may also participate in the
activation of the adaptive immune system by mediating
antigen uptake and/or processing for presentation to B and
T cells [20,44]. In this regard, it has recently been shown
that maleylation of proteins, which converts them to SR
ligands, enhances their ability to elicit antibody and T-cell
responses in the absence of adjuvant in vivo, and enhances
their presentation to T cells by macrophages in vitro [61].
In addition to their potential clearance functions, some
SRs may participate in the recruitment of peripheral
blood monocytes (PBMs) to infected tissues, a process
which requires PBM extravasation through vascular en-
dothelial cells (ECs) (reviewed in [41]). Indeed, it has
been suggested that SR-AI/II may participate in this
recruitment [190]. It may be relevant that M-CSF, which
induces monocyte to macrophage differentiation and may
be released at some infection sites [62], can also upregulate
both SR-AI/II expression and SR-AI/II-mediated cell
adhesion (see below) [221. It has also been suggested that
macrosialin/CD68, which is upregulated by inflammatory
stimuli, may be a ligand for E-selectin [44]. Thus,
macrosialin/CD68 might participate in the initial tethering
and subsequent adherence of PBM to activated ECs
overlying an infected tissue. Interestingly, expression of
CD36 on PBM is upregulated upon their E-selectin
dependent adherence to activated EC [58]. It has been
suggested that this upregulation may be related to the
extravasation of PBM through the EC layer and/or
to PBM-mediated clearance of apoptotic neutrophils
associated with the infection site (see below) [58].
Endothelial cells themselves also transiently upregulate
CD36 expression in response to the pro-inflammatory
cytokine interferon-y [38].
Drosophila hemocytes also accumulate at infection sites.
In addition to phagocytically clearing pathogens, the
hemocytes will often segregate foreign particles (bacteria,
parasites) from host tissues by inducing hemolymph
clotting and melanization, forming nodules around small
pathogens, and encapsulating large invaders within well-
organized and multi-layered cellular capsules [2,3,63,64].
These processes, encapsulation in particular, require
hemocyte-hemocyte adhesive interactions. dSR-CI has
several adhesive domains in its extracellular region, includ-
ing a MANM domain which has been suggested to regulate
homophilic binding interactions in mammalian proteins
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[43]. Thus, dSR-CI may be able to participate in hemocyte
capsule formation. Actively encapsulating hemocytes also
undergo alterations in their surface characteristics [63,64].
Given that insect hemocytes appear to recognize the SR-B
ligand PS [39], it would be interesting to know whether
one of these alterations involves the cell-surface exposure
of PS on activated hemocytes. External exposure of PS
has been shown to occur both in activated mammalian
platelets during the clotting response [65,66], and in
LPS-stimulated monocytes [67].
Scavenger receptor functions in
immune-related processes
Establishment of macrophage, lymphocyte and hemocyte
populations
In order to effectively participate as sentinel and effector
cells in first-line host defense, mammalian monocytes
must establish residence throughout the body as perma-
nently differentiated tissue macrophages [1,68]. It has
been suggested that SR-AI/II (and MARCO?) might
participate in this process as homing and/or retention
molecules [191]. Two recent reports support this hypo-
thesis. First, it has been found that the anti-SR-AI/II
monoclonal antibody 2F8 can inhibit cation-independent
(non-integrin, non-selectin) adhesion of macrophages to
tissue-culture plastic [69] and to frozen splenic, thymic and
lymph-node tissue sections [190]. These adhesion events
appear to require, respectively, a serum SR-AI/II ligand
[69], and an endogenously expressed tissue ligand and/or
homophilic binding interactions between macrophages
and SR-AI/II-expressing cells in tissues [190]. Second,
macrophage colony-stimulated factor directs monocyte to
tissue macrophage differentiation; it also upregulates both
SR-AI/II expression by macrophages and SR-AI/II-medi-
ated macrophage adhesion [22]. Finally, although not part
of the innate immune system per se, it is worth noting
the recent suggestion that SR-AI/II may also participate in
the adhesive events that regulate lymphocyte recirculation
(see [41]), as it is expressed by lymph node high
endothelial venules [20].
It is not known whether any Drosophila hemocytes
establish permanent residence in specific tissues. They
do nonetheless migrate throughout the body of the
developing and adult fly, and in some cases they appear
to follow specific guidance cues [700,71,]. dSR-CI is
expressed in hemocytes before the onset of migration and
contains several domains which participate in the adhesive
interactions of other proteins. Thus, dSR-CI might partic-
ipate in the hemocyte migration process [1110]. Similarly,
croque mort might also facilitate hemocyte migration along
the extracellular matrix [710 ] by recognizing collagen, a
mammalian CD36 ligand [30].
Response to wounding
Wounding induces activation of the innate immune system
in both mammals and invertebrates [1-3,63,64,72-75]
(also reviews in this issue). Monocytes, macrophages and
hemocytes are the central mediators of this innate immune
response, and play critical roles in guarding against infec-
tion, in clearing associated debris, and in wound healing.
It has been suggested that wound recognition by these
cells may be somewhat analagous to the recognition of
infectious microorganisms [2,64,75,76"]; perhaps this is, in
part, another manifestation of pattern recognition. Indeed,
wounding exposes molecular structures and patterns on
damaged cells and tissues, and on recruited platelets,
which are not found on normal cells and tissues [64-66].
SRs may participate in wound recognition, both as adhe-
sion molecules and also as pattern-recognition receptors. It
has been suggested, for example, that monocyte adhesion
to the wound site may be facilitated in part by CD36-
mediated binding to thrombospondin (TSP) secreted by
activated platelets [77]. Since these platelets also express
PS externally [65,66], and as both macrophages and
CD36-transfected cells bind PS vesicles [3400,39] (and see
below), CD36-mediated recognition of activated platelet
PS may also contribute monocyte adhesion. In addition.
because both collagen and PS are exposed on wounded
tissues and cells themselves [65,66], recognition of these
structures by CD36 may contribute to direct binding
of monocvtes to wound surfaces. Similar mechanisms
can be, and in some cases have been ([30], but see
[78]), envisioned to contribute to the initial recognition
of wvounds by both platelets and hemocytes, and to
the growth and stabilization of platelet and hemocyte
clots. Finally, it has been suggested that SR-AI/II may
participate in the clearance of wound-associated debris,
as SR-AI/II expression is dramatically upregulated in glial
cells and recruited macrophages after optic nerve crush
[57]. Other SRs may also be involved in the clearance
of damaged cells, since macrophage binding of oxidized
red blood cells, which are a model for damaged cells, is
completely inhibited by both PS and OxLDL [49*1].
Recognition and engulfment of apoptotic cells
The induction of apoptosis in various cells during the
immune response is an important effector mechanism
for host defense in higher eukaryotes from plants to
animals [79-82]. In animals, apoptosis also plays an
important role in the normal development and turnover
of organs, tissues and cells, including those of the
immune system [79,83,84]. The phagocytic clearance of
apoptotic cells, and of damaged and senescent cells,
is a primary function of monocytes, macrophages and
hemocytes [1,710,79,83]. These phagocytes may engulf
effete cells in part using pattern-recognition mechanisms
similar to those used for the recognition and engulfment
of infectious microorganisms [1,75,760]1. Indeed, apoptotic
cells, like damaged cells and tissues, express surface
characteristics not usually found on normal self cells
[49-*,79,85].
Multiple mechanisms are associated with apoptotic cell en-
gulfment [4900,79], a finding which is not surprising, given
the considerable heterogeneity displayed by macrophages
of different origins [1,68], and the importance of clearing
apoptotic cells from the body [79]. It has repeatedly been
suggested that SRs may participate in some of these
mechanisms [10,11*",19*,34*,49*']. Evidence to support
these suggestions is now accumulating, although the
precise roles, and sometimes the actual identities, of the
SRs involved have not yet been fully established.
Strong support for the direct involvement of SR-AI/II in
apoptotic cell engulfment has been provided by two recent
findings. First, the anti-SR-Al/II monoclonal antibody 2F8
inhibits 50% of apoptotic thymocyte uptake by thymic
macrophages and elicited peritoneal macrophages (N Platt,
S Gordon, J Cell Biochem Suppl 1995, 19B:300). Second,
thymic macrophages from SR-AI/II knockout mice (H
Suzuki, Y Kurihara, T Kodama, personal communication)
exhibit a 50% reduction in apoptotic cell uptake (N Platt,
H Suzuki, Y Kurihara, T Kodoma, S Gordon, personal
communication). Other receptors, perhaps including other
SRs, are also involved in apoptotic cell engulfment by
these macrophages (N Platt, S Gordon, J Cel/Biochem Suppl
1995, 19B:300).
Some SR-Bs also appear to be involved in the clearance
of apoptotic cells. It has been demonstrated that both
PBM-derived macrophages and bone-marrow derived
macrophages use a combination of CD36, the vitronectin
receptor (VnR, avl 3 integrin), and TSP to engulf apoptotic
leukocytes [86,87]. A direct role for CD36 in VnRfTSP de-
pendent apoptotic cell uptake was recently demonstrated
by transfecting a CD36 cDNA into Bowes melanoma and
COS cells, both of which constitutively express the VnR.
The transfected cells, but not the untransfected cells, were
able to phagocytose apoptotic cells in a VnR/TSP/CD36
dependent manner [880'].
Resident and elicited peritoneal macrophages recognize
and engulf apoptotic cells and damaged red blood cells
by VnR-independent mechanisms. At least some of these
mechanisms clearly require the involvement of SRs, as
OxLDL can partially or completely inhibit the binding
and engulfment of these cells, depending on the nature
of the target [490",89*]. The identity of the relevant SRs
is currently unknown, but they could include SR-AI/II
(N Platt, S Gordon, J Cell Biochem Suppl 1995, 19B:300),
CD36 [27"], SR-BI [121"], and macrosialin/CD68 [49"]1
(however, see [45]), all of which bind OxLDL.
At least some of the VnR-independent mechanisms
involve the recognition of PS exposed on the surface of the
target cells. Both putative PS receptors and SRs appear to
participate in this PS dependent process [4900,85,87,89*].
Several findings suggest the intriguing possibility that
these SRs may include the SR-Bs, and perhaps other
CD36 family members. First, CD36 is expressed by both
elicited and resident peritoneal macrophages [27"',30,8901.
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Second, PS vesicles are SR-B ligands and can inhibit
the binding of native and modified LDLs to the SR-Bs
[341']. Indeed, CD36 and SR-BI are the only PS receptors
that have been molecularly well defined. Third, the same
CD36-transfected Bowes cells that engulf apoptotic cells
in a VnRfTSP-dependent manner (see above) can also
bind and engulf shed photoreceptor rod outer segments,
which externally express modified phospholipids, via
a VnR/TSP-independent mechanism (SW Ryeom, JR
Sparrow, RL Silverstein, Clin Res 1995, 42:113A). It will
be interesting to determine whether SR-Bs do indeed
participate in the PS-dependent engulfment of apoptotic,
damaged and senescent cells.
Conclusions
A common characteristic of infectious microorganisms,
damaged cells and tissues, and apoptotic and senescent
cells is the cell-surface expression of molecular structures
and patterns not found on normal host tissues and cells.
That the mechanisms used by vertebrate and invertebrate
immune cells for the recognition of and response to
these diverse targets may be related is an old concept
[1,2,57,75,76"]. These mechanisms may include the
recognition of target cells mediated via pattern-recognition
receptors, as first proposed by Janeway for the recognition
of microbial pathogens [4,5].
It has often been suggested that SRs are just such
pattern-recognition receptors. This review has discussed
the rationale behind these suggestions and has reviewed
some of what is currently known about the involvement
of the SRs in host-defense-related processes. Among
the various SR functions that have been proposed, the
strongest evidence currently supports a role for the
participation of SRs in LPS clearance and in apoptotic cell
engulfment. Many potential functions have been proposed
for the SR-Bs, both here and elsewhere. Interestingly,
some individuals appear to lack all platelet, monocyte
and macrophage CD36 expression, and yet are perfectly
healthy [481]. Given the redundancy built into biological
systems, this finding does not rule out a role for CD36, or
any other CD36 family members, in any of the processes
discussed in this review:
Targeted gene disruption of SR genes should greatly
contribute to the elucidation of the roles that SRs play in
host defense. SR-AI/II knock-out mice have already been
generated (H Suzuki, Y Kurihara, T Kodama, personal
communication), and we can look forward to other SR
knock-outs in the future. Given the similarities between
the innate immune systems of mammals and insects, it is
likely that genetic studies in Drosophila will also contribute
to our understanding of SR functions. Thus, we can hope
that, in the coming years, new studies of SR function will
provide clear insights into the roles that these receptors
play in innate immunity and host defense.
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Note added in proof
The study referred to in the text as (SL Acton et
al., unpublished data) has now been published [910].
Fukasawa et al. [921 have reported that CHO cells
transfected with SR-IB can recognize, and perhaps engulf,
apoptotic cells.
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ABSTRACT Mammalian class A macrophage-specific
scavenger receptors (SR-A) exhibit unusually broad binding
specificity for a wide variety of polyanionic ligands. The
properties of these receptors suggest that they may be involved
in atherosclerosis and host defense. We have previously
observed a similar receptor activity in Drosophila melanogaster
embryonic macrophages and in the Drosophila macrophage-
like Schneider L2 cell line. Expression cloning was used to
isolate from L2 cells a cDNA that encodes a third class (class
C) of scavenger receptor, Drosophila SR-CI (dSR-CI). dSR-CI
expression was restricted to macrophages/hemocytes during
embryonic development. When expressed in mammalian cells,
dSR-CI exhibited high affinity and saturable binding of
125 1-labeled acetylated low density lipoprotein and mediated
its chloroquine-dependent, presumably lysosomal, degrada-
tion. Although the broad polyanionic ligand-binding specific-
ity of dSR-CI was similar to that of SR-A, their predicted
protein sequences are not similar. dSR-CI is a 609-residue
type I integral membrane protein containing several well-
known sequence motifs, including two complement control
protein (CCP) domains and somatomedin B, MAM, and
mucin-like domains. Macrophage scavenger receptors appar-
ently mediate important, well-conserved functions and may be
pattern-recognition receptors that arose early in the evolution
of host-defense mechanisms. Genetic and physiologic analysis
of dSR-CI function in Drosophila should provide further
insights into the roles played by scavenger receptors in host
defense and development.
It has been more than 100 years since Metchnikoff's obser-
vations of phagocytosis in invertebrates led him to propose the
cellular theory of immunity (1). Since that time, studies in
vertebrates have shown that phagocytosis plays a key role in
both adaptive immunity, which involves clonally selected an-
tibody and cellular responses, and nonadaptive, or innate,
immunity (2). Interestingly, invertebrate innate immunity,
which comprises both humoral and cellular components (3-7),
is strikingly similar to that in vertebrates (3, 6). For example,
complement-like serine protease cascade reactions in inverte-
brates are activated in response to infection (8, 9). Some of the
molecules used in these cascades, such as Limulus coagulation
factor C, are structurally homologous to mammalian comple-
ment proteins. Factor C contains complement control protein
(CCP) domains (8), which are also found in a large number of
mammalian complement and complement regulatory proteins,
clotting proteins, and leukocyte cell adhesion proteins (10).
Invertebrates also use a variety of macrophage-associated
processes to respond to microbial infection (3-6, 9), including
phagocytosis of both opsonized and unopsonized pathogens
(3-5, 9, 11).
The immune responses of invertebrate macrophages and
other hemocytes are induced by intact microorganisms and by
exposure to isolated microbial surface constituents, such as
lipopolysaccharide (LPS) and laminarin (3, 8, 9, 12). It has
been proposed that direct recognition of these inducers by
both vertebrate (13-15) and invertebrate macrophages (4, 5) is
mediated by pattern-recognition receptors (2, 3, 7). Such
receptors are predicted to exhibit broad ligand-binding spec-
ificity for molecular structures common among microbial
pathogens. Thus, they may mediate the self/nonself discrim-
ination required to initiate and regulate innate host-defense
responses (2). Macrophage-specific class A scavenger recep-
tors (SR-A) are characterized by broad polyanionic ligand-
binding specificity (16, 17) and, thus, may serve as pattern-
recognition receptors for innate host defense (17, 18). Indeed.
LPS and lipoteichoic acid, which are toxic shock-inducing
surface constituents of Gram-negative and Gram-positive bac-
teria, bind with high affinity to the collagenous ligand-binding
domains of SR-A (14, 15, 18, 19). Scavenger receptors may also
be involved in the recognition of atherogenic lipoproteins (16,
20); the phagocytic clearance of damaged, senescent, or apo-
ptotic host cells (18, 21, 22); and in cell-cell or cell-matrix
adhesive interactions (23).
We have recently demonstrated that Drosophila embryonic
macrophages and the macrophage-like Drosophila Schneider
L2 cell line exhibit a scavenger-receptor activity resembling
that of the mammalian macrophage-specific SR-A (21). We
have now used an expression cloning method to isolate a
cDNAt from L2 cells that encodes a previously unidentified
protein, dSR-CI, which defines a third class of scavenger
receptor. This Drosophila class C scavenger receptor is distinct
from both class A and the recently identified class B (SR-B, ref.
24) mammalian scavenger receptors. dSR-CI is expressed
virtually exclusively in macrophages/hemocytes during embry-
onic development, and its broad polyanionic ligand-binding
properties are almost identical to those of mammalian SR-A.
Nevertheless, there is no significant sequence homology be-
tween SR-A and SR-C. SR-C is a multidomain protein con-
taining several sequence motifs, including the CCP domain,
found in numerous mammalian host-defense proteins.
MATERIALS AND METHODS
cDNA Library Construction and Expression Cloning of
dSR-CI. Poly(A)+ RNA (30 tg) was prepared from Drosophila
Schneider L2 cells as described (25), except that the cells were
homogenized and the DNA was sheared with a Brinkmann
Polytron disrupter (PTIOS probe; three times for 5 s at setting
4). cDNA was synthesized by using an oligo(dT) primer ligated
Abbreviations: dSR-CI, Drosophila macrophage scavenger receptor
class C type 1; LDL, low density lipoprotein: AcLDL. acetvlated LDL:
CCP. complement control protein; DiI-AcLDL, 1,l'-dioctadecyvl-
3.3,3,3'-tetramethylindocarbocyanine perchlorate-labeled AcLDL:
SR-A, macrophage scavenger receptor class A.
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to phosphorylated BstXI linkers [pCTTTAGAGCACA and
pCTCTAAAG (Research Genetics, Huntsville, AL)], size-
selected into either >1.5-kbp or >2.0-kbp fractions, and
ligated into the BstXI site of the expression plasmid pcDNAI
(Invitrogen) (26). DNA pools (1600-4000 clones per pool)
from transformed MC1061/p3 cells (Invitrogen) were trans-
fected into COS-M6 cells, the transfected cells were visually
screened for uptake of fluorescent 1,1'-dioctadecyl-3,3,3',3'-
tetramethylindocarbocyanine perchlorate-labeled acetylated
low density lipoprotein (Dil-AcLDL), and a single clone
(SOo24.11c) was isolated from one positive pool, all as de-
scribed (24, 27). This clone, designated pdSR-CI, was se-
quenced on both strands by using the Sequenase 2.0 (United
States Biochemical) and the GIBCO/BRL PCR-based se-
quencing kits. Sequence comparisons and data-base surveys
were performed with the Genetics Computer Group sequence
analysis software package (versions through 7.3) (28), and
BLAST from the National Center for Biotechnology Informa-
tion (29). RNA blot analysis of L2 and Kc poly(A) ÷ RNA (30)
was performed with a full-length PCR-amplified dSR-CI
cDNA.
In Situ Hybridization to Drosophila Embryos. Clone p6-5,
which contains the 5'-terminal 815 bp of the dSR-CI cDNA,
was constructed as follows. pdSR-CI was double-digested with
EcoRV and Xba I and blunted with the Klenow fragment; the
large vector-containing fragment was purified and recircular-
ized. Two digoxigenin-labeled RNA probes were generated
from Apa I (sense strand)- and Spe I (antisense strand)-di-
gested p6-5 DNA by in vitro transcription from the phage T7
(sense) and phage SP6 (antisense) promoters by using digoxi-
genin-dUTP (Genius 2.0 DIG RNA labeling kit; Boehringer
Mannheim). Canton S strain embryos (0-16 hr) were collected
and processed, in situ hybridizations were performed, and the
embryos were staged, all as described (31, 32).
Cell Culture. Cells were maintained at 370 C in a humidified
5% C0 2/95% air incubator (mammalian cells) or at 25°C in
tightly capped flaskettes (Drosophila cells). Wild-type CHO
cells were grown in medium A (Ham's F-12 supplemented with
PSG (100 units of penicillin per ml, 100 ig of streptomycin per
ml, and 2 mM glutamine) and 5% (vol/vol) fetal bovine
serum), COS-M6 cells in medium B (Dulbecco's modified
Eagle's medium supplemented with PSG and 10% fetal bovine
serum), Drosophila Schneider L2 cells in medium C (Schnei-
der's medium supplemented with PSG and 10% heat-inac-
tivated fetal calf serum), and Drosophila Kc cells in medium D
(D22 medium supplemented with PSG without glutamine).
CHO[mSR-AII] cells, which express murine SR-A type II (33),
were grown in medium E [medium A containing 0.5 mg of
geneticin (G418; GIBCO) per ml]. A stable transfectant (clone
2.6a) expressing dSR-CI, designated CHO[dSR-CI], was iso-
lated by transfecting 1 x 106 CHO cells with 0.5 Ag of pSV2neo
and 9.5 jgg of pdSR-CI by the Polybrene method (30, 34),
selecting transfectants in medium E, and cloning a receptor-
positive (uptake of 1 Mg of protein per ml of Dil-AcLDL)
colony by dilution plating (34).
Assays and Reagents. Scavenger receptor activities in mam-
malian cells at 4°C (measured in six-well dishes) and 370C
(24-well dishes) and in Drosophila L2 cells at 25'C were
determined as described (21, 33, 35). Cell surface binding of
-'I-labeled acetylated low density lipoprotein (I 2I-AcLDL) (2
hr, 4°C) and its binding plus internalization (5 hr, 37'C) are
expressed as ng of cell-associated t25 1-AcLDL protein per mg
of cell protein. Degradation activity is expressed as ng of
1"-I-AcLDL protein degraded in 5 hr per mg of cell protein.
Protein determination was by the method of Lowry et aL (36).
For competition experiments, cells were incubated with 125I-
AcLDL for 5 hr in the absence (triplicate incubations) or
presence (duplicates) of competitor during the assays. Stock
solutions of competitors [e.g., laminarin (Sigma)] were pre-
pared in Dulbecco's complete phosphate-buffered saline
(4-10 mg/ml). These and other reagents (e.g.. sodium butyrate
from Pfaltz & Bauer) were obtained and/or prepared as
indicated or as described (21, 24, 35).
RESULTS AND DISCUSSION
To identify the gene responsible for the macrophage scavenger
receptor-like activity in Drosophila Schneider L2 cells, we
prepared a cDNA expression library from L2 cell poly(A) ÷
mRNA, divided the library into small pools, transfected the pools
into COS-M6 cells, and visually screened the transfected cells for
endocytosis of fluorescent DiI-AcLDL. A single receptor-
positive pool was identified (-350,000 clones screened) and was
subdivided repeatedly to obtain a single functional plasmid
(designated pdSR-CI for plasmid encoding Drosophila scavenger
receptor class C, type I)-[for nomenclature, see Acton et aL
(24)]. Northern blot analysis of poly(A) ÷ RNA showed that the
dSR-CI message (-2.1 kb) was expressed in receptor-positive
L2 cells at a level >50-fold higher than that in scavenger
receptor-negative Drosophila Kc cells (not shown).
A CHO cell line stably transfected with pdSR-CI, CHO-
[dSR-CI], was generated. These cells exhibited at 4°C (Fig. 1A)
high-affinity, saturable t'"I-AcLDL binding (Kd - 2 jig of protein
per ml) and at 370C (Fig. 1B) high-affinity, saturable binding plus
internalization and degradation (Kd 5.5 Mjg of protein per ml).
The degradation of bound and internalized '25I-AcLDL by CHO-
[dSR-CI] cells, which was chloroquine-sensitive (not shown) and
thus presumably lysosomal, was more efficient than that in
Schneider L2 cells (21). This difference may be due to differences
in the assay conditions (e.g., temperature, medium) or in the
fundamental properties of the cultured cells. The affinity of
dSR-CI for t' 5I-AcLDL was comparable to the affinities of the
receptors in Drosophila Schneider L2 cells and of mammalian
SR-A (21, 38, 39). Thus, CHO[dSR-CI] cells express a scavenger
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FIG. 1. Concentration dependence of 'I51-AcLDL interaction with
CHO[dSR-CI] cells at 4°C and 37'C. expressed as ng of cell-associated12 51-AcLDL protein per mg of cell protein. On day 1. CHO[dSR-CI]
cells were plated in medium E into either six-well dishes (125,000 cells per
well) (A) or 24-well dishes (60.000 cells per well) (B). On day 3. the
indicated amounts of 1251-AcLDL in medium A were added and binding
for 2 hr at 4°C (A) or binding plus internalization and degradation for 5
hr at 37'C (B) were determined. The high-affinity values shown represent
the differences between measurements made in the absence (duplicate
incubations) and presence (single incubations) of excess unlabeled
AcLDL (400 jig protein per ml). Untransfected CHO cells exhibit
virtually no scavenger receptor activity (37).
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receptor-mediated endocytic pathway that is similar to those of
L2 cells and mammalian macrophages (16, 17, 21, 38, 39).
A hallmark of SR-A and L2 cell scavenger receptors is their
broad polyanion binding specificity, usually assessed by mea-
suring inhibition of 2"SI-AcLDL binding and subsequent up-
take and degradation (16, 18). Using such an assay, we found
that numerous SR-A polyanionic ligands, in addition to
AcLDL itself, were effective inhibitors/competitors of 12'I-
AcLDL degradation by both CHO[dSR-CI] and L,2 cells.
These included the modified protein M-BSA (maleylated
bovine serum albumin), the four-stranded polynucleotides
poly(I) and d(A5G37 ), and the polysaccharide dextran sulfate.
At concentrations of 400 .g/ml [100 Cgg/ml for d(AsG 37)], they
all reproducibly inhibited scavenger receptor activity by >85%
in both cell types. Furthermore, all were high-affinity com-
petitors for both cell types: their concentrations that gave
half-maximal inhibition ranged from -0.1 to 5 jg/ml (data not
shown). As with SR-A, single-stranded dA37 (100 Ag/ml) and
unmodified LDL and BSA (400 tg/ml) did not compete
(<15% inhibition). Surprisingly, poly(D-glutamic acid) inhib-
ited dSR-CI (see below), although it is not an SR-A inhibitor
(16, 17). These results suggest that expression of dSR-CI could
account for L2 cell-scavenger receptor activity.
While there were many similarities in the scavenger receptor
activities of CHO[dSR-CI] and L2 cells, two notable differ-
ences were observed. First, the apparent Ki values for poly(I)
and d(A5G 37) were lower by a factor of - 10 for CHO[dSR-CI]
than for L2 cells. Second, poly(D-glutamic acid) inhibited both
cell types with relatively high affinities (apparent Ki values 5
25 jig/ml) but with substantially different maximal levels of
inhibition (measured with 400 jg/ml). While poly(D-glutamic
acid) inhibited most of the t1I-AcLDL degradation by CHO-
[dSR-CI] cells (75%), it inhibited only about 20% of the activity
in L2 cells. These disparities between the CHO[dSR-CI] and L2
cells may be due to differences in the assay conditions or in the
properties of the receptors expressed in dissimilar cells from
different species. Alternatively, they raise the possibility that L2
cells may be like mammalian macrophages (17) and express
multiple types of scavenger receptors, some of whose specificities
may differ from that of dSR-CI [e.g., insensitive to poly(D-
glutamic acid)].
Because of the broad polyanion specificity of CHO[dSR-CI]
and L2 cell scavenger receptor-mediated 'I5 -AcLDL degra-
dation, it was surprising to find that laminarin, an uncharged
(031-3)-linked D-glucose polymer, was also a highly effective
inhibitor (apparent Ki values - 2 and 6 Ag/ml, respectively;
>85% inhibition at 400 jg/ml). In contrast, dextran (400
jig/ml), another uncharged glucose polymer, did not inhibit
'
25I-AcLDL degradation (not shown). The mechanism of
laminarin inhibition of dSR-CI activity and its relationship to
laminarin-induced immune responses in cultured Drosophila
cells (12) have not yet been established.
The 2032-bp dSR-CI cDNA encodes a 629-residue polypep-
tide (Fig. 2A). It has a 39-bp 5' untranslated region with an
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FIG. 2. Predicted protein sequence and domain organization of dSR-CI in single-letter code. (A) The cDNA for dSR-CI was cloned and
sequenced. The predicted protein sequence is numbered from -20 for the first in-frame methionine in the putative signal sequence: the first residue
(arginine) after the predicted cleavage site (40) is designated + 1. Cysteines are boxed, and potential N-linked glycosylation sites are underlined.
Potential phosphorylation sites in the cytoplasmic domain (IX) are indicated [*, casein kinase II (41): t. protein kinase C (42): A. cAMP/cGMP-
dependent protein kinase (43, 44)]. The protein is divided into nine domains, some of which belong to previously described motif families (see text).
Consensus sequences for those motifs are indicated below the corresponding sequences in dSR-CI. The CCP consensus sequence is that of Perkins
et aL (45). We generated the MAM and somatomedin B consensus sequences from 13 MAM sequences (7 independent sequences and 6 sequences
of homologs from different species). and 15 somatomedin B sequences (8 independent sequences from 6 proteins, and 7 sequences of homologues).
MAM consensus criteria were as follows: single amino acids or combinations with aromatic (7r = F. W. Y). hydroxyl (o = S. T), or positive or negative
(+ = H. K, R; - = D, E) side chains must be present in -5 independent sequences: aliphatic (a = A, V. L, I) or charged (c = +. -) residues,
in -6; and hydrophobic residues (h = a, 7, M). in all 7. At positions in which only two amino acids occur in at least 6 of the sequences, both are
shown. Somatomedin B consensus residues occur in 25.67 of the 8 independent sequences. For these calculations, residues were assigned an
appropriate fractional occupancy weight when they occurred in a sequence represented by several species homologues. The MAM consensus
sequence differs somewhat from that assembled by Beckmann and Bork (46) when fewer cloned sequences were available. (B) Schematic diagram
of the domain structure of dSR-CI. The signal sequence (Sig Seq), CCP, MAM, somatomedin B (Som B). spacer (Sp). Ser/Thr-rich putative
O-glycosylated (Ser/Thr), transmembrane (TM), and cytoplasmic (Cyto) domains and the potential N-linked glycosylation sites (ball and stick
symbols) are indicated. The domains are numbered as in A.
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in-frame stop codon 15 bp upstream of the putative initiator
methionine and a 106-bp 3' untranslated region containing a
poly(A) signal 84 bp downstream of the termination codon.
The predicted dSR-CI protein is a multidomain type I trans-
membrane protein (Fig. 2B) that has no significant homology
to the mammalian SR-A or SR-B molecules (24, 33). Its
N-terminal 20 residues (Fig. 2A) represent a putative signal
sequence, which is followed by a 609-amino acid (67.6 kDa)
mosaic protein comprising nine domains with six potential
N-linked glycosylation sites (underlined in Fig. 2A). Domains
I (54 residues) and II (53 residues) (Fig. 2A) are members of
the CCP family of domains (10). Their sequences conform to
the overall CCP consensus sequence (69% and 65% identities,
respectively) about as well as other randomly selected CCP
sequences (not shown). Over 160 CCP domains have been
found in more than 30 proteins, including many complement
proteins (e.g., C1r, C2, DAF, CRI), and other proteins in
vertebrates [e.g., clotting factors, selections (47), proteoglycans
(48)] and invertebrates [the Drosophila hikaru genki gene
product (49) and Limulus coagulation factor C (8)]. In many
cases, these -60-residue domains participate directly in bind-
ing interactions with other proteins. It is possible that the CCP
domains in dSR-CI, which apparently are projected signifi-
cantly out into the extracellular space (Fig. 2B and see below),
may play a role in ligand binding.
Domain III (185 residues) is the first known invertebrate
member of the MAM family of extracellular domains (initially
named for Meprin, A5 antigen and receptor protein tyrosine
phosphatase Mu) (46), for which no functions have yet been
assigned. A 25-residue spacer (domain IV) separates the
MAM domain from domain V, a 48-amino acid somatomedin
B-like domain (50). This motif was first described as a fragment
of the extracellular matrix molecule vitronectin.
Domain VI is a 129-residue serine/threonine-rich domain,
which, by analogy with other cell surface proteins, such as the
LDL receptor and the mucins, is presumably heavily O-gly-
cosylated and highly extended (51). Threonine and serine
comprise 55% and 12%, respectively, of all amino acids in this
domain, and within an 87-residue subregion (positions 381-
467), they account for 79% of all residues, while lysine,
arginine, and proline compose all but one of the other 18
residues. Thus, this domain is reminiscent of both vertebrate
and Drosophila mucins (52, 53). Unlike these mucins, domain
VI contains no identifiable internal repeat units at the DNA
or protein levels. Based on typical mucin lengths of 2.5 A per
residue (51), domain VI might extend >320 A from the cell
surface. This would significantly project the N-terminal do-
mains (I-V) out into the extracellular space, potentially facil-
itating their interactions with ligands.
The remainder of the protein is composed of a 29-residue
spacer segment (domain VII), a 22-residue putative transmem-
brane domain (domain VIII), and a 64-residue cytoplasmic
domain (IX), none of which show significant sequence simi-
larity to other proteins. The cytoplasmic domain contains
several potential sites for phosphorylation by various kinases(Fig. 2A) (41-44).
To begin to explore the physiological functions of dSR-CI,
we used in situ hybridization to examine its expression during
Drosophila embryonic development (Fig. 3). Throughout the
stages of development examined, the expression pattern of
dSR-CI was essentially identical to the distribution of macro-
phage/hemocytes (54, 55). For example, dSR-CI expression
was seen during developmental stage 10 [4-5 hr after egg
laying (ael)] in the procephalic mesoderm (Fig. 3A), which
gives rise to all of the embryonic macrophages/hemocytes
(55). During stage 11 (5-7 hours ael; Fig. 3B), the stained cells
appeared to migrate posteriorly into the gnathal buds and into
the tail end of the germ band (which is adjacent to the head due
to germ-band elongation) and anteriorly into the head and
clypeolabrum. During stage 12 (7-9 hr ael), germ-band re-
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traction carried the tail region cells to the posterior end of the
embryo (Fig. 3C). In addition, dSR-CI-expressing cells ap-
peared to migrate both posteriorly and anteriorly along the
ventral and dorsal surfaces of the ventral nerve cord (not
shown), so that by late stage 12 (Fig. 3C), punctate single-cell
staining could be seen in the grooves of the ventral nerve cord.
By stages 13/14 (10-11 hr ael, Fig. 3D), stained cells appeared
to have migrated not only throughout the head and tail regions
of the embryo but also around the gut. By stage 11, some
dSR-CI-positive cells were found in cavities (Fig. 3E), where
macrophages/hemocytes accumulate (55, 56). In later stages,
stained cells, rather than being integrated into defined tissues,
were found scattered throughout the hemocoel. Here, mac-
rophages/hemocytes both deposit extracellular matrix (54)
and phagocytose apoptotic cells (32, 55, 56). Expression of
dSR-CI precedes the onset of apoptosis in stage 11 (ref. 56).
Finally, we observed that dSR-CI was expressed in multive-
sicular macrophage-like cells, which presumably contained ap-
optotic corpses (Fig. 3F and refs. 55 and 56). Therefore, we
FIG. 3. Expression of dSR-CI mRNA in Drosophila embryos. In
situ hybridization in embryos was performed with a digoxigenin-
labeled dSR-CI antisense RNA probe as described in text and was
visualized with Nomarski optics. The stage ("St.") of embryonic de-
velopment is indicated. cl, clypeolabrum; gb. germ band: pm. procephalic
mesoderm; vnc. ventral nerve cord. (Bars in E and F = 10 Atm.)
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conclude that dSR-CI expression in embryos is primarily, if not
exclusively, restricted to macrophages/hemocytes. Occasionally
we observed unstained cells with a macrophage-like morphology.
It is not clear whether this was due to low sensitivity of the staining
assay or to the presence of a distinct population of dSR-CI-
negative macrophages.
The broad polyanionic binding specificity, mosaic structure,
and macrophage/hemocyte-specific expression of dSR-CI sug-
gest that this receptor may participate in a variety of macro-
phage/hemocyte functions. These include host defense (e.g.,
pathogen recognition and phagocytosis) (3, 7, 18, 21), cell-cell
or cell-matrix adhesion (18, 54), wound healing (4, 5), and
possibly recognition and clearance of apoptotic and senescent
cells (18, 21, 22, 56). Macrophage scavenger receptors, such as
dSR-CI, are attractive candidates for the pattern-recognition
receptors that help confer the polyspecificity and self/nonself
discrimination required for innate immunity in both verte-
brates and invertebrates (2, 3, 7, 18, 21). Furthermore, the
presence of CCP domains in dSR-CI places this receptor in a
superfamily of proteins, many of which are involved in verte-
brate and invertebrate host defense. It should be useful to
determine if there are vertebrate homologues of dSR-CI and
if there are additional classes of scavenger receptors in inver-
tebrates (e.g., homologues of mammalian SR-A and SR-B).
The application of genetic techniques available in Drosophila,
along with additional molecular and physiologic studies,
should provide a powerful approach for the investigation of
scavenger receptor structure and function.
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Appendix C
The SRCR superfamily: a family reminiscent of the Ig
superfamily
(As published in Trends in Biochemical Sciences (1994) 19, 5 - 8.)
-- page 190 --
The paper presented in this appendix, of which I am the second author, describes the
Scavenger Receptor Cysteine Rich (SRCR) domain superfamily of proteins. The first
known SRCR domain was defined by the C-terminal sequence of the class A, type I
mammalian macrophage scavenger receptors. The domain has since been found in
more than one dozen other proteins, many of which are expressed by cells of the
immune system (see also Resnick, 1996). The first known function for an SRCR
domain has recently been described (Bowen et al, 1996) - mediating the binding of the
SRCR domain-containing protein CD6 to its Ig domain containing ligand, the activated
leukocyte cell adhesion molecule (ALCAM). The primary author of this paper was
David Resnick. My contribution to this work was limited to assisting with the amino
acid sequence alignment of the SRCR domains and recognizing the higher-order
repeat structure of SRCR domains in the WC1 and M130 proteins, as described
herein.
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The SRCR superfamily: a family
reminiscent of the Ig superfamily
Many proteins are molecular mosaics
composed of a wide variety of con-
served sequence motifs which com-
prise structurally distinct domains'. In
many cases, these motifs are charac-
terized by short, disulfide-stabilized do-
mains present in the extracellular por-
tions of membrane proteins and in
secreted proteins' -2. Examples include
the immunoglobulin repeat34, kringle
domains, epidermal growth factor
(EGF)-like repeats, complement C9/LDL-
receptor domains, Ly-6 repeats56 and
the P-domain 7. These domains are well
suited for a variety of biochemical tasks,
including ligand binding, and are readily
combined with themselves or with
other types of domains for the con-
struction of complex mosaic proteins.
Proteins containing as few as one and
as many as 36 copies of any one single
type of domain have been reported"9.
One ancient and highly conserved
family of cysteine-rich protein domains
was recognized during the analysis of
the structure of the type I macrophage
scavenger receptor'0". This class of
domain, designated the SRCR (scavenger
receptor cysteine-rich) domain, was in-
itially defined by the presence of one to
four copies per polypeptide chain of an
approximately 101-residue motif in the
type I scavenger receptor, the speract
receptor, CD5/Lyl and complement fac-
tor I (CFI) (a total of 13 sequences,
including nine independent sequences
and four sequences of homologs from
different species). The recent cloning of
genes encoding 24 additional, indepen-
dent SRCR domains, and ten additional
homologs, has allowed us to revise our
initial description of the consensus
SRCR domain and to define two distinct
subgroups. The recently available
sequences, which were identified using
the programs BLASTN and TBLASTN 12,
are those of CD6 (Ref. 13), the
cyclophilin-C-binding protein' 4 and its
homolog the MAC2-binding protein'5
(CyCAP/MAC2-bp), the WCI antigen'6,
M130 (Ref. 17), a new CR homolog
(EMBL accession No. S15468), and two
new homologs each of CD5/Lyl (Refs
18, 19) and the scavenger receptor2 0' 21.
Thus, the superfamily of SRCR-domain-
containing proteins includes eight dif-
ferent members derived from five mam-
malian (human, bovine, murine, rat and
rabbit), one amphibian (Xenopus laevis)
and one invertebrate (sea urchin)
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species (Table D). The sequences of the
SRCR domains are shown in Fig. 1.
An alignment of all 33 independent
SRCR domains (total of 47 sequences)
is shown in Fig. 1. Positions at which
there is greater than 50% sequence
identity are shaded. To simplify the
sequence comparisons, we have divided
the SRCR superfamily into two groups,
A and B, based primarily on the differ-
ences in the spacing pattern between
their cysteine residues (Fig. 2). All of
the group A domains contain six cys-
teines, while most of those in group B
have eight cysteines. Although several
members of group B contain only six
(WCI-1, M130-8, CD5-2 and bovine
CD5-1) or seven (CD6-1) cysteines, the
presence of cysteines at the C' and C'
positions and other sequence features
clearly suggest that they are members
of group B.
Independent consensus sequences
for groups A and B, as well as a com-
bined overall consensus sequence, are
shown at the top of Fig. 1. The overall
consensus sequence includes residues
at 41 out of 101 possible positions. The
principle differences between the group
A and B sequences are: (1) cysteines
are not present at sites C' and C4 in
group A (aromatic residues almost
invariably replace the C4 cysteines) and
(2) group B contains a conserved
glycine adjacent to the C4 position and
a moderately well-conserved trypto-
phan two residues before position C6
which are not found in group A.
Table I. Proteins containing SRCR domainsa
Number of SRCR
Protein (abbreviation) domains per chain Source Functions Location
Macrophage scavenger 1 Mammalian Binding and endocytosis Cell surface
receptor, type I (MSR) macrophages of diverse ligands
Cyclophilin C (CyCAP) or MAC2 1 Murine bone marrow stromal Binds cyclophilin C and MAC2, Secreted fluids,
binding protein (MAC2-bp) cell line, murine macrophages a lactose/galactose-specific lectin e.g. breast milk.
and human breast carcinoma cells tears, plasma
Speract receptor 4 Sea urchin sperm Binds speract, a sperm- Cell surface
(SperactR) activating peptide
Complement factor I (CFI) 1 Mammalian and amphibian plasma Protease, regulation of the Secreted into
complement cascade plasma
WC1 11 Mammalian CD4-, CD8-, gd T cells Unknown Cell surface
M130 9 Human macrophages Unknown Cell surface
CD6 3 Mammalian T cells and son1 Unknown Cell surface
specia.ized B cells
iCD5 3 Mammalian T cells and some Binds CD72, a B-cell Cell surface
specialized B cells surface protein
"Adapted from Ref. 26.
© 1994, Elsevier Science Publishers. (UK) 0968-0004/94/$07.00
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Overall Consensus aRL. ... G. 
Group A Consensus aRLa... G..
Group B Consensus aRL....G..
Cys Consensus #
MSR-b VRLV. .GGSG
MSR-h VRLV..GGSG
MSR-1 VRLV. .GGRG
MSR-m VRLV. .GGSG
CyCAP-h MRLV. .NGAS
MAC2bp-m MRLA . DGGA
SperacR-1 IRLI .. HGRT
SperactR-2 LRMI. .LGDV
SperactR-3 IRLM..DGSG
SperactR-4 VRIV.. .GMG
CFI-h VSLK. .HGNT
CPI-x PTLT.QNGEP
WCl-1 LiLK. .DGVH
WC1-2 VRLA..GGDG
WC1-3 VRLMT.NGSS
WC1-4 LRLV. .DGGG
WC1-5 LRMVSED..Q
WC1-6 IRLV .,DGGG
WC1-7 VRLA..GGDG
WC1-8 VQLMK.NGTS
WC1-9 LRLV..DGGG
WCi-10 LRMVSED..Q
WC1-11 LRLR . .GGDS
M130-1 LRLV. .DGEN
M130-2 MRLT.. RGGN
M130-3 LRLV. .DGVT
M130-4 LRLR. GGGS
n130-5 PRLV. .GGDI
M130-6 IRLV. .NGKT
M130-7 LRLV. .NGGG
M130-8 LRLTSEASRE
M130-9 IRLQ. .EGPT
CD6-1 VRLT. .NGSS
CD6-2 LRLV. . DGGG
CD6-3 WRLT. .GGAD
CD5-lh ARLT. .RSNS
CDS-lb MRLS. .GSGS
CD5-1r VMLS..GSNS
CDS-m VMLS. .GSNS
CD5-2h LVAQ. .SGGQ
CD5-2b LVAE. .PGGL
CD5-2r LVPG. HEGL
CD5-2m LVPG. HEGL
CD5-3h SRLV..GGSS
CD5-3b SRLV. .GGSD
CD5-3r SRLV. .GGSS
.. DS5-3m SRLV. .GGSS
... G.VEa.. ... WG..oaC ±..W ...... ...... A.Va C+.LGC...A .. h....... h.h......a ha..h.C.G.
..EG.VEah. ... WG ... aC -.. W...-.. ...... A.VV C+.aGx..GA .. a....... .. FG.... Ph ha..a.C.G.
.C.G.VEa.. .G.WG..oaC ±..x.a.... ...... A.Va C+QLGCG..A a.h....... a.h......a Wh..h.C.G.
1 2 3 4 5
.HEGRVEIFH
.HEGRVEILH
.HEGRVEILH
AHEGRVEIFH
ANEGRVEIFY
TNQGRVEIFY
ENEGSVZIYH
.NEGTLBTFW
.HEGRVEIWH
QGQGRVEVSL
DSEGIVBVKL
.GKGIIKVKL
RCEGRVEVKH
PCSGRVEVHS
QCEGQVEMNI
PCAGRVEILD
QCAGWLEVFY
RCSGRVEILD
PCSGRVEVHS
QCEGQVEMKI
PCGGRVEILD
QCAGWLEVFY
ECSGRVEVWH
KCSGRVEVKV
MCSGRIEIKF
ECSGRLEVRF
RCAGTVBVEI
PCSGRVEVKH
PCEGRVELKT
RCAGRVEIYH
ACAORLEVFY
SCSGRVBIWH
SCSGTVBVRL
ACAGRVEMLE
RCEGOVBVHP
KCQGQLEVYL
RCQGRLEVSN
KCQGLVEVQM
KCQGQVEIQM
HCAGVVEFYS
RCAGVVEFPYS
RCTGVVEFYN
RCTGVVEFYN
ICEGTVEVRQ
VCEGSVEVRS
VCEGIAEVRQ
VCEGIAEVRQ
EGQWG. .TVC
SGQWG..TIC
NGQWG..TVC
QGQWG..TIC
RGRWG. .TVC
RGQWG..TVC
ATRWG. .GVC
DGAUG..SVC
DDAWG..TIC
GNGWG..RVC
VDQDKTMFIC
PTFEQELPLC
QGEC. .TVD
GEAWI. .PVS
SGWR. .ALC
QGSWG..TIC
NGOTW. .SVC
QGSWG. .TIC
GEAWT..PVS
SGRWR. .ALC
QGSWG .TIC
NGTWG .SVC
NGSWG. .TVC
QEEnG .TVC
QGRWG. .TVC
QGEG. .TIC
QRLLG .KVC
GDTWO. .SIC
LGAWG. .SLC
EGSWG .TIC
NGAW. .TVG
GGSWG..TVC
EASWE .PAC
HGEWG..SVC
RGVWN. .TVC
KDGWH. .MVC
GTEWY. .AVH
NG.MK. .TVC
ENKWK. .TVC
.GSLG.GTIS
.GGLG.GTIG
.GSRG.GTIL
.GSWG.GTIL
GAQWA. .ALC
GKGQKWDTLC
RSQWA..ALC
RSQWE. .ALC
DDRWELRG..
DDRWEVRV..
DDHWELRA..
DDRWDIRA..
DNLWNLLD. .
DNLWDLTD..
DWWWHMEN..
HTDPGT.D..
DDGWDWAD..
DD.MSDHE..
KSSWSnRE..
GKQWSNRE..
GYRNTLKD..
DGNPTLAT..
ASHWSLAN..
DDGWDLDD. .
RNPMEDIT..
DDRWDLDD..
DGNFTLPT..
ASHWSLAN..
DDDMDLDD..
RSPMEDIT..
DDSWSLAE..
NNGWSMEA..
DDNFNIDH..
DDGWDSYD..
DRGWGLKE..
DSDFSLEA..
NSHWDIED..
DDSWDLSD..
KSSMSETT..
DDSWDLDD..
GALWDSRA..
DDTWDLED..
DSEWYPSE..
SQSWGRSSKQ
SQSWGQLSLY
SSSWRLSQDL
SSSWRLSQDH
YEAQDKTQDL
IEPQNDIKDL
YKAKARPVDL
YKAKDRPLGL
DSSSARSSLR
DDSWAKGTAR
DSSAARGPGR
DSSAARGRGR
: ..... GLVV CRSLGYK.GV
...... GQVV CRSLGYP.GV
...... GQVV CRSLOYR.GV
...... GQVV CRSLGYQ.EV
...... AHVV CRALGYE.NA
...... ASVV CRALGFE.NA
..... ANVT CKQLGFP.GA
...... GNVA CRQMOYSRGV
...... ANVV CROAOYR.GA
...... AKTV CYNAGYKWGA
...... ANVA CLDLGFOQQGA
...... ANYVV C~QLGSTIGA
...... ASVV CRQLGCGA.A
...... AQI CAELGCGK.A
...... ANVI CRQLGCGV.A
...... ARVV CRQLOCGE.A
...... VSTI CRQLOCGD.S
...... ARVV CKQLGCGE.A
...... AQVI CAELGCGK.A
...... ANVV CRQLGCOV.A
...... ARVV CRQLGCGE.A
...... VSVI CRQLGCGD.S
...... AEVV CQQLGCGQ.A
...... VSVI CNQLGCPT.A
...... ASVI CRQLECOS.A
...... AAVA CRQLGCPT.A
...... ADVV CRQLGCGS.A
...... ASVL CRELQCGT.V
...... AHVL CQQLKCGV.A
...... AHVV CRQLGCOE.A
...... VGVV CRQLGCAD.K
...... AQVV CQQLGCGP.A
...... AEAV CRALGCGG.A
...... AHVV CRQLGCGW.A
...... AKVL CQSLGCOT.A
WEDPSQASKV CQRLNCGVPL
QVAPRQFLKL CQELQCRDPL
WKNANEASTV CQQLGCGNPL
SKNAQQASAV CKQLRCGDPL
E......NFL CNNLQCGSFL
G...... QL CAALQCGSFL
G......NLI CKSLQCGSFL
G......NLI CKSLQCGSFL
W ...... EEV CREQQCGSVN
R......VEV CREQQCGNVS
W ...... EEL CQEQQCGNL.
W ...... EEL CREQQCGDL.
QSVH . . .KR
QAVH .... KA
KSVH....KK
LAVH.... KR
TQAL. .. .GR
TQAL....GR
RQFY . . .RR
KSIK....TD
VKASGF..KG
SRAAGSAEVS
DTQR... .RF
DASASD. .KV
IGFP.... GO
VSVL....GH
ISTP... .GO
LNAT....GS
GTLN.... SS
LDAT....VS
VSVL....GH
ISTP.... RG
LNAT....GS
GSLN... TS
LEAV....RS
IKAP....GW
VSPS....0GS
VTAI....GR
LKTS....YQ
VSIL....GGO
LSTP....GG
INAT....GS
GKIN... .PA
LKAF....KE
EAAS. ...QL
VQAL....PG
VERP....KG
..........
........ LL
..........
..........
..........
..........
..........
..........
..........
..........
..........
. . . . . . . . . .
AYFGKGTGPI
AHFGQGTGPI
AYPGQGTOPI
AHFGQOGTOPI
AAFGPGKGPI
AAFGQGSGPI
AYPGAHVTTF
GHPGFSTGPI
EDFGFTWAPI
APFDLE.APP
KDLDLSINST
FSLVTEKPPE_
AYIGPGLGPI
ELPRESSAQV
PHLVEEGDQI
AHFGAGSGPI
VALREGFRPQ
SPFGTGSOGPI
MPFRESDGQV
PHLVEGGDQI
AHPGAGSGPI
VGLREOGSRPR
AAFGPONGSI
ANSSAGSGRI
SNPGEGSGPI
VNASKGPGHI
VYSKIQATNT
AHPGEOGNGQI
ARFGKGNGQI
AHFGEGTGPI
SLDKAMSIPM
AEPGQGTOPI
APPTPELPPP
LHPTPGROPI
LPHSL.SGRM
SLGPPLVTYT
SSSRYFKEVQ
ALGHLTLWNR
ALGPFPSLNR
KHLPETEAGR
KPLPETEEAQ
THLSRIETAG
THLSGTEAAG
SYRVLDAGDP
SYRGLDPSEK
ISFHVMDADR
ISPHTVDADK
WLNEVFCFGK
NLNEVFCFGR
WLNEVPCLGM
WLNEVMCFGR
MLDEVECTGT
MLDEVQCTGT
WVYKMNCLGN
ILDAVDCEGT
HTSPVMCTOV
IIDGITCSGV
ECLHVHCRGL
HCIQATCRGL
VLLYTSCEGT
WAEEFRCEGE
LTARFHCSGA
WLDNLNCTGK
WVDRIQCRKT
WLDEVNCRGE
WAEEFRCDGG
STAQFHCSGA
WLDDLNCTGK
WVDLIQCRKM
WLDEVQCGGR
WMDHVSCRGN
WFDDLICNGN
WLDSVSCQGH
WLFLSSCNGN
WAEEFQCEGH
WRHMFHCTGT
WLDEMKCNGK
VVDNVQCPKG
WLNEVKCKGN
PAAGNTSVAA
HRDQVNCSGA
Y...YSCNGE
POSSIICYGQ
FQKLIICHGQ
PKNQILCQGP
PQNQVFCQGS
AQDPGEPREH
TQKP...EGQ
TPAPAELRDP
TPAPAELRDP
TSRGLFCPHQ
TLGGFYCPPG
TSPGVLCTQE
TSPGFLCAQE
The sequences of the SRCR domains
in CFI and CD5, particularly the CD5-2
domains, are the least well-conserved
members of the superfamily, and are
responsible for much of the gapping
seen in the alignment (Fig. 1). In the
case of CD5-2, although the amino-ter-
minal half of this SRCR domain clearly
conforms to the consensus sequence,
most of the residues in the carboxy-
terminal half of the domain differ sub-
stantially from the consensus (Fig. 1).
Because of this lack of sequence homol-
ogy, we did not attempt to align two of
the three cysteines in the carboxy-
terminal half of CD5-2 with the con-
sensus cysteine positions; any par-
ticular alignment would be somewhat
arbitrary. Because the CFI and CD5
sequences played important roles in
the initial analysis of the SRCR
domain'o, the alignment of sequences
and the definition of the SRCR con-
sensus shown in Fig. I differ from those
proposed previously.
All but one of the 33 independent
SRCR domains have six or eight cys-
teines. Analysis of the structure of the
type I macrophage scavenger recep-
6
torn suggests that some, and possibly
all, of its SRCR domain's cysteines
participate in intradomain disulfide
bonds. Furthermore, the cysteines in
CyCAP/MAC2-bp do not participate in
intermolecular disulfide bonds 14,15.
Based on the known structures of other
cysteine-containing domains (such as
immunoglobulin, kringle, Ly-6 repeat, P-
domain), we assume that in most SRCR
domains the conserved cysteines par-
ticipate in intradomain disulfide bonds.
The pattern of cysteine pairing into
disulfides has not been established
experimentally; however, sequence
analysis suggests two likely disulfide
pairs. The cysteines at positions C' and
C' in group B domains may be disulfide
bonded, because this pair of cysteines
is always present in group B but not in
group A (Fig. 2). A similar argument
suggests that the cysteines at positions
C2 and C7 form a disulfide bond. These
cysteines are present in the human,
murine and rat CD5-1 domains but not
in their bovine counterpart. This pair of
cysteines is also absent in WCI-I and
M130-8. On the other hand, in CFI,
WCI-2 and WCI-7, only one member of
this pair is present; the other is appar-
ently substituted by a cysteine at a dif-
ferent site. If these proposed C'-C4 and
C2-C7 pairs are correct, the remaining
two potential disulfide pairs are either
C3-C5 and C6-C8 , C3-C6 and Cs-C s, or
C3-C8 and Cs-C6. It is important to note,
however, that not all of the cysteines
need participate in intradomain disul-
fide bonds, as is clearly the case for at
least one of the seven cysteines in
CD6-1.
A schematic representation of the
known SRCR-domain-containing pro-
teins is shown in Fig. 3. All of the mem-
bers of this group are cell-surface
or secreted polypeptides containing
between one and 11 SRCR domains.
Other than the scavenger receptor tri-
mer", the oligomeric states of these pro-
teins are unknown, although MAC2-bp
forms a large multimer' s. Proteins con-
taining multiple SRCR domains in a single
polypeptide chain have short inter-
domain spacers whose median length
is six residues. Our dendrigraphic 23 and
visual analysis of the sequences of two
such proteins, WCI and M130, revealed
an interesting higher-order repeat,
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E ... a..C.. .... .....
E . L.-C.h ..........
E...aW.C .. ... ......
ESS.IEECRI
ESS .IEECKI
ESS .IEECKI
ESS. IENCKI
ESS.LASCRS
EAS .LADCKS
ETR .LEDCYH
BAH.ITECNM
EDR .LIDCIL
ENETLSQCQM
ETS.LAECTP
ENS.LAECAL
EST.VSDCEH
EPE.LWVCPR
ESF.LWSCPV
ESH.VWRCPS
DTS.LWQCPS
ESQ.VWRCPS
EPE.LWSCPR
ESF.LWSCPV
ESH.VWRCPS
DTS.LWQCPS
ESS.LWDCVA
ESA.LWDCKH
ESA.LWNCKH
EPA.VWQCKH
ETS.LWDCKN
ESH.LSLCPV
EQH.MGDCPV
ESR.IWQCHS
PDT.LWQCPS
ESS.LWDCPA
NAT.LAGAPA
EAY.LWDCPG
ELT.LSNCSW
LGS.FSNCSH
LGS.FSNCSL
PWS.FSNCST
PWS.ISNCNN
QPLPIQWKIQ
RPLPIRWEIQ
RPLPIRWEAQ
RPLPIRWEAP
K...LSQCHE
I.. .LSRCHK
K...LSQCYQ
K...LSQCYH
RQWGVRA...
RQWGTRA ..
RQWGVRV...
NQWGVLS...
LGWMVSR. ..
LGWLKSN...
RPYGRPWL..
PVTPYQHA .
RDGWTHS ..
KVSADMT...
TKRRT ....
RKLP .....
SNIXDYRNDG
VPCGGT...
TALGGPD...
RGWGQHN. ..
DPWNYNS...
WGWRQHN...
VPCPGGT...
TALGGPD...
RGWGRHD...
GPWKYSS...
EPWGQSDo ..
DGWGKHSN..
QGWGKHN...
HEWGKHY ..
WQWGGLT...
APRPEGT...
TALGASL...
HGWGQQN...
SPWEKRL...
RRWGHSE...
LLCSGAEWRL
LP.GQHY...
RFNNSNL...
SRNDNM ....
NRGRQV ...
SSLGQ ....
TSSQDQ....
NSSCTSLENC
NPKCTSLEQC
NGSCTSLQQC
NGSCVSLQQC
LWERNSY...
LEEKKSH...
L.QKKTH...
L.QKKKH...
......... A.VhC.
.. C .... .DAGV.C.
.... C ..... .. A.VhCS
7 8
.... CSHS.. EDAGVTCT
.... CSHG.. EDAGVTCT
.... CSHS.. EDAGVTCT
.... CGHE.. KDAGVVCS
.... CRHE.. RDAGVVCT
.... CNAO.. WAAGVECL
.... CPYTHN WDVGVVCe
.... CYHV.. EDASVVCA
.... CAT... GDVGVVCE
.... nMGYQ.. DPADVVCY
...... QDN.. QVKAYTC
.... YNWG.. RDAGVVCS
....CNS. . GSAQVVCS
.... CSHG.. NTASVICS
.... CRHK.. QDAGVICS
.... CSPK.. EEAYIWCA
.... CNHQ. EDAGVICS
.... CLHS.. GAAQVVCS
.... CSG.. NTASVICS
.... CRK.. EDAGVICS
.... CSPK.. EEAYISCE
.... CKE.. EDAGVRCS
.... CTH.. QDAGVTCS
.... CDHA.. EDAGVICS
.... CNHN.. EDAGVTCS
.... CDHY.. EEAKITCS
.... CSHS.. RDVGVVCS
.... CPSE.. QVASVICS
.... CRHK.. EDAGVICS
.... ASPS.. EETWITCD
.... CGHK.. EDAAVNCT
.....C..... EVVEHACR
.... CGHK.. EDAGVVCS
.... CSQS.. LAARVLCS
.... C ..... HSLGLTCL
.......... DSLALICL
.... C..... LPLSLVCL
....C..... LPLSLICL
FRKIKPQKSG RVLALLCS
FRKVQPWVGG QALGLICS
FQKTTVQEGS QALAVVCS
FPQKTTAQEGG QALTVICS
... .... KKVFVTCQ
....C..... KRVFVTCQ
.... C..... KRVFITCK
.... CN.... KRVFVTCQ
RFgure 1
Comparison of the sequences of 47 SRCR domains from eight proteins. The
sequences were aligned using both the program PILEUP24 and manual adjustment.
Only 33 of the 47 SRCR sequences listed represent independent SRCR domains,
the remaining sequences are homologs from other species (e.g. four species of
scavenger receptor, two species of CR, etc.). Residues are shaded when at least
17/33 independent sites are identical (when there are four homologs, each
sequence contributed 0.25 to the total count; for two homologs, each sequence
contributed 0.5 to the total). Consensus sites are indicated in the top row. Overall
consensus when 222.25 of the 33 positions are occupied by a single amino acid
(capital letter) or a single class of residue [a, aliphatic (A, I, L, V); x, aromatic (F, W,
Y); h, hydrophobic (a, I, M); +, positively charged (H, K, R); -, negatively charged (D,
E); ±, charged (-, +); o, S or T]. Consensus sequences for Group A domains
(24.75/7 sites) and Group B domains (217.5/26 sites) are also shown. A similar,
independently derived, consensus sequence has already appeared' 7. In addition,
the consensus cysteine positions are identified by number. For multiple SRCR
domains in individual proteins, the domains are numbered from the amino terminus.
Abbreviations used are as follows: MSR, macrophage scavenger receptor type I;
CyCAP, cyclophilin-C-associated protein; MAC2bp, MAC2-binding protein; SperactR,
speract receptor; CR, complement factor I; and WC1, WC1 antigen. In the cases
where multiple species homologs are presented, the following abbreviations for
species are used: b, bovine; h, human; m, murine; r, rat; I, rabbit (lapin); and x,
Xenopus laevis.
GroupA 1 25 ý 12
GroupB 9 1 15 12 4 25 9 9 9
FRgwe 2
Consensus spacing of cysteines in group A and group B SRCR domains, based on
the alignment in Fig. 1; the average number of residues between the cysteines is
indicated.
which had previously been identified as
an internal repeat in WCI at the DNA
sequence level16 and was independently
identified in a somewhat different form
by Law and colleagues' 7. This repeat is
defined by a cassette of five SRCR
domains, designated [b-c-d-e-d]. The
amino-to-carboxy-terminal ordering
of the SRCR domains in WCI and
M130 can be represented as follows:
WCI (domains 1-11), a-[b-c-d-e-d]-
[b-c-d-e-d]; and M130 (domains 1-9),
h-i-j-k-[b-c-d-e-d]. The [b-c-d-e-d]
cassette contains an unusually long,
well-conserved, 35-residue spacer
between the c and d domains and
appears three times in highly con-
served, but not identical forms, twice in
WCI and once in M130. Apparently,
WCI and M130 are derived from a com-
mon cassette-bearing ancestor. This
cassette might impart some common
function to these integral membrane
proteins.
The biochemical functions of SRCR
domains have not been established
with certainty; however, it seems poss-
ible that most, if not all, of these
domains are involved with binding to
Scavenger CyCAP/
receptor type I MAC2-bp
Speract
receptor
CFI WCI
antigen
M130 CD6 CD5
Figure 3
Models of proteins in the SRCR domain superfamily. Models illustrating the number and
relative positions of SRCR domains (open circles) in eight proteins are shown. Also shown
are the numbers of cysteines in each domain.
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other cell-surface or extracellular mol-
ecules. In the case of the speract recep-
tor, the SRCR domains form 91% of the
extracellular portion of the molecule,
and thus probably mediate the binding
of its ligand, the sperm-activating pep-
tide speract24. Similarly, the SRCR
domains form most of the extracellular
sequence of CD5, and probably define
the binding site for CD72, the only
known ligand for CD5 (Ref. 27). The car-
boxy-terminal SRCR domain of the type
I macrophage scavenger receptor is not
required for the protein's assembly,
intracellular transport, cell-surface
expression or binding of its known
polyanionic ligands; a second natural
isoform of the scavenger receptor, type
II, is virtually identical to the type I
receptor except that it does not have
the carboxy-terminal SRCR domain".
Thus, in scavenger receptors, the SRCR
domain may impart an additional, but
as yet undefined, binding capacity.
All of the known mammalian SRCR-
domain-containing proteins are ex-
pressed on the surfaces of cells associ-
ated with the immune system and host
defense functions (T cells, B cells and
macrophages) or are secreted and
known or suspected of being involved
with host defense (CFI and CyCAP/MAC2-
bp). This is strikingly reminiscent of the
immunoglobulin superfamily of cys-
teine-containing protein domains. Single
or multiple tandem copies of immuno-
globulin domains also appear in diverse
secreted and membrane-associated pro-
teins. These domains participate in a
variety of binding interactions that play
critical roles in host defense3 '.
Additional studies will be required
to determine the detailed molecular
structures of SRCR domains and their
functions.
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